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The acquisition of protective immunity is essential for survival. Protective itmllunity 
can be divided in innate immunity and acquired immunity. These two parts of the immune 
system have evolved to closely interact (I, 2). Cells of the innate immune system, such as 
dendritic cells and macrophages, recognize potentially hazardous substances by their pariic~ 
ular carbohydrate signature using germline-encoded receptors (3). In addition, innate imlllu-
nity is thought to playa major role during the early phases of the immune response as well 
as in activating and regulating the acquired immune response. Acquired immunity mediates 
antigen-specific ll111l1une responses directed against those antigens selected by the innate 
immune response to be potentially noxious (I). The cells which are essential in effecting the 
acquired immune responses are the Band T lymphocytes. These cells specifically recognize 
foreign antigcns using their antigen receptors, the B ccll rcccptor (BCR) and the T ccll rcccp-
tor (TCR), respectively. These antigen receptors are encoded by genes which are produced by 
somatic gene rearrangement processes (3). The interaction between the two patis of the 
immune system is essential both for the maintenance of immunity (the presence of an 
immune response) towards infectious agents and for the maintenance of tolerance (the 
absence of an immune response) to the body's O\vn tissues. Tolerance can be divided into cen-
tral tolerance, which is implemented during the differentiation of T lymphocytes in the thy-
mus, and peripheral tolerance, which is implemented in the periphery. 
The acquired ill1ll1une response is orchestrated by helper T (Th) lymphocytes, regulat-
ing antibody production by B lymphocytes, clonal expansion of cytotoxic T lymphocytes and 
intracellular killing by macrophages. Th lymphoc)1es differentiate in the thymus from a com-
mon pluripotent precursor. During their thymic differentiation, T cells are selected for their 
ability to recognize non-self antigens presented in the context of major histocompatibility 
(MHC) antigens. This restriction to a non-self-specific TCR repertoire is essential for the 
maintenance of central tolerance. Mature Th cells in the periphery are activated by the cog-
nate interaction with antigen-presenting cclls (APC), such as dendritic cells and 
macrophages, which have internalized (paris of) potentially infectious substances. During 
this interaction, helper T lymphocytes spccifically recognize these antigens in the context of 
the MHC class II molecules presented on the surface of the APC (4). In this way, antigens 
which have beeullon-specifically internalized and degraded by the APe are specifically rec-
ognized by the T cells using their TCR. The activation state of the APC is the decisive factor 
in the outcome of the T cell activation in terms of induction of peripheral tolerance (no 
response is needed) or immunity (an immune response is required). 
During the differentiation from pluripotent progenitor cells in the thymus to mahlre 
naive T cells in the cll-culation and eventually to activated effector cells during an immune 
response, T cells continuously undergo fate decisions until at some POlllt apoptosis is 
induced. At many of these critical moments in T cell differentiation, the cell must be recep-
tive to signals from the environment, ,vhich mediate regulation of the genetic program. 
Thereafter, the coordinated expression of cohorts of genes wilf alter the phenotypical and the 
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functional characteristics of the differentiating T cell. 
The work addressed in this thesis investigates various aspects oftlle regulation ofT cell 
difterentiation and helper T cell-mediated immune responses. Tills introduction will give a 
brief overview of the CUlTent knowledge on T cell differentiation, activation, efiector func-
tions and melllOlY formation. 
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THYMIC T CELL DIFFERENTIATION 
1.1. INTRODUCTION 
T lymphocytes arise from ll1ultipotential bone marrow~derived precursor cells within a 
specialized organ, the thymus. Extrathymic T cell differentiation has been repOlied, but is 
considered to contribute minimally to the peripheral T lymphocyte pool (5, 6). T cells are 
'educated' in the thymus to recognize peptides in the context of MHC molecules and under-
go hvo selection processes. These are known as positive selection (selection for .MHC-
restricted recognition of antigens) and negative selection (selection against recognition of 
self-peptides) (7-10). In order to avoid reactivity to self, T cells recognizing self-peptides in 
the context of lvlHC are clonally deleted (negatively selected) during T cell differentiation 
(11-14). Only a small proportion of all T cells are positively selectcd and will eventually sur-
vive to mature T lymphocytes. Generally, positive and negative selection arc thought to result 
from the samc MHC/Ag-TCRn!l interaction (15,16). 
In addition to the processes of positive and negative selection, developing T cells also 
enter a difierentiative program resulting in the cOll1lllitment of the T cell into one of the two 
distinct lineages of lvlHC class 1- or MHC class II-restricted T lymphocytes. lvlHC class I 
recognition will result in the formation ofCDS+ T lymphocytcs, thc cytotoxic T cells (17, IS). 
Recognition of MHC class II will result in thc formation of CD4+ T cells, thc helper T cells 
(19,20). This differentiative program results in the selective expression of the appropriate 
coreceptor gene, and is known as lineage commitment (21). The process of lineage commit-
ment is thought to be regulated independently of positive selection (22). Lineage commitment 
ensurcs the functional competence of mature T cells: CD4+ T cells recognize MHCJlIpeptide 
complexes presented on APC whereas CDS+ T cells recognize lvlHCIIpeptide complexes prc-
sented on all cells of the body (23). Fully matured CD4+ and CDS+ T cells will enter the 
periphery, and, as recent thymic emigrants, they contribute to the naive peripheral T cell pop-
ulation. 
1.2. STAGES OF T CELL DIFFERENTIATION AND SELECTION PROCESSES 
IN THE THYMUS 
T cells differentiating in the thymus are phenotypically distinguished by the expression 
of CD4 and CDS coreceptors. T cclls are cither double negative (DN). double positive (DP) 
or single positive (SP) for these two cell-surface antigens (figure I; adapted from 16). 
Upon enhy into the thymus, the bone marrow-derived progenitor cell is at the DN stage. 
The DN population is generally subdivided into four distinct subsets, defined by differential 
expression of the alpha chain of the interleukin 2 receptor (IL-2Ra; CD25) and phaliocyte 
glycoprotein-l (PGP-l; CD44) (24). At the most immature stage, the precursor cells express 
CD44, but not CD25. These so-called thymic lymphoid progenitor (TI.P) cells maintain the 
capacity to differentiate into all lymphoid lineages: B lymphocytes, T lymphocytes, NK cells 
and lymphoid dendritic cells (25). Commitment to the T cell lineage is accompanied by the 
induction of CD25 expression, and the immature T cells enter the pro-T cell stage 
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(CD25+CD44+). Pro-T cells are cycling cells, which are dependent on IL-7 for their prolifer-
ation. At the pro-T cell stage, TCRfJ gene rearrangements have not been initiated yet, but 
rearrangements at the TCRy locus can be detected (26). This implies that pro-T cells initiate 
expression of recombillatioll-activatillg genes (Rag). RAG proteins (RAG-I and RAG-2) 
independently mediate somatic rearrangement of TCR and BCR genes by the induction of 
double-strand DNA breaks at specific sites in the TCR and BCR locus (27, 28). During the 
transition to the next stage ofT cclI maturation, the early pre-T cell stage, the cells lose CD44 
exprcssion and shut down proliDferation (29). During this early pre-T cell stage 
(CD25+CD44-), TCRfJ genes begin to be rearranged. The rearranged TCRfJ is expressed at the 
cell suriace complexed to pre-Ta as the pre-TCR-complex. Gnly those cells which producc 
a fimctional TCRfl protein will downrcgulate CD25 expression and proceed to the next phase 
ofT cell maturation. These late pre-T cells are proliferating cells which have a CD25-CD44-
phenotype (30-32). This selection process is refelTed to as fl-selection (16). Cells which have 
undergone B-selection will then initiate expression ofCD4 and CDS coreceptors genes. 
At the CD4+CD8+ DP stage, T cells start rearranging their TCRa genes. Upon the 
recognition of Ag/MHC complexes by the newly formed TCRaB receptor -the event initiat-
ing positive selection-, T cells will terminate RAG expression, which results in the abroga-
tion of TCRa gene rearrangement. In addition, the T cells increase expression of TCRaB on 
their cell surface and start to express the activation marker CD69. The process of positive 
selection serves to select for a peripheral T cell pool with an MHC-restricted TCR repelioire. 
Double-positive T cells which fail to receive the TCRafl-mediated signal within 3-4 days will 
cnter the apoptotic pathway (16). Positively sclected cells will downregulate coreceptor 
CD4-CDS- Double Negative CD4+CDS+ Double Positive Single Positive 
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Several stages ofT cell differentiation can be distinguished in the thymus based on the expression of cell-surfuce 
markers. Based on the expression of CD4 and CD8 coreceplors, three major stages of difierentiation can be char-
acterized: Cf)4/CDS double negative, CD4/CD8 double positive and CD4 or CD8 single positive. CD4/CDS double 
negative T cells can be Hlrthcr divided in 4 developmental stages based on the expression ofCD25 and CD44. 
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expression, thereby developing into the CD4 ioCD8 io TCW"' CD69+ cells (33). Subsequently, 
CD4 coreceptor expression is induced again, giving rise to CD4+CD8io TCRal'inUlU CD69+ 
cells. This subpopulation still contains precursors for both CD4 and CD8 SP cells. At this 
point, T cells differentiate into either CD4 SP or CD8 SP cells. In both lineages, maturing 
cells will eventually terminate CD69 expression and initiate high expression ofCD62L (L-
selectin), a cell surface receptor which is functionally involved in homing of the mature T 
cells to the lymph nodes. Mature thymocytes exit the thymus as CD4 or CD8 SP 
CD69- CD62Lhi cells. 
T ceJls which are specific for self peptides are negatively selected during thymic dif-
ferentiation (34-36). Negative selection functionally restricts the peripheral TCR repertoire to 
the recognition of nOll-self peptides presented in the context of lYmc. As such, negative 
selection is responsible for maintaining central tolerance. Negative selection can occur at any 
stage ofT cell development fi'om the DP CD69-1- stage onward. The mechanisms responsible 
for positive and negative selection have not yet been revealed into great molecular detail. 
Two major models have been proposed to explain the processes of positive and nega-
tive selection. As both positive and negative selection are mediated by interactions of the 
TCRal' receptor complex with MHCI Ag complexes, the nature of the antigenic peptide is 
usually considered to be of critical importance for the outcome of the thymic selection 
processes (16). The tlrst model, the qualitative/peptide lIIodel, proposes that it is solely the 
nature of the antigenic peptidc and the quality of the TCRall derived signal it induces, which 
determines the outcome of the selection process: low afiillity peptides will induce positive 
selection, whereas high affinity peptides will induce negative selection (37-40). In contrast, 
the ffi'idity/qu(Jntitative model proposes that positive selection is the result of low avidity thy-
mocyte interactions, whereas high avidity interactions will result in negative selection (38, 
41,42). This model therefore allows for an effect of costimulatOiY receptors on thc outcome 
of the selection process. Most importantly, however, in this model multiple TCRul'-MHC/Ag 
interactions are integrated into one cumulative signal, which determines the cell tate, there-
by encompassing not only peptide affinity but also peptide abundance. This integrated signal 
thus allows for a 'signalling gradienf with functional thresholds, ranging from low avidity 
interactions resulting in apoptosis ('death by neglect'), to a certain avidity-threshold which 
needs to be surpassed to ensure positive selection, to a high-avidity threshold, which, when 
surpassed, will induce negative selection by clonal deletion (l6). 
1.3. Lll'lEAGE COMMITMENT DURING T CELL DIFFERENTIATION 
In addition to positive selection, the recognition of AgIMHC complexes at the DP stage 
of T cell differentiation also initiates the process of lineage commitment. Lineage commit-
ment results in T cell difierentiation into CD4 or CD8 SP cells (21). Studies on TCRnl' trans-
genic and MHC class I and II-deficient mice have shown that the MHC-specificity of the 
TCR dictates commitment of the developing T cells into the CD4 or CDS lineages (17, 18, 
20). T cells expressing an.MHCI-restricted TCRuB complex will maintain expression of the 
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CDS coreceptor, and differentiate into CDS single positive cells. Alternatively, T cells 
expressing an MHCIl-restricted TCRap complex will maintain CD4 expression, committing 
to the CD4 lineage. Lineage commitment of DP cells into single-positive cells expressing a 
CD4/CDS coreceptor with an lYlliC-specificity matching that of their TCRafl complex 
ensures the immunological competence of the mature CD4 and CDS positive T cells (23). 
Several mechanisms have been proposed to be responsible for lineage commitment (figure 2; 
adapted from 43). The instructional model postulates that the simultaneous co-engagement of 
TCRnfl and either of the coreceptors instructs the T cell to selectivcly downregulate expres-
sion of the other coreceptor gene, resulting in the commitment to the appropriate lineage (44). 
In contrast, the stochastic/selection mode! for lineage collllllitment postulates that the T cell 
randomly terminates expression of either coreceptor gene, resulting in 'intermediate' pheno-
types (CD4+CD8'o and CD4'oCD8+) which are then selected for the expression of the appro-
priate coreceptor (with matching MI'IC-specificity) (45). Finally, the aSYlllllletric cOllllllillllelll 
model postulates that CD4 and CD8 lineage commitment have fundamentally different 
requirements. According to this model, CD8-lineage commitment requires Iineage-instmc-
tional signals, whereas CD4 lineage commitment occurs in the absence of these signals (46, 
47). 
Recently, an attractive mechanism for lineage commitment has been proposed (figure 
3; 48). According to this coreceptor reversal model, all DP T cells downregulate CDS expres-
sion upon MHCI Ag recognition by the newly formed TCRnfl complcxes. Dowmnodulation 
of CDS coreceptor expression will result in a decreased TCR-mediatcd signal for MHCI-
restricted TCRafl-expressing cells. For cells expressing lvlliClI-restricted TCRafl complex-
es, however, loss of cell surface expression of CDS will not affect the strength of the 
TCRafl-derived signal. In the latter case, the CD4+CD8'o T cells will continue to shut down 
CDS expression, resulting in the differentiation into MHCII-restricted CD4 SP thymocytes. 
Alternatively, loss ofTCRaB-mediated signal transduction results in an enhanced sensitivity 
of thc developing T cell to IL-7-mediated signal transduction, allowing for the delivery of a 
difierentiative signal by IL-7, which then results in coreceptor reversal: upon IL-7-induced 
signal transduction the CD4+CDS'o T cells expressing MHCI-restricted TCRa~ complexes 
,viII terminate expression of CD4 and induce re-expression of CD8, eventually resulting in 
the differentiation into CD8 SP cells. 
In a sense, the coreceptor reversal model combines the illstrllct;ol1al model with the 
a~J'mmetric commitment model, recognizing the CD4+CD8 10 stage of ditl'erentiation as the 
momcnt of selcction/instruction rather than the DP stage. T cells at the CD4+CD8 Io stage are 
instructed (by TCR-mediated signals) to become CD4 SP whcn they catTy an MUCH-restrict-
ed TCRnfl, but are instmcted (by IL-7R-mediated signals in the abscnce of TCR-mediated 
signals) to become CDS SP instead when they cany an MUCI-restricted TCRafl. Therefore, 
the processes of CD4 and CDS lineage commitment have fundamentally different mecha-
nisms. This novel concept might reflect a broader mechanism for appropriate cell fate deci-
sions of bipotential cells. 
FIGURE 2 
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.Models for CD4/CDS lineage cOlllmitment. 
Four models have been proposed for the process of lineage commitment to CD4'~ or CDS+ T cells by positively 
selected DP T eeUs. The instructiona/model assumes that MHC-delivered signals will instmct the T cell to down-
modulate expression oCthe inappropriate corceeptor gene. The stochastic 0/' selectioll model assumes that signaled 
DP T ceUs randomly shut down expression of one of the two coreceptor genes. The cells which have shut 
down-expression of the irrelevanl coreceptor gene, will be selected by J\tHC-dependent signals. The asymmetric 
commitmel/! model assumes that CD4lineage cOlllmitmcnt is the default pathway, whereas CDS lineage conllllilment 
requires I\.·fHCI-delivcred instnIctional signals. TIle coreceptor reversal model assumes thai all positively selected 
DP T cells will initially downregulate expression of CDS. At the subsequent CD4+CDSloCD69+ slage, the T cells 
cOlllmit to the appropriate lineage: MHCII-restricted T cells will continue to downlllodulate CDS coreceptor gene 
expression and develop into CD4 SP cells. MHCI-restricted T ceJls will revert coreceptor gene expression by 
re-expression of the CDS gene and downmodulatioll of CD4 gene expression. This coreceptor reversal is dependent 
on LL-7-delivered instnlctional signals. 
1.4. REGULATION OF T CELL DIFFERENTIATION 
T cells mature in close interaction with their thymic microenvironment (49). 
Commitment to the T celililleage occurs at the pro-T cell stage, before the onset afTeR gene 
rearrangement (25). Pro-T cells are dependent on IL-7 for their proliferation. At the next 
stage, expression of Rag genes induces TCR gene rearrangement. Expression of Rag genes 
and somatic realTangemcllt of antigen-receptor genes is specific for cells of the lymphoid lin-
eage. Although the thymic lymphoid progenitor retains the capacity to develop into the B cell 
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FIGURE 3 
Regulation of T cell differentiation in the thymus. 
Regulation ofT cell thymic T cell ditlerentiation by several families of proteins. Bold anllotations indicate a block 
in the corresponding phase ofT cell diflerentiation in the abscnce of the respective gene. Annotations in italics indi-
cate a regulatory eftect of the protein at the indicated stage ofT cell diftereniiatioll. (see text for details). 
lineage, the unique microenvironment of the thymus supp0l1s the differentiat~on into the T 
cell lineage (49). It has been shown that the unique three-dimensional architecture of the 
thymus plays an important role in allowing for efficient differentiation of progenitor cells into 
the T cell lineage (50). Stepwise reciprocal interactions between the T cells and the thymic 
stroma are of critical importance for the acquisition and maintenance of this unique thymic 
architecture (51). 
T cell differentiation in the thymus is subject to stringent regulation. Cellular difteren-
tiation is usually accompanied by global changes in gene expression, resulting in the acqui-
sition of a gene expression profile characteristic for a pal1icular cell type or stage of differ-
entiation or development (ontogeny). Transcriptional regulation of eukmyotic gene expres-
sion occurs at multiple levels (52). The most direct regulation of transcriptional activity is 
implemented by control elements which are part of the core promotor, the regulatory promo-
tor or potential enhancer sites, interacting with DNA-binding proteins (called transcription 
factors) which directly influence the ability of the RNA polymerase II complex to initiate 
transcription (53). Transcription factors are proteins which have a DNA-binding domain as 
well as a protein-protein interaction domain. An additional important regulatOlY mechanism 
acts at the level of accessibility for transcription factors and the RNA polymerase II complex 
to the DNA. This level of regulation is mediated by more specialized elements like silencers 
and locus control regions (LCR), as well as by the degree of DNA methylation (53). 
Transcriptionally silent genes are often found in regions of 'condensed' chromatin. Induction 
of transcriptional activity at these loci is often associated with chromatin remodeling, result-
ing in decondensation of the chromatin. Chromatin remodeling sustains extensive changes in 
chromatin structure, such as increased histone acytelation of nucleosomal DNA and 
decreased DNA methylation on cytosine-guanine (CpG) dinucleotides (53-55). These 
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changes in chromatin structure also result in enhanced accessibility for transcription factors, 
which can be experimentally monitored by the analysis of DNase hypersensitive sites (52). 
Cell-fate decisions of pluripotent progenitor cells are characterized both by the expres-
sion of lineage-associated transcription factors and by changes in the balance of these tran-
scription factors (56). A number of transcription factors have been implicated in the regula-
tion of various steps ofT cell differentiation (figures 4 en 5; 25, 56-59). The fetal outgrowth 
of the earliest thymic progenitors is dependent on the transcription £1ctorS Ikaros, PU.l and 
GATA-3. Whereas PU /./. and Ikm'Os'/- TCRa!'+ T cells do develop after bitth, GATA-3-1-
embryonic stem (ES) cells fail to contribute to the T cell lineage (60-62). The transition from' 
the thymic lymphoid progenitor stage to the pre-T cell stage (CD44+CD25- to CD44+CD25+) 
has been shown to be critically dependent on the transcription factor c-myb (63). The transi-
tion fi-om the late pre-T cell stage to the DP stage is dependent on presence of either lymphoid 
enhancer factor-I (LEF I) or T cell factor-I (TCF I), two related members of the high-mobil-
ity group (HMG) family of DNA-binding proteins (64, 65). Two other HMG family mem-
bers, HMG-I and HMG-2, have been shown to be involved in VDJ recombination by pro-
moting RAG-mediated dsDNA cleavage at 23-mer recombination signal sequence (RSS) 
sites (66). The HMO factors are assumed to constitute downstream components of the evo-
lutionalY conserved Wingless/Wnt signaling cascade (59). In addition, helix-loop-helix 
(HLH) proteins have also been implicated in the regulation of thymic T cell differentiation. 
Helix-loop-helix proteins 
Two families ofHLH proteins have been shown to regulate various stages ofT cell dif-
ferentiation. The E-box family of basic HLH DNA-binding proteins recognize conserved 
DNA sequences known as E-box elements, which are implicated in the regulation of cell-type 
specific gene transcription (67). The Id family ofHLH proteins, lacking the basic DNA·bind-
ing domain, form non-DNA-binding heterodimeric complexes with E-box proteins (68). In 
this way, Id proteins have been shown to act in a dominant negative fashion on the function 
of the E-box h1mily members. The members of the E-box family of DNA-binding basic HLH 
proteins HEB, E2A and E2-2 have been shown to be involved in T cell differentiation (69). 
Analysis of thymocyte populations in E2A-I- mice revealed a marked reduction of overall thy-
mocyte numbers, especially at the DN and the DP stage, accompanied by increased SP cell 
numbers, especially of CD8+ SP cells. Numbers of thymic lymphoid progenitor cells were 
within normal ranges, whereas strongly decreased numbers of pre-T cells were observed, 
consistent with a partial block of the commitment of the TLP to the T cell lineage (70). The 
E2A encoded protein E47 was shown to regulate the maturation ofDP thymocytes (71). 
Targeted deletion of tile HEB gene resulted in a partial block in T cell differentiation at 
the transition from the latc pre-T cell stage to the DP stage (69, 72). A more severe phenotype 
than that of either HEB-I- of E2A-I- animals was observed in mice homozygous for a HEB 
allele encoding a dominant-negativc HEB protein, indicating a role for HEB-E2A het-
erodimers in T cell differentiation. In these mice, aj3 T cell differentiation was blocked at the 
pre-T cell stage (73). The Id protein family member Id3 has been shown to play multiple roles 
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FIGURE 4 
Proteins involved in the regulation of thymic T cell differentiation. 
Scveral families of proteins arc involved in the regulation of T cell dillcrentiatioll in the thymus. Proteins are 
schematically depicted with relevant protein domains. (Zn, Zinc~fillgcr domain; Act, activation domain; sr, signal 
peptide; Cys-rich, Cystein rich domain; TM, transmembrane domain; PEST, PEST-sequence). 
in T cell differentiation (74, 75). Depending on the maturation stage under scrutiny, overex~ 
pression of Id3 inhibited commitment to the T ccll lineage or to the aB-TCR lineage in fetal 
thymic organ culturcs (FTOC), resuiting in strongly increased numbers of NK cells and 
TCRyo T cells, respectively (74, 76). Detailed analysis ofT cell differentiation in Id3-1- mice 
revealed a block in its role in the regulation of positive and negative selection at the DP stage 
(75). As these data are consistent with the observed phenotype in HEB-I- and E2A-I- mice, the 
effect of Id3 on T cell differentiation can be attributed to its dominant-negative role on bHLH 
protein function. Overexpression of Idl in a transgenic approach resulted in a massive illduc~ 
tion of apoptosis during thymic T cell differentiation as well as a strong increase of the num~ 
ber of DN T cells (77). 
lkoros 
The transcription factor Ikaros, a member of the Kruppel family of Zinc fInger 
DNA-binding proteins, was shown to control various essential steps in T cell differentiation 
(78). The Ikaros gene encodes a tinnily of proteins by means of alternative splicing (79-81). 
:Mice homozygous for a targeted deletion of the Ikaros gene exons encoding the C~tenninal 
Zinc-finger/DNA-binding domain (DN-I- mice) have a complete lack of lymphoid cells, 
including all precursor stages (82). This C-tenninally truncated Ikaros protein binds lkaros 
family members but inhibits DNA~binding of the heterodimer, and therefore exerts a domi-
nant~negative effect on Ikaros function. In heterozygous mice (DN+I-) this dominant-negative 
activity of the tnlllcated Ikaros protein results in thymocytes with augmented proliferation. 
These mice rapidly develop Iymphoproliferative disorders and die ofT cell lymphomas (83). 
Mice with a targeted deletion of exon 7 of the ikams gene, coding for the N-terminal 
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Zinc finger domain of Ikaros proteins (Ikaros-C-I-), resulting in the expression of a true null 
mutation of the Ikaros gene, have a complete block in B cell differentiation from the earliest 
pro-B cell stages onwards. T cell development was absent at all fetal stages in lkaros-C-I-
mice, but thymocyte precursors arc detected starting a few days after bilth. Detailed analysis 
of the various T cell populations in adult lkaros-C-I- mice revealed normal numbers of thy-
lllocytes at 1 month of age. However, CD4+ SP TCRuB thymocyte numbers were strongly 
enhanced. In addition, oligoclonal and monoclonal thymocyte populations predominate in the 
Ihymuses of older Ikal'Os-C-I- mice. Peripheral TRCa~ T cell numbers are restored in adult 
animals, but NK cells and cerIa in types of TCRyo T cells are absent (84). A more detailed 
analysis of mice homozygous for the Ikaros null mutation (lkaros-C-I-) revealed decreased 
numbers of CD44+ DN and CD44-CD25+ DN thymocytes, but normal numbers of CD44-
CD25- DN thymocytes. In addition, Ihe Ikal'Os-CI- null mutation could rescue the block in T 
cell development of RAG-J-I- mice, resulting in development of DP and even CD4 SP T cells 
in the thymus of double knockoul mice (78). Taken together, these data show that lkaros is 
involved in the regulation of TCR-signalling thresholds during ~-selection (pre-TCR) and 
during positive selection and lineage commitment (TCRa()). 
A possible mechanism for Ikaros function was revealed in microscopy studies of Band 
T lymphocytes (85-89). Using confocal microscopy and immuno-fluorescence in situ 
hybridization (imll1uno-FISH), it was shown that Ikaros proteins associate with transcrip-
tionally silent genes in heterochromatin foci in interphase nuclei, comprising clusters of cen-
tromeric DNA (87). The association of Ikaros with heterochromatin was independently 
observed by another group as well, using imll1unogold electron microscopy (89). Interaction 
of a gene with centromeric heterochromatin can mediate transcriptional repression, indicat-
ing that Ikaros may function as a regulator of transcriptional repression (87, 90). Protein com-
plexes containing Ikaros proteins purified from a thymoma cell line were shown to contain 
an additional T-cell specific Ikaros-family member, designated Helios. HelioslIkaros com-
plexes were shown to associate selectively with centromeric clusters in T cell nuclei (88). 
Centromeric clustering of Ikaros with transcriptionally silent genes was shown to occur in 
cells preparing for cell cycle in lymphocytes difierentiating along the 8- or the T-cell lineage. 
Mature B- and T-Iymphocytes only displayed the centromeric heterochromatin foci when 
they were induced to enter cell cycle, but not when they were allowed to maintain in a rest-
ing state (86). These observations implicate Ikaros proteins in differentiation-induced tran-
scriptional silencing of genes by repositioning of these genes to centromeric heterochromatin 
loci (86). 
Notch 
The Notch £1mily of cell surface receptors regulate developmental cell-fate decisions 
and affect the processes of proliferation, difierentiation and programmed cell death (91, 92). 
In general, Notch receptors regulate cell-fate decisions by mediating either signals derived 
from identical, equipotent cells (lateral specification/inhibition), signals derived from a dit' 
ferent cell-type (inductive signaling) or signals derived from the cell itself(cell-autonomous 
General introduction 20 
signaling) (91, 93). Notch-I, -2 and -3 and their ligand Jagged-2 are all expressed in the thy-
mus in variable fractions of all subpopulations of immature T cells. Thymic stroma also 
expresses the Notch-ligands Jaggcd-l and -2, indicating a multitude of potential interactions 
pntatively regulating T ceIl differentiation via the Notch pathway (94). 
Notch h1mily members have been shown to playa role in regulating cell-fate decisions 
at T cell lincage commitment, at af)N versus yo-T cell lineage cOlllmitment and at CD4 ver-
sus CD8 lineage conllllitment (95). An essential rolc for Notcill in thc regulation ofprccur-
sor cell commitment to the T cell lincagc was shown in mice in which inactivation of the 
NotchI gene could be induccd using the Cre/loxP system (96). In the absence of Notch I , T 
cell differentiation was arrested at the TLP (CD25-CD44+ DN) stage. These mice displayed 
B cell differcntiation in the thymus, indicating that the thymic lymphoid progenitor cells 
might have adapted an alternative cell £1te in the absence of Notch 1. This notion was further 
substantiated by the observation that retroviral transduction of an activated form of Notch I 
into bone llalTOW precursor cells resultcd in T cell differentiation in the bone malTow in the 
absence of B cell differentiation (97). Using mice which were heterozygous for a targeted 
deletion of one of the two Notchl alleles, it was shown that Notch1+f+ and Notchl+l- cells did 
not contributc equally to the TCRaj) and TCRyo lineages, whereas they did contribute equal-
ly to the 8 cell lineage. As the overrepresentation of Notch1+f+ cells was more pronounced in 
the TCRaj) lineage than in the TCRyo lineage, it was concluded that Notch apparcntly regu-
lates the aj)- versus yo-T ceIl lineage commitment (98). The effect of Notch I on aj)-lineage 
commitment \vas only observed in the presence of Notchl+f+ cells, indicating that the 
Notch-mediated regulation might bc thc result of lateral inhibition (95). However, mice 
homozygous for a targetcd dclction of Jagged-2, a ligand for Notch which is highly expressed 
in the thymus, had a specific defect in yo-T ceIl development, indicating that Notch also plays 
a role in yo-lincage commitment (99). Together, these data suggest a complicated regulation 
ofT ccIl commitment into the aj) and yo lineages by Notch tinnily members. At the DP stage 
ofT cell development, Notch 1 has been implicated in the regulation of thymocyte mahlration 
independently of TCRlNrrIC interactions by preventing apoptosis due to death by neglect or 
negative selection (91,100-102). In addition, an activated form of Notch I has bcen shown to 
induce an increased differentiation ofDP T cells into CDS SP T cells in transgcnic micc (103). 
GATA-3 
The transcription factor GATA-3 belongs to a family of proteins which bind to DNA at 
GATA-consensus sites through a highly conselved C, Zinc tinger domain (104, 105). The 
GATA family of DNA binding proteins contains 6 malllll1alianlllembers which can be divid-
ed into two subfamilies based on expression pattem and genomic structure. GATA-I, -2 and 
-3 are all expressed in hematopoietic cells, and display a similar gcnomic organization. 
GATA-4, -5 and -6 are expressed in developing cardiac structures, in the gut, the urogenital 
system and in the brain, and share two indepcndcnt transactivation domains in the N-tenni-
nal rcgion, which are conserved between GATA-4, -5 and -6 but not between the other 
GATA-family members (106-110). All GATA-family proteins contain a DNA binding domain 
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of two C4 Zinc fingers. The C-tenninal Zinc finger is essential and sufficient for DNA bind-
ing to the GATA recognition sequence (T/A)GATA(A/G) (111-113). In addition, the N-ter-
minal Zinc finger and the region placed in between the two Zinc fingers has been shown to 
playa role in protein-protein interactions. The N-tenninal Zinc finger does not display inde-
pendent DNA binding, but does stabilize the GATA-I-DNA interaction (113-116). Recently, 
the interaction between the two Zinc fingers of GATA-I has been shown to modifY the 
GATA-l/DNA interaction, resulting in stabilization or disruption of the interaction, or hl 
modification of the specificity of the interaction (117). 
GATA-proteins regulate transcriptional checkpoints during mammalian differentiation 
(58). GATA-I, GATA-2 and GATA-3 play different roles in hematopoiesis. GATA-J is 
expressed in erythroid, eosinophilic, megakaryocytic and mast cells (113, 118-120), and is 
essential for terminal difterentiation of erythrocytes and megakaryocytes (104, 121). 
GATA-J-I- animals die at an early embryonic stage, due to severe anemia. Erythroid 
development of GATA-J·I- ES cells is arrested at an early proerythroblast stage (104, 122, 
123). GATA-2 is involved in the regulation of the hematopoietic progenitor cell proliferation. 
Targeted deletion of the GATA-2 gene results in early embryonic death associated with severe 
anemia. GATA-2-1- ES cells make no contribution to any hematopoietic lineage in chimeric 
mice (124, 125). GATA-3 was [u'st identified as a transcription tactor binding of the TCRa 
enhancer (126). GATA-3 binding sites have also been found in the TCR{J and TCRo 
enhancers, as well as in the CD8a and the JL-5 promotor regions (127-130). In addition to 
the expression of GATA-3 in hematopoietic cells, GATA-3 is also expressed during elllblyon-
ic development in kidney and the central nervous system (131). 
The two Zinc finger domains and the region in between these two Zinc fingers are high-
ly conserved between GATA-I and GATA-3 (132,133). In addition to the conserved Zinc fin-
ger domains, the large N-tennillal and C-terminal regions ofthe OATA-3 protein were shown 
to be essential for efficient transcription of a reporter gene placed under transcriptional con-
trol of the minimal c:fos promotor and four GATA-binding sites from the TCRo enhancer 
(133). Mice homozygous for a targeted deletion ofthe GATA-3 gene die at an early fetal stage 
(day II). GATA-3-1- mice display massive internal bleeding, severe deformations of the brain 
and spinal cord and growth retardation (134). A more recent study revealed that an attenuat-
ed induction of tyrosine hydroxilase and dopamine f3 M hydroxiiase in the sympathetic nervous 
system leading to noradrcnaline deficiency in GATA-3~/~ animals is a major cause of early 
fetal death (135). Pharmacological rescue ofGATA-3·1· fetuses beyond day II by feeding cat-
echol intermediates to pregnant females can'ying GATA-3-/~ fehlses, revealed the occurrcnce 
of various abnormalities in the absence of GATA-3 later in fetal development, such as renal 
hypoplasia and aberrant development of cephalic neural crest-derived structures, implicating 
a role for GATA-3 in the differentiation of multiple cell lineages. These pharmacologically 
rescued GATA-3-1- fetuses also displayed severe thymic hypoplasia at fetal day 16.5 (135). 
Rag-2-1- complementation analysis revealed contribution of GATA-3-1- emblyonic stem (ES) 
cells to all hematopoietic lineages except the T lymphoc)1e lineage (61). Therefore, it was 
concluded that development of GATA-3·1· T lymphocytes was blocked before or at the DN 
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progenitor stage (61). In addition, targeting GATA·3 I11RNA by an antisense approach in 
FTOC inhibited generation of thymoC)1es from fetal liver progenitors but not from fetal 
thymic cells (136). Taken together, these data implicate a crucial role for GATA·3 in early T 
cell development. 
PERIPHERAL T CELL DIFFERENTIATION 
1.5. T CELL ACTIVATION AND DIFFERENTIATION 
During the differentiation ofT cells in the thymus, T cells are selected for their capac· 
ity to recognize non·selfpeptides presented in the context ofMHC molecules. Recent thymic 
emigrants contribute to the peripheral T cell pool as circulating na'ive, resting T lymphocytes. 
These naIve T cells will become activated upon TCR·dependent recognition of a peptide pre· 
sented in the context ofMHC on the surface of an APC. Such peptides are derived from extra-
cellular antigens which have been internalized by these cells, either aspecificaJly (in the case 
of dendritic cells and macrophages) or specifically (in the case of B lymphocytes). 
TCR-induced signaling pathways eventually result in phenotypical changes in the activated 
T cell which are characteristic for the acquisition of an eflector cell phenotype, such as (I) 
cytoskelet.l changes, resuIting in an altered structure, mobility and size of the T cell, (2) 
changes in chromatin structure (histone acetylation and CpG demethylation) allowing the 
activated T cell to induce transcription oflarge numbers of genes, and (3) changes in the gene 
expression profile, endorsing new effector functions onto the activated T cell (137·140). 
Although recognition of an MHC/peptide complex by the TCR will initiate the activa· 
tion of a na"lve T cell, a second (costimulatOlY) signal is required for a nalve T cell to become 
fully activated (141). TCR·mediated T cell activation will be further discussed in section 1.6. 
In the absence of costimulatory signals, the T cell will be functionally disabled by transition 
into an unresponsive state defIned as anergy (142, 143). This so·called two·signal model for 
T cell activation plays an essential role in the maintenance of peripheral tolerance (144·146). 
B7 family members (CD80 and CD86) expressed on the cell surface of APC deliver costim· 
ulation by interaction with the T cell surface receptor CD28 (147). As the various types of 
APC express ditle-rent levels of costimulatory molecules <?n their surface, presentation of 
antigenic pep tides by the various types of APC will result in functionally difterent outcomes 
of the activation of na'ive T cells. Only activated dendritic cells (the so-called professional 
APC) express suflleient levels of costimulatory molecules (CD80 and CD86) to fully activate 
a naIve T cell and induce differentiation of an activated T cell into an effector cell. Other types 
of A PC, such as macrophages and B lymphocytes, will functionally disable a naIve T cell by 
the induction of anergy. Most APC can functionally activate antigen-experienced T cells, as 
these have far less stringent costimulatory requirements (148). 
Eventually, fully activated naIve Th cells will acquire an eflector phenotype afler 4·5 
days, and will vel)' rapidly induce efiector functions upon renewed recognition of the appro-
priate MHC/Ag complexes. CD4+ T cells regulate Th cell·dependent immune responses both 
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by the production of soluble mediators (cytokines and chellokines) and by the cognate inter-
action with B cells and macrophages. Cytokines are pleiotropic proteins which induce a mul-
titude of responses in various cell types (see table 1&2). Chemokines arc chemotactic mole-
cules which are involved in the regulation of leukocyte migration (149). The capacity to pro-
vide help to B cells in proliferation and antibody production is an imp0l1ant effector function 
ofCD4+ T cells, in which the production ofcytokines such as IL-2, IL-4 and IL-6 as well as 
CD40/CD40L-dependent cognate B cell-interactions play critical rolcs (150). In addition, 
CD4+ T cells mediate delayed-type hypersensitivity (DTH) responses by thc production of 
cytokines such as IFNy, Iymphotoxin, GM-CSF and TNFa and by cognate interactions with 
TABLE t: The errects or "ariolls cytokines on n· and T-lymphocytes and other hematopoietic cell types. 
Cytokine 
lL-2 
IL-3 
lL-4 
IL-5 
[L-6 
IL-IO 
IL-12 
IL-13 
IFNy 
Ellect on B lymphoctye 
Gro\\1h, J chain synthesis 
Growth, activation, IgI! 
isotype switching (Y1' E), 
~n-fCrr,p 
Differentiation, IgH 
isotype switching 
Growth, Diilercntiation, 
Ig production 
Anti·proliferative, ~,rncrr p 
DifterentiatiOll, 
IgH isotype switching 
Diftercntiation, IgH isotype 
switching (Y2A) 
Ellcct on T Iymphocytcs 
Growth, Survival 
Growth, survival, typc-2 
dificrcntiation 
Induccs ILA production in 
CD4+TccIls 
Anti·proliferativc 
Type-I differentiation, 
induces IFNy production 
Anti-proliferative 
Efiect on other cells 
NK cclls: Growth 
Hematopoietic progenitors: 
gro\\1h 
Ivtacrophages: 
inhibits activation 
Eosinophils: Growth, 
difterentiation 
Inhibits macrophage 
cytokine production; co-stimulates 
mast ecll growth 
I\TK cell activation, 
IFNy production 
Macrophage and NK cell 
activation, induction ofMHCIIII 
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macrophages through membrane-bouud forms ofTNF (151, 152). CDS+ T cells mediate cyto-
toxicity against cells infected with virus or intracellular bacteria and against hUllor cells, both 
by secretion of the content of cytotoxic granules (mainly perforin and granzymes) and by 
cognate intcraction with the target cell (153). 
Upon antigen-specific activation, the naive T cell enters a program of cellular difteren-
TABLE 2: A short owniew of the producing cell t~'pcs of the most rele\'llnt cytokines llnd o\'eITiew of Jllk 
IWl! Stilt molecules iuyolwd in signallransdnction of each individual cytokine. 
C)1okine 
IL-2 
1L-3 
1L-4 
IL-5 
JL-6 
IL-IO 
IL-12 
IL-13 
lFNy 
Producers 
activated T cells 
TcelJs 
activated Th2 cells, NKI.l+ T cells 
activated Th2 cells 
activated 1112 cells 
activated Th2 cells 
Dendritic cells 
activated Th2 cells 
activated Th 1 cells, CDS+ T celis, 
NK cells 
Slats Jaks 
Stat5a, StatSb, Stat3 Jakl, Jak3 
SlatSa, Stat5b Jakl, Jak2 
Stal6 Jakl, JakJ 
Stat5a, Stat5b Jakl, Jak2 
Stat3 Jakl, Jak2, Tyk2 
Stat3 Jakl, Tyk2 
Stat3, Stat4 Jak2, Tyk2 
Stat6 Jakl,Jak3 
Statl Jakl, Jak2 
tiation. The nature of the antigen, the strength of the TeR-mediated signal, the nature of the 
costimulatOlY signal provided by the APe and the cytokines present in the microenvironment 
of the T cell direct the differentiation into one of variotls types of effector T cells. The two 
most extensively characterized T cell effector phenotypes are the type-I and type-2 T cells. 
This distinction can be made amongst both CD4+ and CD8+ T cells (154). The two types of 
helper T cell and thcir differentiation from the naIve Th cell will be discussed in sections 1.7 
and 1.8. In a latcr phase of the immune response, \vben the antigen which initiated the 
immune response has been cleared from the body, effector T cells will enter theit; final genet-
ic program in a physiological process called activation-induced cell death (AI CD), leading to 
the induction of apoptosis (155). A small number of antigen-experienced cells will remain in 
the circulation as resting cells, which arc responsible for the maintenance of immunological 
memory. 
Traditionally, immunological memory is defined functionally as the faster and stronger 
response of an animal following a renewed exposure to an antigen it has already encountered 
in the past (156). These enhanced responses could in part be explained by a higher frequen-
cy of antigen-experienced cells, or alternatively by qualitatively difterent functional proper-
ties of the memmy cells (157 -159). The functional differences between naIve and memmy Th 
cells have only recently been extensively characterized (160). Using transfer shldies ofTCR-
transgenic Th cells into T cell-deficient hosts, it was shown that memory Th cells display 
Peripheral T cell diDcrcntiation 25 
enhanced kinetics of cytokine production and cell division as well as enhanced production of 
cytokines and an enhanced proliferation to suboptimal Ag-specific stimulation, as compared 
to naive Th cells with the same clonotypic specificity (160). This study confIrms the results 
from previous studies performed on polyclonal T cell populations which already suggested 
these functional differences between memory and naIve cells (148, 161-163). A complicating 
factor in the study of memory T cells has always been the use of memory T cell-specific 
markcrs to phenotypically distinguish these cells from the majority of resting naIve and acti-
vated effector cells (156). Generally, naIve murine T cells are charactcrizcd as CD62Lhi, 
CD45RBhl and CD4410, whereas memmy T cells have the opposite expression of these cell 
surface markers: CD62L'o, CD45RB'o and CD44hl. Recently activated T cells, however, 
cxprcss thc samc pattcrn of cell surface markcrs as memory cells, but can be distinguished by 
the expression of the activation markers CD25 and CD69. So, resting mcmOlY cells are con-
tained within the CD25', CD69', CD44h1 , CD45RBlo, CD62L'ocell population (156). 
1.6. SIGNAL TRANSDUCTION BY THE TCRa!l-COMPLEX 
Recognition of MHC/ Ag complexes on the surface of an APC initiatcs a signaling cas-
cade mediated by the TCR complex. The TCR complex consists ofthe antigen-spccific TCR-
a and -13 chains which arc non-covalently associated with thc invariant CD3-y,-O,-E and TCR-
<; chains (figure 5; 164). The clonotypic a and!l chains of the TCR complex have only min-
imal intracellular portions and cannot perform signal transduction. Thc signal transducing 
components ofthe TCR complex, the CD3-y, -0, -f and TCR-<; chains, are members ofa fam-
ily of immnnoreceptor signal transduction subunits which contain immunoreceptor tyrosine-
based activation motifs (ITAM) (138,139). None ofthe components of the TCR complex has 
endogenous enzymatic activity. Signal transduction by the TCR is performed by non-recep-
tor protein tyrosine kinases (PTK; figure 6, 7), which are recruited into the TCR complex 
upon activation (165). Recognition of lvIHCIIIAg complexes on the APC will bring Lck, 
which is associated to the CD4 coreceptor, into the TCR complex (figure 6). Lck, a Src-fam-
i1y PTK, will then phosphmylate tyrosine residues in the ITAM motifs of the CD3-y, -O,.-f 
(one !TAM motif in each chain) and TCR-<; chains (three ITAM motifs per chain). 
Phosphorylated ITAM motifs scrvc as docking sites for the Src-homology 2 (SH2) domain of 
the ZAP-70 PTK (165). Importantly, the recruitment and activation of ZAP-70 and the Src 
families ofkinases result in a cascade of downstream signaling events (figure 8) (137). 
One major pathway inducing TCR-dependent T cell activation is the phospholipase 
C-yl (PLCyl) pathway. PhosphOlylation of the adaptor protein LAT (linker of activated T 
cells) attracts PLCyl to the cytoplasmic mcmbrane, leading to activation of protein kinase C 
(PKC) and consequcntly in increascs in intracellular calcium concentrations. As a result, the 
calcium/calmodulin-dependent phosphatase calcilleurin is activated, which in turn dephos-
phOlylates the transcription factor NF-AT (nuclear t:1ctor of activated T cells). Consequently, 
NF-AT is translocated to the nucleus and its affinity for DNA is increased (166, 167). It has 
been show that Tee-family protein-tyrosine kinases Itk and Rlk play an essential role in 
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FIGURE 5 
Structure of the T cell receptor complex. 
The T cell receptor contains of the TCRn and TCR~ chain, which arc 
the major extracellular components of the receptor complex. and rec-
ognize the I\,mCIAg complex. on the antigen-presenting cell. in addi-
tion, the CD3y, CD3b, CD3e and TCR~ chains comprise the intracel-
lular signaling portion of the TCR complex.. Thcse receptor subunits 
contain immulloreceptor tyrosine activation motifs (ITAIVf), which arc 
essential for the initiation of signal transduction by the TCR. 
PLCyl activation upon TCR-mediated signaling. T cells from mice with a targeted deletion 
of the Ilk gene displayed altered TCR-signaling, resuiting in impaired proliferation and IL-2 
production upon TCR-crosslinking as well as defects in thymic T cell differentiation and thy-
mocyte selection (168-170). Enforced expression of Rlk throughout T cell differentiation 
resulted in the development of hypenesponsive T cells) characterized by augmented PLCy 1 
activation. The expression ofthe Rlk transgene could partially restore the defects observed in 
Itk-I- mice) suggesting a functional redundancy bet\veen these t\vo Tec family members (171). 
Mice with a targeted deletion of the Rlk gene displayed only mild defects in TCR signaling. 
T cells from mice with a targeted deletion of both the Ilk and the Rlk gene, however, were 
shown to be unable to perform inositol triphosphate (lp) production, calcium immobilization 
and mitogen-activated protein (MAP)-kinase activation upon TCR-signaling (172). These 
data indicate a critical role for the combined function of Itk and Rlk in PLCy I activation. The 
mechanism of Itk-dependent PLCyl activation involves thc association ofItk with phospho-
rylated linker for activation ofT cells (LAT) (173, 174). In contrast, Rlk has been shown to 
associate with and phosphorylate the adaptor molecule SLP-76, also resulting in PLCyl acti-
vation (175). 80th ltk and Rlk associate with the recently identified T cell-specific adaptor 
molecule RIBP, which was shown to be essential for TCR-induced IL-2 production and pro-
liferation (176). 
Lck-dependent activation ofZAP-70 also results in the activation ofp2l RAS• The adap-
tor molecules LAT and SLP-76 are essential for p21 RAS activation by ZAP-70 (177, 178). 
p21 RAS plays an essential role in the induction IL-? gene transcription by the activation of 
mitogen-activated kinases (179), leading to c-Fos activation, as well as by activation of the 
JNK pathway, resulting in c-Jun activation. JunlFos heterodimerization will induce their 
translocation into the nucleus as transcription factor AP-l, which acts in concert with NF-AT. 
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FIGURE 6 
Proximal signalling e\'ents in TCR-mcdiated signal transduction. 
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1 
Downstream 
substrates 
Upon rceognition of the MHCWAg complex on the antigen-presenting cell, the CD4 eoreeeptor molecule will be 
brought into close proximity of the TCR complex. Lek, a Syk-family tyrosine kinase which is constitutively associ-
ated with the CD4 molecule will phosphorylate critical tyrosine residues in the ITAM motifs oflhc TCR~ ,mtl CD3 
chains. Phosphorylated ITAr..'f motifs serye as docking sites for adapter proteins such as ZAP-70, which will then be 
phosphorylatcd by Lck. Activated ZAP-70 will initiate a number of downstream signaling pathways. 
Amongst the gene-products that are induced by activated NF-AT are a number of cytokines, 
such as IL-2, IL-4, IFNy, GM-CSF and TN Fa as well as various cell surface receptors, 
including CD40L and FASL, all of which are phenotypical characteristics of effector T cells. 
In addition to the induction of gene transcription, TCR-signaling also induces changes in the 
organization of the cytoskeleton (ISO). 
An additional downstream pathway is induced by the activation of phosphatidyl-inosi-
tol3-kinase (P13-K), resulting in the increased inositol lipid turnover and production of ph os-
phatidyl inositoI3,4,5-tri-phosphate (PIP3) (lSI). Two adaptor molecules have been suggest-
ed to recruit PI3-K to the cell membrane upou TCR-signaling: LAT and T cell receptor-inter-
acting molecule (TRIM) (lS2). PI3-K regulates the Tec family member Itk, which in turn reg-
ulates PLCyl (lS3). In addition, PI3-K regulates guanosine exchange factors (GEF) for Rho 
tiunily GTPases such as Rac, Rho and Cdc42 (ISO). The best characterized lymphocytic Rho 
family GEF is vav-l, which is recruited to the plasma membrane by interaction with PIP 3 
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Tyrosine Kinases 
Btk, Tee, Itk 
Rlk 
SH3 LekiFyn 
SH3 SH2 ZAP-70 
II JH7 
Adapter Proteins 
I SH311 SH2 II sH31 Grb2 
l'iM' LAT 
SH2 ,1:01+1 I SOCS 
II SH3 II SH2 II ProJGly-rich II SH3 II Gads 
I I f!Y'sl\wl I proline-rich I SH2 SLP-76 
I j;BY-'iii~$ I SH3 II SH2 I I SH3 I I Vav 
i;ii.I.j proline-rich ["HI e-Cbl 
Transcription factors 
SH2 Stat 
y 
NHR DNA Binding lui NF-AT 
FIGURE 7 
Proteins inmlved in signal transduction in T cells. 
Numerous proteins have been implicated in TCR and cytokine-receptor signal transduction pathways.flere, a selec-
tion orlhe most relevant proteins havc been depicted schematically with relevant protein domains (PH, pleckstring 
homology; SH, Src-homology; TH, Tee-homology; PY, phosphotyrosme; lH, 1ak-homology; T!Vr, trans-membrane 
region; sacs, saCS-box domain; Pro/Gly-rich, proline/glycinc rich domain; Ring, Ring-Hnger domain; Vb, 
Ubiquitination domain; TD, tnmsactivation domain; NHR, NF-AT homology region). 
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(I 80). Tyrosine kinase activity at the membrane will than activate the nucleotide exchange 
factor Yav-1. Subsequently, Rho GTPases will initiate various signaling pathways, amongst 
which the regulation of the dynamic organization of the actin cytoskeleton (184,185). 
1.7. HELPER T CELL SUBSETS 
C calcine"r;n :> 
8 ~ 
~e transcription 
FIGURES 
Downstream pathways in TCR-induced signal transduction. 
Lck phosphorylation of adapter proteins induces activation of several dowllstream signaling pat!nyays. Some rde-
\'ant signaling pathways arc schcmatically depictcd hcre: Rafh\[ck/Erk and ]\·fAP-KlJNK pathway leading to lonna-
tion of the transcription (hctor AP-I (JunfFos helcrodimcr); PLCyl activation inducing the PKC pathway and the 
Ca2+/caIcineurin pathway, leading to NF-AT activation. Genc transcription is induced by cooperate transcriptional 
activity of AP-I and 1\TF-AT. 
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Since their original description in the 1980s, functionally distinct effector Th subsets 
have been distinguished phenotypically on the basis of the prome of cytokines they produce 
after activation (Table 3) (186, 187). Thl cells are charactcrized by the production ofIL-2, 
interferon-y (IFNy) and tumor necrosis factor-fl (TNFfl), whereas Th2 cells typically produce 
IL-4, IL-5, IL-9, IL-IO and 1L-13. An intermediate effector phenotype (ThO) can also be 
detected, and is characterized by the concomitant production ofIL-2, IFNy, and IL-4. In addi-
tion to their cytokine production profiles, Th cell subsets can also be distinguished on the 
basis of their expression pattern of cytokine and chemokine receptors as well as some other 
cell surface markers (149,188,189). Thl cells have lost cell surface expression ofIFNyR2, 
whereas the expression of IL-12Rfl2 and IL-18R is absent on Th2 cclls (190-192). In addi-
tion, Thl cells are characterized by the expression of P-selectin glycoprotein ligand-I 
(PSGL-I), whereas Th2 cells specifically express TI/ST2, a member ofthc IL-IR family of 
proteins (193, 194). 
The expression patterns of chemokille receptors on human helper T cell subsets have 
been characterized in great detail. The level of expression of some of these receptors (CCR I, 
CCR2, CCR3, CCR5) is dctermined both by effector phenotype and activation state of the 
cell (189). From the studies on Th cells, it can be concluded that CCR5 (195) and CXCR3 
(196) are preferentially expressed by Thl cells whereas expression of CCR3 (197), CCR4 
(195, 197) and CCR8 (198) is specific for human Th2 cells. ThO effector cells have a mixed 
chemokine receptor expression profile (189). The chemokine expression patterns for murine 
he1ljer T cell subsets have been studied in far less detail. It has been shown, however, that 
murine na'lve Th cells and 1'111 cells express CCR7, '''hich is absent on murine Th2 cells, 
resulting in a different localization of these cells in the spleen (199). 
The two Tit cell subsets mediate distinct eflector functions in vivo. Thl cells are 
involved in immune responses against intracellular pathogens and mediate immune rcspons~ 
es such as DTH and in some cases direct cytotoxicity. Th2 cells are important in the defense 
against extracellular pathogens and mediate humoral immune responses (200-202). Activated 
Th2 effector cells deliver essential signals to B cells (cytokine- and CD40L-mediated), both 
for the induction of B cell differentiation into immunoglobulin (Ig)-producing plasma cells as 
well as for the induction of Ig isotype switching to the IgG I and IgE isotypes (203). 
TARLE 3: Phenotypical characteristics ofThl and Th2 effector cells. 
Spcciiic phcnotype 
C)1okine profile 
Cytokine receptors 
Othcr mcmbranc receptors 
Chemokinc reccptors 
Elicited by 
Thl 
G~'[~CSF, IL~2, IL~3, 
TFNy, LT, TNFa 
ILJ2R~2, 1L18R 
PSGL-I 
CCR5, CCR7, CXCRJ 
Intracellular pathogcns 
Th2 
GM-CSF, IL-J, 1L-4, IL-5, 
1L-6, IL-9, IL- 10, IL- J3 
IFNyR2 
TIIST2 
CCRJ. CCR4, CCR8 
Extracellular pathogens 
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Cytokines produced by Th2 cells also activate mast cells and eosinophils (200-202). 
The abili!y of CD4+ T cells to difterentiate into Th2 or Th 1 cells is critical in eftecting 
a susceptible or resistant phenotype to Leishmania major infection in mice, renecting a pos-
sible ill vivo relevance of polarized Th cell responses (204-206). In addition to the regulation 
of the type of imlllune response which is induced, effector Th cells also regulate the activi-
ty of the opposite subset. The production of IFNy by Th I effector cells inhibits Th2 cell dif-
ferentiation and proliferation (207, 208), whereas the Till cells themselves have lost respon-
siveness to IFNy at the receptor level (192,209). The production of cytokines by Thl-difter-
entiated cells is inhibited indirectly by the production ofIL-IO by Th2 effector cells, which 
acts on the APC compartment (210). 
Over the last few years, it has become clear that Th cells can dificrentiate into various 
effector phenotypes other than the 'classical' Thl and Th2 phenotypes. These alternative Th 
subsets are characterized by the expression of cytokilles which are involved in the negative 
regulation of immune responses. The Th3 subset ofCD4+ T cells is characterized by the pro-
duction of high levels of1'GFj3 as well as IL-4 (211). Functionally, Th3 cells are implicated 
in regulating mucosal immune responses and can play a role in preventing autoimmune 
responses. In addition, a CD4+ T cell subset specifically regulating Th 1 responses has been 
described (212). This eflector phenotype, designated Tri (regulatory T cell-I), is character-
ized by the production of high levels of IL-I 0 in the absence of appreciable amounts of 
IL-4. 
1.8. REGULATION OF HELPER T CELL DIFFERENTIATION 
The differentiation of uncommitted naiVe Th cells into Th I or Th2 effector cells is a 
tightly regulated process. Recently, considerable progress has been made in understanding 
the underlying mechanisms governing this program of cellular difterentiation (I 88, 213-215). 
In particular, the regulation of Th2 difterentiation has been revealed into great detail (I 91, 
216-226). A new model for Th cell differentiation can be extracted fi'om these studies. This 
model is depicted in figure 10 for Th 1 differentiation and in figure II for 1'112 differentiation. 
In order to enter the genetic program leading to Tit cell differentiation, the resting naiVe 
Th cell needs to receive concomittant activating (TCR-delivered) and differentiation-induc-
ing (cytokine receptor-delivered) signals (226). Upon activation by TCRaj3 mediated signals 
(in the presence of costimulation), the naiVe Th cell will enter the cell cycle and start express-
ing low levels of IL-2 (217, 226). Expression of other cytokine genes upon activation requires 
enlly of the activated naIve Th cell into the S phase of the first cell cycle, underscoring the 
requirement for de /laVa DNA synthesis of cytokine gene expression (217, 226). Full differ-
entiation into Thl or Th2 effector cells, characterized by high-level cytokine production 
requires several cell divisions, taking generally up to 4 days (213). 
Cytokine-induced signaling pathways are essential in driving the differentiation of acti-
vated naiVe CD4+ T cells from the cOlllmon precursor into either phenotype (187, 201, 202, 
227, 228). IL-12 induces the differentiation of naIve Th cells into the Th I eftector phenotype 
(229-232) by activating the transcription factor Stat4 (for signal transducer and activator of 
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transcription-4) (225, 233, 234). IL-4 directs CD4+ T cell dificrentiation towards the Th2 
efiector phenotype (235-238), which is mediated by Stat6 activation (239-241). Therefore, 
the activation of Stat4 versus Stat6 is critical in inducing Ih cell difterentiation in response 
to cytokines. Stat-independent induction of Ih cell difierentiation, however, has also been 
repOIted (224, 242-244). Nevertheless, in the majority ofTh cell-mediated immune respons-
es, Ih cell differentiation seems to be dependent on cytokine-mediated activation ofStat-fac-
tors. 
Over time, Th cell phenotypes becollle stabilized (245). This is in part due to loss of 
sensitivity to cytokine-induced difierentiative signals (188, 246). Whereas Thl cells have 
been shown to have a loss of sensitivity to IL-4R-mediated signal transduction (247), Th2 
cells actively downregulatc the IL-12R[l2 subunit, resulting in a complete loss of IL-l2-
induced signal transduction (191, 225). In addition to a loss-ot~sensitivity to cytokine-medi-
ated differentiative signals, Tit cells acquire fixed and heritable chromatin structures at rele-
vant genetic loci, such as those containing cytokine genes (213, 248). This epigenetic regu-
lation of eftector gene expression contributes to Ih cell phenotype stabilization. 
In addition to chromatin changes at relevant genetic loci, transcription factors playa 
central role both in the regulation of Th cell dificrentiation and in the cell type-specific 
expression of (cytokine) genes (188, 213, 215, 246). Recently, it has become clear that tran-
scription t:'lctors playa dual role in the regulation ofTh cell differentiation by actively induc-
ing difterentiation into the one lineage while actively repressing differentiation into the oppo-
site lineage (188, 214, 215). The recently identified transcription t:1Ctor T-box expressed in T 
cells (T-bet), was shown to be expressed in Thl cells but not in Th2 cells (249). Expression 
ofT-bet, however, is not confined to the T cell lineage, and is also correlated with expression 
of IFNy in B cells and NK cells. During Th cell difierentiation, expression of T-bet was 
shown to induce IFNy production and actively repress !L-4 and especially !L-5 production. 
In Th2 clones, ectopic expression ofT-bet resulted in suppression of IL-4 and IL-5 expres-
sion, but not in induction of IFNy expression (249). 
Conversely, expression of the transcription factor GATA-3 has been shown to be upreg-
ulated during Th2 differentiation and downregulated during Till differentiation (250, 251). 
GATA-3 expression in uncolllmitted helper T cells results in repression of IFNy-production 
and induction ofTh2 differentiation independently ofStat6 (224). In addition, ectopic expres-
sion of GATA-3 in committed Thl cells induced Th2 cytokine expression and chromatin 
remodeling at the 1L-4 loclls reminiscent of Th2-colllmitted cells, whereas repression of 
IFNy-production by GATA-3 was inconsistently observed (221). Both GATA-3 and T-bet are 
induced by TCR-mediated Th cel! activation (249, 250). In addition, Stat4 induces T-bet aud 
represses GATA-3, whereas Stat6 induces GATA-3 (191,223,249). The effect of Stat6 on 
T-bet has not yet been analyzed (249). In conclusion, the induction ofT-bet versus GATA-3 
might be decisive in the differentiation of naiVe Th cells into Th I or Th2 phenotypes (188, 
215). 
1.9. SIGNAL TRANSDUCTION BY THE IL-4 RECEPTOR 
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ILA-induced signaling pathways are key regulators for driving Th2 differentiation. The 
IL-4 receptor (IL-4R) complex is responsible for transmitting the !lA-delivered signals 
across the cell membrane (252). The IL-4R complex contains the ILARa chain which binds 
!L-4 with high affrnity, and the common gamma chain (ye), which is also used by the IL-2 
and IL-7 receptor complexes (253). Non-hematopoietic cells have been described to use IL-
13Ra rather than yc to form a functional IL-4R complex (254). 
Signal transduction by the ILAR complex is dependent on activation of Janu~ kinase 
(Jak)-family members of receptor associated tyrosine kinases (255). Jak-I and Jak-3 arc con-
stitutively associated with ILARa and yc chain, respectively (figure 9; 256, 257). The 
IL-4Ra chain is 785 amino acids long, containing a 553 amino acid cytoplasmic region (258), 
which contains five highly conserved tyrosine residues. Binding ofIL-4 to ILARa induces 
heterodimerization of the !LARa chain with the yc chain, resulting in tyrosine phosphOlyla-
@ 
I common 
IL-4Ra .. gal1)ma?iL-4\ ?iL-4\ 
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EjJ' 
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FIGURE 9 
Signal h'ansductioll by tbe IL-4 receptor cOlllplex. 
Binding ofIL-4 to tbe extracellular part of the IL-4Ra chain induces heterodimerization with the cornmon gamma 
chain. As a resuit, Jak kinases, which are constitutiyely associated to the intracellular part of the receptor chains, will 
phosphorylate critical tyrosine residues in the cytoplasmic tail of the cytokine receptor. These phosphorylated tyro-
sine residues serye as docking sites Jor multiple signaling molecules. In the case of lL-4, Jakl phosphoryhttes tyro-
sine residues in the IL-4Ra chain, whieh induced Stat6 docking to these phosphotyosine residues. Phosphorylated 
Stat6 homodimerizes and transioeatcs to the nucleus to initiate gene transcription of IL-4-responsive genes. 
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tion of Jak-I and Jak-3 and consequently in rapid tyrosine phosphOlylation of the IL-4Ro. 
chain itself(252, 259). These phosphOlylated tyrosine residues then serve as docking sites for 
downstream signaling proteins which recognize these residues with their Srcwholllologyw2 
(SH2) or phosphotYl'Osine-binding (PTB) domains (252). Downstream signal transduction 
pathways include the insulin receptor substrate (IRS)w 112 pathway and the activation of Stat 
factors. Activation ofIRS-112 by IL-4R engagement induces cellular proliferation in response 
to TL-4 (260, 261). 
Activation of Stat factors by activated Jak family members is responsible for the rapid 
induction of gene transcription by cytokines (262, 263). Stat-6 is the primary Stat protein 
h1mily member activated in response to IL-4, and is responsible for the induced or enhanced 
transcription of IL-4-responsive genes (239, 241, 264, 265). Stat-6 binds the phosphOlylated 
tyrosine residues in the IL-4Ra chain through a highly conserved SH-2 domain. Activated 
Jak kinases then activate Stat-6 by phosphorylation of a C-tenninal tyrosine residue (266). 
PhosphOlylated Stat-6 homodimerizes and translocates into the nucleus to activate gene tran-
scription (263, 267). Activated and dimerized Stat factors recognize the semi-palindromic 
DNA sequence TTC(N)3/4GAA known as IFNy-activated sequence (GAS) motif (268). 
1.10. REGULATION OF IL-4R-MEDIATED SIGNAL TRANSDUCTION 
Signal transduction of the IL-4R complex can be modified by multiple mechanisms. A 
more generalized regulatory mechanism in tyrosine-phosphorylatiollwdependent signal trans-
duction is dephosphOlylation of signaling intermediates by phosphotyrosine phosphatases 
(PTP) such as SH-2 containing posphatases SHP-I and SHP-2 or the SH-2-containing inosi-
tol-5-phosphatase (SHIF) (269). A modulatory role for these PTP in !L-4-induced signal 
transduction has been suggested by studies using phosphatase inhibitors (270). 
Another regulatOlY mechanism in IL-4R mediated signal transduction involves direct 
inhibition of Jak-I activity by suppressor ofcytokine signalling-I (SOCS-I) (271). SOCS-I 
inhibition of Jak activity is mediated through interaction of a conserved SH-2 domain in 
SOCS-l with a critical tyrosine residue in the activation loop of Jak proteins, resulting in 
diminished Stat activation (272). This efiect of SOCS-I on Jak- I -mediated Stat6 activation 
could be due to shielding of the critical phosphotyrosine in Jak-I, or alternatively to target-
ing of Jak- I for pl'Oteosomal breakdown. As SOCS-I is an immediate-early gene induced by 
IL-4wmediated Stat-6 activation, this regulatory pathway resembles a classical negative feed-
back loop on !L-4-mediated signal transduction (273). 
SOCS-l is a member of a family of SH-2-containing proteins which exert a specific 
negative regulation of the Jak/Stat pathway (273-276). The regulatory activities of this fam-
ily of proteins were first recognized in SOCS-l, which was characterized as an inhibitor of 
!L-6-induced Jak/Stat-mediated signal transduction by three groups independently (277-279). 
These groups called the protein SOCS-I, Stat-induced Stat-inhibitor- I (SST- I) and JAK-
binding protein (JAB), respectively. The molecule was characterized to be a family member 
of the already cloned cytokine-induced Scr-homology-2 containing (CIS)-I protein (280). 
The SaCS-family of adaptor proteins is characterized by a central SH-2 domain and a C-ter-
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minal conserved region called the SOCS-box domain (figure 7). The CIS/SOCS family of 
proteins contains 8 members (CIS-l and SOCS I-SOCS7) (281). The mechanisms of inhibi-
tion of Stat activation differ between family members (276). CIS-l has been shown to direct-
ly bind to phosphmylated residues on the IL-3Rfl and erythropoietin (EPO) receptor chain, 
and plays a role in the inhibition of IL-3- and EPO-induced Stat activation (280). SOCS-I 
and SOCS-3 have been shown to specifically associate with phosphmylated Jak proteins 
using their central SH-2 domains and N-terminal flanking sequences (282, 283). SOCS pro-
teins have been implicated in proteosomai breakdown of their targets, as it was shown that 
the SOCS-box interacted with elongin-S/C (284). Mice with a targeted deletion of SOCS-1 
were reported to succumb to a complex disease associated with IFNy hyperresponsiveness 
(285, 286). SOCS-2-targeted mice displayed markcd gigantism, associated with deregulated 
growth hormone and insulin-like gro\\1h factor signaling (287). Targeted deletion of 
SOCS-3 resulted in early embryonic death associated with marked erythrocytosis, whereas 
enforced expression of SOCS-3 results in a specific suppression offetal erythropoiesis. These 
data implicate SOCS-3 in the negative regulation of fetal liver hematopoiesis (288). 
1.11. REGULATION OFThl DIFFERENTIATION AND GENE EXl'RESSION 
Thl differentiation of activated nalve Th cells depends critically on IL-12-induced acti-
vation ofStat4 (225, 229-234). The mechanism ofStat4-induced Thl differentiation, howev-
er, remains unclear (188, 215). Stat4 has been shmvn to downreguiate expression of 
GATA-3 and is suggested to induce expression ofT-bet (188, 223, 249). Taken together, these 
activities would favor differentiation ofTh cells into an IFNy-producing phenotype, as T-bet 
has been shown to strongly induce IFNy production, whereas OATA-3 downregulates IFNy 
production (221, 223, 249). However, 1L-2 gene expression, which is maintained in difteren-
tiated Thl but not in differentiated Th2 cells, cannot be dependent on T-bet, as this transcrip-
tion factor exerts a negative regulatmy eftect on 1L-2 transcription (249). The activity of 1'-
bet might be reflected in the lower levels of IL-2 cxpressed by difterentiated Thl cells as 
compared to naive activated Th cells (188). Still, additional factors must be responsible for 
the Th2-specific down-regulation of IL-2. 
As discussed earlier, expression of the Th I-specific fFNy gene is in part regulated by 
chromatin structure at the IFNy locus (216). Several intracellular signalling pathways con-
tribute to IFNy gene transcription (figure 10) (215). Activation-inducible transcription t:1ctors 
implicated in IFNy gene expression arc NF-KB, NF-AT andATF-2 (215). IL-18-mediated sig-
nal transduction, resulting in NF-KB activation, has been reported to strongly enhance IFNy 
production (289). Two NF-AT binding sites were initially characterized, one of which was 
shown to also bind NF-KB (290, 291). In addition, two NF-AT sites have been identified by 
DNA footprinting analyses (292). Finally, the MAP kinase pathway appear~ to contribute to 
IFNy production (293, 294). Additional transcription factors putatively regulating IFNy gene 
expression are jun, CRES and Oct-I, which together with ATF-2 bind a 25 bp proximal pro-
motor region (295). RegulatOlY elements in the LFNy promotor region interacting with the 
newly described Thl-specific transcription factor T-bet, which has been shown to induce 
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potent IFNy prodnction, have not yet been described (249). 
Regulation of JL-2 gene expression seems to be directly controlled by the 300 bp prox-
imal promotor region, which has been shown to confer tissue specificity and inducibility in 
transient transtection studies in vitro (296). The proximal 300 bp promotor region contains 
multiple composite NF-AT/AP-I binding sites as well as an NF-KB site, two Oct sites and the 
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CD2SRE, all of which are essential for optimal lL-2 expression (297). This proximal promo-
tor region, however, was insufficient for ill vivo high levellL-2 expression in a transgenic 
mouse model, which instead required a more exteuded 600 bp lL-J promotor region (298). 
The additional 300 bp upstream of the proximal promotor region probably contain regulato-
ry elements required tor chromatin remodeling at the lL-2 locus (297, 299). In addition, 
post-translational regulation implemented at the level of lL-2 mRNA stability is mediatcd by 
CD2S-delivered signals, and reflects the biochemical equivalent of costilllulation (300). 
1.12. REGULATION OF Th2 DIFFERENTIATION AND GENE EXPRESSION 
Th2 differentiation of activated na'ive Th cells is most efficiently induced by 
IL-4-dependent Stat6 activation (235-241), although Stat6-independent Th2 differentiation 
has been observed (224, 243, 244). In one of these cases, the Th2 differentiation was depend-
ent on GATA-3, suggesting an autoregulatory mechanism to be responsible for the Stat6-
independent GATA-3 activity (224). The other rcports have not addressed the issue of the 
GATA-3 dependence of the Stat6-independent Th2 differentiation (243, 244). It seems 
unlikely that Stat6 directly induces lL-4 gene transcription (30 I). An inducible activated form 
of Stat6 was shown to induce GATA-3 and c-Maf in Thl cells, resulting in ILA production 
(220). Ectopic expression ofGATA-3 in polarized Thl cells induced Th2 cytokine expression 
and chromatin remodeling at the IL-4 locus reminiscent of Th2-conllnilted cells (221). So, 
activation ofGATA-3 by Stat6 scems to be the key event in Th2 differentiation (figure II). 
Transcription of the IL-4 gene is regulated by accessibility of chromatin at the lL-4 
loclls as described before, as well as by Th2 cell-specific and activation-inducible transcrip-
tion h1ctors (213). Studies in transgenic mice initially showed that a 3 kb region containing 
the JL-4 promotor could transfer tissue-specific expression of lL-4 (302). The elements 
responsible for preferential expression in Th2 cells were then demonstrated to be located in 
the -741-bp to +60-bp region of the lL-4 promotor (303). A more detailed analysis ofthe JL-
4 promotor region rcvcalcd the presence of five NF-AT sites, two of which are composite NF-
AT/Al)-l sites which werc shown to be critical for iu vitm induction of lL-4 gene transcrip-
tion (302, 304-30S). NF-AT family members are differentially expressed between Thl and 
Th2 cells. NF-ATcl was shown to be a direct transcriptional activator of the IL-4 gene (309-
311). The two other lymphoid family members, NF-ATe2 and NF-ATc3, have redundant roles 
in negatively controlling Th2 differentiation and IL-4 production, most likely by the induc-
tion of unidentified NF-AT target genes which playa critical role in negatively regulating Th2 
responses (l8S). 
The Th2 cell-type specific transcription factor c-Maf has been shown to play an impor-
tant role in ILA production (2IS, 219, 312). In mice with a targeted deletion of the c-Mqf 
gene, IL-4 production was severely impaired, whereas transgenic expression of c-l\1qfresult-
cd in an ILA-dependent increased Th2 differentiation and effector function (2IS, 219). The 
AP-l family member c-Maf is a basic region/leucine zipper factor and binds a consensus 
sequence (MARE for c-Maf responsive element) in the lL-4 proximal promotor region (312). 
Expression of c-MaJ is induced by TCR-mediated Th2 cell activation. Finally, the role of 
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GATA-3 in direct transactivation of the IL-4 promotor seems to bc minimal (188). 
Transcription of the IL-5 gene, however, is directly transactivated by GATA-3, which binds a 
double GATA-consenslls sitc at positions -70 to -59 in the proximallL-5 promotor (128, 251, 
313,314). 
The coordinate expression of the IL-4, IL-5 and IL-13 genes has recently been found to 
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be regulated by a conserved (84% homology between human and mouse) non-coding 
sequence located in between the /L-4 and IL-13 loci. This 402 bp sequence appears to be 
involved in the long-range regulation of gene transcription by modulating chromatin struc-
ture, and therefore functions as an LCR (222). It has been observed that this sequence con-
tains putative OATA-3 binding sites (315). Therefore, the IL-4, IL-5 and IL-13 proximal pro-
motor regions might only playa limited role in the regulation of cell-type specific expression 
of these Th2 cytokine genes. 
AIM OF THIS THESIS 
T cell differentiation is tightly regulated. Most of the regulatory processes involved in 
the differentiation of the various types of mature T cells, have not been elucidated into great 
detail. The aim of this thesis is to investigate the regulation of cell-fate decisions by T lym-
phocytes at variolls stages of their differentiation. 
\Ve analyze regulation ofTh cell differentiation at various levels, including regulation 
at the cellular level by production of cytokincs lL-4 and IL-I 0, intracellular regulation of the 
signals elicited by the TCR and the IL-4 receptor and the regulation by the transcription 1:1c-
tor GATA-3, which was shown to be essential and sufficient for Th2 diilerentiation. As 
GATA-3 has been shown to be critical for the development of the T cell lineage, we also ana-
lyze the role of this transcription factor during thymic differentiation of T cells into detail. 
In Chapter 1 a general introduction Oli T cell differentiation in the thymus and in the 
periphery is provided. In Chapters 2, 3 and 4 the role of OATA-3 in T cell differentiation is 
analyzed. To analyze transcription of the CATA-3 gene during T cell development, we gener-
ated a strain of mice in which a lacZ reporter gene was inserted into the CATA-3 locus. In 
Chapter 2, the levels of GATA-3 gene transcription at the subsequent stages ofT cell differ-
entiation are analyzed. In addition, we evaluated the contribution of LacZ-tagged GATA-3-
deficient ES cells to the T cell lineage in chimeric mice. 
To be able to investigate the role of OATA-3 in thymic as well as in peripheral T cell 
differentiation in vivo, we generated transgenic mice in which CATA-3 expression was mod-
ified. In contrast to the normal, modulated expression, i.e. low levels during phases of TCRa 
and TCR{3 gene rearrangement, in CD8 SP cells and in Thl cclls, the CD2 LCR provided 
expression throughout T cell differentiation. In Chapter 3, we describe the effect of dysregu-
lation of GATA-3 expression on T cell differentiation in the thYIllUS, and in Chapter 4 the 
effect of the enforced expression of GATA-3 on the differentiation ofThl and Th2 cells and 
on Th memOlY cell formation. 
Chapter 5 describes the analysis of ill vivo difterentiation of SIAl9 CD4+ T cells into 
effector phenotypes. These mice have a specific Th2-defect, characterized by low IgE 
responses, which can be attributed to a 1:1i1ure of SJA/9 CD4+ T cells to produce sufficient 
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!lA. In Chapter 6, an attempt is made to analyze the role ofSaCS-3 in T cell activation and 
differentiation. The sacs family of proteins has been implicated in the regulation of 
cytokine receptor signaling, indicating a potential role in Thl and Th2 diflerentiation. In 
Chapter 7, the results obtained ill this thesis project arc disclissed in the context of the current 
knowledge ofT cell differentiation. 
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ABSTRACT 
GATA-3 is a zinc-finger transcription factor which is essential for both early T cell 
development and differentiation of Th2 cells. To quantify GADJ-3 expression during T cell 
differentiation in vivo in the mouse, the GADl-3 gene was targeted by insertion of a IneZ 
reporter by homologous recombination in ES cells. Although we could detect GATA-3+ cells 
throughout T cell differentiation in the thymus, the proportions of GATA-3+ cells varied con-
siderably between the distinct stages of differentiation. The two periods of T cell receptor 
(TCR)a and TCR{3 gene recombination, which occur in quiescent or slowly dividing cells, 
were associated with low proportions of GATA-3+ cells. Conversely, the stage of rapidly pro-
liferating cells, which insulates these two waves of TCR gene rearrangement, was charac-
terised by a large proportion of GATA-3+ cells. In addition, we generated chimeric mice by 
injection of GATA-3-deficient, laeZ-expressing emblyonic stem cells into wild-type blasto-
cysts. In this ill vivo competition analysis, no contribution of GATA-3-deficient cells to the T 
cell lineage was detected, not even in the earliest CD44+CD25- double negative (CD4-CD8-) 
cell stage in the thymus. These results parallel data implicating other GATA family members 
as key regulators of proliferation and survival of early hematopoietic cells. \Ve therefore pro-
pose that GATA-3 is required for the expansion ofT cell progenitors, and for the control of 
subsequent proliferation steps, which alternate periods of TCR gene recombination in the 
thymus. 
INTRODUCTION 
T-cell differentiation proceeds in the thymus through a highly regulated program in 
which precursor cells from fetal liver or bone marrow expand and progress through a series 
of distinct maturational stages (\,2)_ On the basis of CD4 and CD8 expression, thymocytes 
can be subdivided into four main popUlations, the most immature of which are the CD4-CD8-
double negative (DN) cells. A detailed assessment of differentiation stages within the DN 
compartment, which represent only 2-5% of adult thymocytes, is based upon TCR loci con-
figuration and expression of the surf.1ce markers CD44 (phagocyte glycoprotein-I) and CD25 
(lL-2R n-chain) (2-3). The most immature DN population has the CD44+CD25- phenotype, 
and the transition to the next stage is marked by the induction of CD25 (4-7). During the next 
step, the CD44+CD25+ DN cells decrease in size and TCR{3 gene rearrangements are initiat-
ed and completed. Only those cells that produce a functional TCRB chain are then selected 
for further maturation, enter the cell cycle and expand rapidly to generate CD44-CD25- cells 
(1,2.4). These cells upregulate CD4 and CD8 expression and concurrently initiate TCRa gene 
rearrangement. Subsequently, CD4+CD8+ double positive (DP) cells are positively selected 
on the basis of TCRnj3 expression and differentiate flIrther into either CD4+ or CD8+ single 
positive (SP) mature thymocytes (I). 
Several transcription i:'lctors have been shown to be essential for the differentiation of 
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the T cell lineage (5,6). One of these is GATA-3, which belongs to a family of transcription 
factors that bind to a GATA consensus motif through a highly conserved C4 zinc finger 
domain (7-9). GATA-3 is abundantIy expressed in the developing central nervous system, 
adrenal gland and kidney, but within the haematopoietic system expression appears to be COll-
fined to T cells (10-12). Mice with targeted null mutations of the GATA-3 gene die on embry-
onic day 12, displaying anaemia and central nervous system defects (10). GATA-3 was shown 
to be expressed in the most immature subset of day 12 fetal thymus cells, \vWch have the 
CD44+CD25- DN phenotype, and was shown to be essential in early T cell development, 
using anti-sensc GATA-3 oligonucleotides in fetal thymic organ cultures (13). Moreover, 
RAC-2-1- complementation experiments in vivo demonstrated that the differentiation of 
GATA-3'/' T cells is blocked at or before the CD4'CD8' DN stage of thymocyte developmeut 
(14). In addition to this very early requirement, GATA-3 is selectively expressed in mature 
Th2 cells (15,16). GATA-3 binding sites are prescnt in the promoter regions of all Th2 
cytokine genes, as well as in regulatory regions of the CD8a, TCRa, TCR{3 and TCRi5 genes 
(5 and references therein). 
It is currently not known at which mahlrational stages GATA-3 exerts its critical 
function. We have targeted the GATA·3 gene by inserting a laeZ reporter by homologous 
recombination in ES cells. The presence of the lacZ reporter gene, placed under direct 
GATA-3 transcriptional and translational control, enabled us to quantify the GATA-3 expres-
sion profile during T cell differentiation ill vivo, revealing an association between GAT/1-3 
expression and steps of cellular proliferation. \Ve have also generated chimeric mice by 
injecting laeZ-expressing embryonic stem (ES) cells into wild-type blastocysts, and followed 
these cells during T cell differentiation. 
MATERIALS AND METHODS 
GENERATION OF HETEROZYGOUS AND CHL'IEIUC l'IHCE 
The generation of the targeting vectors, containing the E. coli 1llslacZ and the 
taulaeZ- Iwgromycin fusion genes has been described (Van Doorninck et al., submitted). 
Briefly, the genomic murine CATA-3 gene was PCR-modified by introducing an Neal restric-
tion site at the start codoll. Subsequcntly, a BspHI-X/lO/ fragmcnt with a nlslaeZ cassette (19) 
was insel1ed in-frame into the Nco! and Cia! sites of the genomic GATA-3 fragment, delet-
ing most of the second exol1. To generate the 1llslacZ targeting construct, the modified frag-
ment was ligated to a subclone, containing the PGK-hygromycin resistance gene cassette 
(kindly provided by H. te Riele), and to the downstream4-kb EeoRi-SacI genomic fragment, 
containing the thymidine kinase gene from the previously described GATA·3'''o targeting con· 
stmct (10). The GATA-3 laulaeZ vector was derived from the IIlslaeZ targeting construct by 
exchanging the Ills by a tau fragment (Van Doorninck et al., submitted). E14 ES cells were 
cultured and transfeeted as described (19). Homologous recombinants were screened by 
Southern blot analysis and chimeric mice were generated by injection of homologous reCOlll-
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binant ES cells into C57BL/6 blastocysts. To obtain the heterozygous GA1fl_J+/1I1s1acZ and 
GA1I1':'3+//0111(1CZ for the lacZ expression studies, wild type E14 ES cells were transfected. 
Chimeras were crossed with C57BLl6 wild type mice to yield GATA-3+/a{;/"cz mice, 
GATA_J+//mdacZ mice, as well as GATA-J+/+ mice, which served as controls. For the genera-
tion of the chimeric mice (figure 4) GATA_J+llacZ and GATA_JllcollacZ ES cells were obtained 
by transfection ofGA7IJ-3+/aw ES cells (10), with a targcted deletion within the GATA-3 genc 
on one allele (tigure I). 
FLOW CYTOMETRIC ANALYSES 
Preparation of single-cell suspensions, determination of f)-Galactosidase activity using 
FDG and subsequent incubations with mAb have been described previously (19). For three-
colour flmv cytometry 0.5-1xl05 events were scored using a FACScan analyzer (Becton 
Dickinson, SUll1lyvale, CA). For four-colour analysis, Ixl05 - 2xl 06 events were scored using 
a FACSCalibur dual lascr instrument (BD). The following mAb were purchased from 
Pharmingen (San Diego, CAl: PE-conjugated anti-CD4 (L3T4), anti-CD25 and anti-
CD II b/Mac-I, Cy-Chrome conjugated anti-CDS (Ly-2), anti-CD44 and anti-B220 
(RA3-6B2), biotinylated anti-CD4, anti-CDS and anti-lgM. Secondary Ab used were PE-con-
jugated (Caltag Laboratories, CAl or allophycocyanin (APC)-conjugated streptavidin 
(Phanningen). FOG and To-Pro3 were from Molecular Probes Europe BV (Leiden, The 
Netherlands). 
Till AND TIl2 CELL CULTURES 
Single cell suspensions from spleen were enriched for T cells by incubation with mAb 
to MHC class II, CDI6/32, heat stable antigen, and Gr-I and subsequent treatment with rab-
bit C. The resulting cell suspensions were incubated with biotinylated anti-CD40, anti-B220 
and anti-CDS, and subsequently with streptavidin-conjugated microbeads. Using a MACS 
column separation, cell populations were obtained that were ~90% CD4. Cells were cultured 
in the presence of 10 mglml anti-CD2S and 50 U/mJ IL-2 in plates pre-coated with 50 mg/ml 
anti-CD3. Priming for Th I responses was with 50 nglml IL-12, 100 U/ml IFNy and 10 flg/ml 
anti-IL-4 and for Th2 responses with 50 flg/ml IL-4 and 10 ftg/IllI anti-IFNy. After 4 days of 
culture, cells were transferred to new 96-wells plates, coated with anti-CD3, and at day 7 lacZ 
expression was determined as described above. 
RESULTS 
WITHIN THE HEMATOPOIETIC SYSTEM GATA-3 EXPRESSION IS 
RESTRICTED TO THE T-CELL LINEAGE 
To follow the expression pattern of GATA-J, mice were generated in which a lacZ gene 
was introduced at the ATG translation stali, either fused a nuclear localisation signal sequence 
(1I1s1acZj, or to the tall gene (talllacZj, resulting in cytoplasmic lacZ localisation (figure I). 
The expression of GATA-3-dirccted lacZ was analyzed in heterozygous GA1I1_3+/nls/acZ 
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The horizontal line represents GA1;'1~3 genomic DNA. The tour exolls (EI to E4) of the GATA-3 gene are depicted 
by boxes. The arrows indicate the orientation of the hygromycin (hyg) and the neomycin (nco) resistance genes. TIle 
restriction enzyme sites shown include B, BamHI; C, ClaI; H, HindlIl; R, EeoRI; N, Ncol and S, SacI. 
and GATA-J+IllIIdacZ mice, by using fluorcscein-di-B-D-galactopyranoside (FDG) as a sub-
strate in flow cytometric analyses. Single cell suspensions fi'om thymus, spleen, mesenteric 
LN and peritoneal cavity of 5 ,veek-old mice were evaluated for laeZ activity in conjunction 
,vith surface expression of B cell- or T cell-specific surface markers. The analyses described 
below were performed on GATA_J+/nMacZ mice. In addition, we independently investigated 
GATA_J+ltmdacZ mice, in which comparable proportions of laeZ+ cells were identified in the 
individual stages ofT cell development. 
In spleen and mesenteric LN, expression of GATA-J was found to be restricted to 
CD4+ T cells, which manifested proportions of laeZ cxpressing cells of22-25%, while laeZ 
activity was velY low in CDS+ T cells, and absent in B cells (figure 2). No laeZ activity was 
detected in the Mac-I hi myeloid or Mac-I lo NK cell populations in the spleen and peritoneal 
cavity (data not shown). 
To verify that the laeZ activity of the targeted GA1I1_3nlslacZ allele reflected the actu-
al expression pattern of the GATA -3 gene, we investigated purified splenic CD4+ T cells fiOlll 
heterozygous GATA_J+lnls1acZ mice after in vitro culture lIsing priming conditions for either 
Till or Th2 cells. During the differentiation to Th2 cells, the proportion of laeZ+ cells 
increased fi'om 6-12% in freshly isolated splcnic CD4+ cells to -40% in activated CD4+ T cell 
blasts at day 7, whereas after all analogous Th 1 priming, lacZ expression decreased to unde-
tectable levels. These results are consistent \vith the repOIied specific expression of GATA-3 
in Th2 cells (15,16). 
EXPRESSION OF GATA-3 DURING EARLY T CELL DIFFERENTIATION 
In the thymus, a significant propOliion of the CD4-CD8- DN early cell fraction (28'Yo±13) 
expressed laeZ (figure 2B). To investigate the GATA-3 expression profile in this fraction in 
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Three-colour flow cytometric analyses of GATA_3+lnlslacZ cells from mesenteric LN (A) and thymus (il). Data arc 
shown as 5% probability CD4/CD8 contour plots (left). The indicated populations were gated and analysed for loc2 
expression. The results are displayed as histograms with the percentages of lacZ+ cells indicated (right). The CD4-
CDS- cell population in LN consisted for >98% ofB cells. 
(C) Four-colour flmv CytOlllctriC analyses of GATA_3+lnlslacZ cells from thymus. CD4-CD8- DN cells with relative-
ly high forward scatter were analysed for CD25 and CD44 expression, as displayed in 5% probability contour plots 
(left). The gated tour populations were analysed for 10cZ expression; the percentage of laczt cells is indicated in the 
histograms (right). 
(D) Summary of GATA-3 gene expression during T cell differentiation. In tbe indicated stages, the proportions of 
10cZ+ cells are given as mean ± SD of 6-13 mice examined. 
more detail, we performed four-colour t10w cytometry. The ON cell populations with high 
forward scatter characteristics were gated, and subdivided into four populations, based on dif.-
ferential expression of C044 and C025 (figure 2C and 20). LacZ was expressed in 23±5% 
of the most immature population of C044+C025- pro-T cells. The size of this lacZ+ Ii-action 
decreased to 6%±2 after transition to the next differentiation stage ofC044+C025+ ON pro-
T cells. [n the next stage ofC044-C025+ ON pre-T cells 14%±2 of the cells were lacZ+. This 
popUlation mainly contains non-dividing small cells, where TCR{3 rearrangements are initiat-
ed and completed (1,17, IS), but S-I 0% are large-sized cycling cells in which the appearance 
of a functional TCR!> chain has triggered rapid cell division (I,IS). These !>-selected cells 
subsequently downregulate C025 to give rise to the C025-C044- ON subpopulation that 
entirely consists of large proliferating cells. This subpopulation manifested a high proportion 
of lacZ expressing cells (38±3%, figure 2C and 20). When they progress (0 the next matura-
--COB ------.. 
--FSC~ 
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FIGURE 3 
Correlation between GATA~3 expression and cell size. 
(D) Three~colour flow c}1ometric analyses of GATA~ 
3+!lIlslacZ cells from thymus. A 5% probability 
CD4/CD8 contour plots is shown (top left). The indicat~ 
ed CD4+CDS+ DP thymocyte population was gated and 
1)< analysed for laeZ expression (top right). TIle FSC of the 
-- lacZ ------.. laeZ+ and laeZ+ DP cell populations are displayed as 
-- FSC------.. 
histogram overlays (bottom left). TIle mean FSC was 
380 for the laeZ+ and 327 for the laeZ- cell population. 
For ccll cycle analyses, thymocyte cell suspensions were 
labelled with anti-CD4, anti-CDS and To-Pro3. 
CD4+CDS+ DP thymocytes were gated and analysed for 
FSC and DNA-content. The 5% probability contour plot 
displayed (bottom right) shows that cycling cells (S, G2 
and !v[ phase) have larger FSC values. 
tion stage of smaller, non-dividing CD4+CD8+ DP cells, in which the TCRa gene reanange-
ments occur (1,17), GATA-3 expression decreased: 160/o±6 of the cells were lacZ+. At the 
transition to the SP stages, the proportion of GATA-3 expressing cells increased, paliicularly 
in the CD4+ cells (to 840/o±6) but also in the CD8+ cells (to 33±12; figure 2). 
In sunUllaty, we found that the two waves TCR gene rearrangements were associatcd 
with low proportions of GADI-3 expressing cells, insulated by the CD25-C044+ DN cell 
stagc, which contained a large propOltion of GATA-3 positive cells (figure 20). 
CORRELATION BETWEEN GATA-3 EXPRESSION AND CELL SIZE 
The observation that the proportions of GATA-3+ cells are highest in developmental 
stages, in which cellular proliferation occurs, suggested coupling of GATA -3 expression to the 
cell cycle. As cycling thymocytes are larger in size (figure 3; 17), we analyscd the relation 
between GATA -3 transcription and the cell cycle by {aeZ expression and forward scatter 
(FSC) values, respectively. 
\Ve could not dctcct any significant differences in FSC values between lacZ+ and 
/acZ- cells in the mature CD4+ or CD8+ cell populations in thymus. In contrast, within the 
CD4+CD8+ cell population, we found that the lacZ+ population contained relatively more 
large cells (mean FSC~371±16, IF5), as compared to the lacZ~ population (mean FSC~ 
332±5) (figure 3). Within the four subsets of CD4-CD8- DN cells, a similar cOlTelation was 
only found for the CD44-CD25+ DN subset: mean FSC~663±19 for the lacZ+ population and 
mean FSC~583±8 for the lacZ- population. These results indicate that the correlation between 
expression of GATA-3 and cell size is only present during the phases of TCR{3 rearrangement 
(in CD44+CD25~ ON cells) and TCRa rearrangement (in CD4+C08+ cells). 
GATA-3 IS ALREADY REQUIRED AT THE EARLIEST T CELL PROGENITOR 
STAGE IN THE THYMUS 
To investigated whether GATA-3 deficient cells are able to contribute to the most imma-
ture subpopulation of CD44+CD25~ DN thymocytes, we compared the contribution of het-
GATA_3+fnls!acZ 
Chimera 
lacZ 
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FIGURE 4 
Absence of GATA_J/It'ollllslllcZ cells in the T cell lin-
eage in chimeric mice. 
Three- or tour- colour flow c}1ometric analyses of 
thymus or spleen cells. The indicated cell populations 
were gated and analysed tor /acZ expression. The 
results arc displayed as histograms with the percent-
ages of lac7..+ cells indicated. 
Cells were stained with FDG tor lacZ activity, biotiny-
lated anti-CD4 and anti-CDS and -streplavidin-APC, 
anti-CD25-PE and anti~CD44-CyChrome (top) or 
with FDG, anti-CD4-PE and anti-CDS~CyChrome 
(middle, bottom). The data shown arc representativc 
tor two GAT,-l_3+llIlsfacZ and fivc GA7il_JllcollllslacZ 
chimeric mice analysed. 
erozygous GATA_3+/nlslacZ and GATA-3 deficient GATA_3I/eoll/ls/ucZ ES cells to the T ceilline~ 
age in chimeric mice generated by injection into wild-type blastocysts. These two different 
types ofES cells were obtained by electroporation of GATA-3+/l/eo ES cells, which have a tar-
geted deletion within the GATA-3 gene on one allele (figure I; 10), dependent on the allele 
where the homologous recombination with the GATA-31IacZ-Hygl'O targeting vector had 
occurred. Because we could follow the ES-cell derived thymocytes and T cells by their l([cZ 
expression, this system provides an ill vivo competition assay (19) to detect the proliferative 
ability of GATA-3 targeted cells. 
Both types ofES cells contributed significantly (50-70%) to heart, brain, kidney and 
lungs, as assessed by glucose phosphate isomerase isozymes and Southern blot densito-met-
ric analyses (data not shown). In these assays, only the GATA_3+llIlslacZ ES cells contributed 
to the thymus. Consistent with these findings, lacZ+ cells ,,,ere present in the CD4+ popula-
tion in spleen and thymus of the two GATA_3+/JllslacZ chimeras analysed (figure 4). Also with-
in the CD4-CD8- DN compartment, low but detectable numbers of laeZ expressing cells were 
present in the GATA_3+llIlslacZ chimeric mice. \Vhen we analysed the most immature thymo-
cyte population ofCD25-CD44+ DN cells, the GATA-3+;a','acZ chimeras contained -2% lacZ+ 
cells (figure 4). 
In contrast, no contribution of the GATA_311i!o!1I1s1acZ ES cells to the T cell population 
in the spleen or thymus was found in the five chimeras analysed (figure 4). Also within the 
CD44+CD25- DN subpopulation of GATA_3+;aMacZ chimeras, a distinguishable population of 
lacZ expressing cells could not be identified. The fractions of cells «0.5%) that were pres-
ent as a shoulder of the histogram, were also found in non-chimeric wild-type control mice, 
and latgely consisted of Mac- I + cells with high background autofluorescence levels (data not 
shown). Likewise, l([cZ+ cells could not be detected in any of the three other DN subsets, 
defined by CD44 and CD25. In sunuuaty, these results showed that GATA-3-deticient cells 
did not contribute to the T cell lineage, not even to the earliest CD44+CD25- DN cell stage in 
the thymus. 
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DISCUSSION 
The insertion of a lacZ reporter cassette enabled us to perform a quantitative assessment 
of ill vivo GATA-3 expression in each successive step ofT cell differentiation. The two thy-
mocyte populations that largely consist of slowly dividing cells that are in the process of rear-
ranging their TCRP and TCRa loci, contained the lowest proportions of GATA-3 expressing 
cells. Moreover, these two cell populations were the only ones in which we observed a cor-
relation between GATA-3 expression and cell size (figure 3). The two waves of TCR gene 
rearrangements were insulated by a developmental phase of large cycling cells with a high 
propmiion of GATA-3+ cells. As the CD44'CD25+ DN population consists of two subsets, 
representing resting cells prior to TCRP selection and cycling cells that have passed TCRP 
selection (18), our findings suggests that GATA-3 expression is upregulated in those cells that 
have passed TCRP selection. 
The apparent coupling of GATA-3 expression to the cell cycle would parallel lindings for 
other GATA family members. Overexpression of GATA-l was shown to overcome terminal 
erythroid difterentiation and to result in a higher level of cell division, suggesting that 
GATA-l is a master regulator of the choice between proliferation and difierentiation, by act-
ing on the cell-cycle apparatus in a dose-responsive manner (20). The activation of an oestro-
gen-inducible GA7I1-2 protein promoted proliferation and inhibited the terminal differentia-
tion of chicken primary elythroblasts (21). Analysis of GATA-2'/' ES cells and hematopoietic 
cells from yolk sac ill vitro showed that GATA-2 is required for the expansion of multipoten-
tial hematopoietic progenitors, but dispensable for the terminal differentiation of erythroid 
cells and macrophages (9,22). Over-expression of the cardiae GATA-4 protein in P 19 cells 
increased the number of cardiomyocytes following difterentiation (23). As over-expression 
of GA7II-6 in Xenopus blocked cardiac diflerentiation and increased the number of cells in 
the myocardium, it was concluded that GATA-6 may act to maintain heart cells in the precur-
sor state (24). The GATA-3 expression pattern, which we have identitied in this repmi, would 
allow a role for GATA-3 in the regulation of early T cell development towards cell division 
and differentiation via the cell-cycle machinery, thereby establishing the inverse relationship 
between TCR gene segment recombination and cellular proliferation. 
Our fmdings in the GATA_3I1collll.5lacZ chimeras demonstrated that the absence of GATA-3 
abolished the development of the most immature T-lineage cell precursors in the thymus, i.e. 
the CD44+CD25' DN cells. GATA-3 activity could be required for the proliferation or sur-
vival of cells within this immature fraction in the thymus, or alternatively for the 
development ofT-lineage restricted progenitors in fetal liver or bone marrow, which seed the 
thymus (2). The latter would be supported by the observation that GATA-3 antisense oligonu-
cleotides strongly inhibited the generation of T cells from fetal liver progenitors in fetal 
thymic organ cuihlres, while antisense oligonucleotides only had a limited suppressive effect 
on T cell development from fetal thymus progenitors (13). 
Tn summary, our results show that GATA-3 is required for the development of the earli-
est T cell progenitors and point at a role for GATA-3 in the control of proliferation steps, 
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which alternate the stages of differentiation in which TCR/3 and TCRo. gene rearrangements 
occur. The observed association of GATA-3 expression and cellular proliferation in early T 
cell precursors, makes it attractive to investigate T cell development in transgenic mice with 
manipUlated expression windows or expression levels of the GATA-3 transcription factor. 
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ABSTRACT 
The zinc-finger transcription factor GATA-3 is of critical importance for development of 
the T cell lineage and for commitment ofTh2 cells. To study the rolc ofGATA-3 in T ccll dif-
ferentiation, we analyzed and modified GATA-3 expression in vivo. In mice carrying a tar-
geted insertion of a laeZ reporter on one allele, we found that GA7I1-3 transcription in 
CD4+CD8+ doublc positive (DP) thymocytes correlated with the onset of positive selection 
events, i.e. TCRaB upregulation and CD69 expression. LacZ expression remained high (~80 
% of cells) during maturation of CD4 single positive (SP) cells in the thymus, whereas the 
fraction of lacZ expressing cells decrcased to <20% in CD8 SP cells. We modified this pat-
tern by ectopic GATA-3 expression driven by the CD2 locus control region, which provides 
transcription of GATA-3 throughout T cell difierentiation. In two independent CD2-GATA-3 
transgenic lines, ~50% of the mice developed thymic lymphomas before the age of9 months. 
These Iymphoblastoid tumors were DP CD69+ CD3+ cells that appeared to differentiate along 
the CD4 lineage. In tumor-free CD2-GATA-3 transgenic mice the total numbers of CD8 SP 
cells in the thymus were in the normal ranges, but their maturation was hampered, as indi-
cated by increased cell death of CDS SP cells and a selective deficiency of mature 
CD691oHSAlo CDS SP cells. In the spleen and lymph nodes the numbers ofCD8+ T cells were 
significantly reduced. These findings indicate that GATA-3 supports differentiation of .the 
CD4 lineage and inhibits the maturation of CD8 SP cclls in the thymus. 
INTRODUCTION 
In the thymus early CD4'CDS' double negative (DN) precursors develop into mature 
CD4 or CDS single positive (SP) T cells following a tightly regulated program of cellular dif-
lerentiation (1-4). The DN population is generally subdivided into four distinct stages ofdif-
ferentiatioll, defined by differential expression of the surface makers IL-2 receptor a chain 
CD2S and phagocyte glycoprotcin-I CD44 (S). Precursor T cells rearrange their TCR(3 genes 
during the CD2S+CD44' DN stage, and only those cells that produce a functional TCRfl pro-
tein proceed via a proliferative phase to the CD2S'CD44' ON stage (3, 6, 7). These cells rap-
idly upregulate CD4 and CD8, and stali to rcarrange their TCRa genes. 
After successful TCRa gene rearrangement, TCRaB-bearing immahIre cells are select-
ed for MHC recognition during the process ofpositil'e selection (8-10). Concomitantly, DP 
T cells will undergo lineage commitment to ensure the correlation of the TCR specificity for 
MHC class I with the CD8 lineage and for MHC class [[ with the CD4 lineage, respectively 
(2, II, 12). In addition, potential self-reactive T lymphocytes are eliminated by selection 
against seU:recognition within the MHC context (13). 
T cell development is regulated by a large number of transcription factors (14, IS). One 
of the transcription factors critically involved in T cell development is GATA-3, which was 
originally identified in the T cell lineage as a protein that binds to the TCRa gene enhancer 
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(16). GATA-3 is a member of a homily of transcription factors that bind a GATA-consensus 
motif through a highly conserved C. zinc-finger binding domain (17). Mice with a targeted 
deletion of GATA-3 die between embryonic day II and J 2, displaying massive internal blced-
ing and central nervous defects (18). GATA-3 expression is abundant in the developing cen-
tral nervous system, adrenal gland and kidney. \Vithin the hematopoietic system GATA-3 
expression is largely confined to T lymphocytes (18-21). In mature T helper cells, GATA-3 
has been shown to be essential for Th2 differentiation (22, 23), and has been implicated in the 
regulation of locus accessibility of the lL-4, lL-5 and fL-l3 genes by chromatin remodeling 
(24-26). 
The GATA-3 gene is already expressed in the earliest CD25'CD44+ DN progenitors in 
day J 2 fetal thymus (27). Antisense GATA-3 oligonucleotides inhibited T cell development 
from fetal liver precursors in fetal thymic organ cultures, indicating the critical importance of 
GATA-3 forT cell difierentiation (27). Moreover, RAG-2'" complementation experiments ill 
vivo demonstrated that the development of GATA-3'" emblyonic stem (ES) cell-derived T cell 
precursors is arrested at or before the DN stage (28). In such GATA-3"'IRAG-2'" chimeric 
mice, the GATA-3-deficient ES cells contributed significantly to nOllhaematopoietic tissues 
and to the erythroid, myeloid and 8 cell lineages. In chimeric mice generated by injection of 
GAul-3 deficient {acZ-expressing ES cells in wild-type blastocysts, we previously showed 
that GATA-3'" ES cells did not contribute to the T celliincage, not even to the earliest subset 
of CD25'CD44+ DN thymic DN progenitors (21). 
As GATA-3'" cells display a block before the earliest T cell progenitor, few data are 
available on thc role of GATA-3 during 'I cell development in the thymus. Using mice with 
an insertion ofa lacZ reporter in the GATA-3 gene on one allele (GATA_3+llIlslacZ), we exam-
ined the propoltion ofGATA-3 expressing cells as a function ofT cell development (21). We 
found significant GATA-3 expression at the earliest DN stage in the thymus. The two waves 
of TCR{3 and TCRu gene recombination were associated with low propOltions of {acZ+ cells. 
The stage of rapidly proliferating C044·CD25· ON cells, which demarcates these two peri-
ods of TCR realTangement, was characterized by a large proportion of lacZ expressing cells. 
The proportion of {acZ+ cells increased again as DP cells progressed into CD4 or CDS SP 
cells. The presence of significant proportions of {acZ+ cells withiil the CD8 SP 'I cell sub-
popUlation in the thymus was in strong contrast with the almost complete absence of lacZ 
expression in mature COS+ T cells in the periphery (21). 
The differential regulation of GATA-3 gene expression in the CD4 versus the CDS line-
age prompted us to investigate its expression during positive selection and CD4/CD8 lineage 
cOlnmitment in the thymus in more detail. \"le analyzed the GATA_3+llIlslacZ mice, using addi-
tionalmarkers for the maturation stages ofDP and SP cells, including CD3, TCRall, heat sta-
ble antigen (HSA), L-selectin (CD62L) and palticularly CD69, which is typically induced by 
TCR signaling and therefore marks cells that are in the process of positive selection (29-33). 
Furthermore, we investigated the functional role of GATA-3 during T cell deVelopment in 
vivo by the generation of transgenic mice with enforced GATA-3 expression driven by the 
human CD2 locus control region (LCR), which provides expression of the GATA-3 transgene 
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throughout T cell dillerentiation (34). 
MATERIALS AND METHODS 
MICE 
The GATA_3+lnfsfacZ mice in which one GA7IJ-3 allele was replaced by a lacZ reporter 
have been described previously (21). For the generation of the CD2-GATA-3 constl'llct, the 
translation initiation site was mutated (ATG to GTG) in a murine GATA-3 cDNA clone and 3 
HA epitope tags were added together with a new ATG and Kozak's consensus sequence. 
Subsequently, the - 2 kb mGATA-3 was cloned into a human CD2 mini-gene Bluescript SK 
vector, with -5 kb ofCD2 5'promoter sequence and - 5.5 kb 3' CD2 flanking sequences (35). 
The latter contained the 3' untranslated sequence and poly(A) addition site of the CD2 gene, 
as well as the LCR, which was shown to confer T-cell specific, copy-dependent, integration 
site independent expression in transgenic mice (34). A 13.2-kb linear fragment was injected 
into pronuclei ofFVBXFVB fertilized oocytes at a concentration of~2 nghtl. Founder mice 
were identified by genomic Southern blotting and crossed onto an FYB background. To deter-
mine the genotype of the subsequent generations, tail DNA was analyzed by Southern blot-
ting of either EcoRI IXbal double digests hybridized to a 2 kb Hilldlll CD2 LCR probe (36), 
or EcoRI digests hybridized to a 800 kb paliial GATA-3 cDNA probe (20). 
FLOW CYTOMETRIC ANALYSES 
The preparation of single-cell suspensions, determination of B-galactosidase activity 
using Iluorescein-di-jl-D-galactopyranoside (FDG), mAb incubations and three or four color 
cy10metry have been described previously (37). The following mAb were purchased from 
Phanningen (San Diego, CAl: FITC-conjugated anti-CD3c and anti-TCRajl, PE-conjugated 
anti-CD4 (L3T4), anti-CD24/heat stable antigen (HSA), anti-CD25 (clone 3C7), anti-CD62L 
and anti-CD69, CyChrome-conjugated anti-CD4, anti-CDS and anti-CD44, biotinylated anti-
CD4 and anti-CD8, APC-Iabeled anti-CD3c and anti-CD4. Secondary antibodies used were 
PE-, TriColor, or APC-coluugated streptavidin (Caltag Laboratories, Burlingame, CAl. FDG 
and To-Pro3 were from Molecular Probes Europe BV (Lei den, The Netherlands). FITC-
labeled Annexin V was from Nexins Research BV, Hoeven, The Netherlands. 
For intracellular detection ofGATA-3 protein, cells were fixed and permeabilized using 
para formaldehyde and saponin, as described (38) and subsequently incubated with the 
Hg-3-31 anti-GATA-3 MoAb (Santa CI'llZ, Dan Diego, CAl and FITC-Iabeled anti-mouse 
IgG I (Pharmingen) as a second step. 
Chapter 3 
RESULTS 
GATA-3 EXPRESSION IS STRONGLY Th'DUCED DURING POSITIVE SELEC-
TION OF DOUBLE-POSITIVE T CELLS 
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\Ve have previously quantified the GATA-3 gene expression profile during thymic T cell 
differentiation in vivo, by placing a laeZ repOlter gene, containing a nuclear localization sig-
nal, under direct GA7i1-3 transcriptional control. In these GATA_3+lnfs/acZ mice GATA-3 direct-
ed laeZ expression was analyzed by flow cytometl)' using fluorescein-di-B-D-galacto-pyra-
noside (FDG) as a p-galactosidase substrate, and differential expression of GATA-3 in DP 
(-16% IneZ+ cells), CD4 SP (-84%) and CD8 SP (-33%) cells was found (21). Since it has 
been shown that double positive T cells differentiate into mature single positive T cells via a 
series of phenotypically distinct subpopulations, reflecting the multistage process of positive 
selection and CD4/CDS lineage commitment (17-22), we investigated GATA-3 gene expres-
sion in these subpopulations in more detail. 
Upon MHC/TCRup interaction in DP cells, the surface expression of the CD69 marker 
is upregulatcd (29-32), followed by a down-regulation of the CD4/CDS coreceptor surface 
expression (2). Therefore, we analyzed laeZ activity in conjunction with surface expression 
ofCD4, CDS and CD69 (figure I). The majority ofDI' cells (-S5%) did not express CD69 
on the cell surface, and in this CD69- DP population lacZ was expressed in -19 % of cells. 
By contrast, within the CD69+ DP subpopulation, IneZ was expressed in -54% of the cells. 
After subsequent down regulation of coreceptor expression and transition into the 
CD4'oCD810 subpopulation, -86% of the CD69+ cells expressed IneZ (figure I). The 
CD4'oCD810 cells have been shown to subsequently enhance CD4 expression (2), thereby 
developing into the CD4+CDS'o subset, which still contains precursors for both CD4 and CD8 
single positive T cells (2, 39-41). LneZ expression was present in-86% of these CD4+CD8'0 
CD69+ cells (figure I). In addition, we found that in the DP, CD4IoCDS'o and CD4+CDS'o 
subpopulations, laeZ expression correlated with the expression levels of TCRuJ3 or CD3 on 
the cell sUlface (Shown for TCRup in figure I). These results indicated that the induction of 
GATA-3 transcription coincides with CD3 and TCRup upregulation and CD69 expression in 
DP cells. 
GATA-3 GENE EXPRESSION IS DOWNREGULATED AFTER COMMITMENT TO 
THE CDS LINEAGE 
Bipotential CD4+CD8'0 CD69+ T cells differentiate into either CD4 or CD8 SP cells by 
shutting down expression of the reciprocal coreceptor gene (2, 39-41). Final maturation of SI' 
thymocytes is accompanied by downregulation of CD69 and I-ISA on the cell surface and 
induction of high-level expression of CD62L and CD44 (33, 42, 43) 
As shown in figure I, laeZ expression was present in -87% of the cells committed to the 
CD4 lineage (CD4+CD8-CD69+TCRuPhi cells) and in -78% of the more mature CD4+ cells 
with a CD69-I-ISA'o surface profile. By contrast, during the maturation of CD8 lineage cells, 
-40% of the CD69+HSA + and only -16% of the mature CD69-HSA'o CD8+TCRuPhi cells 
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Analysis of /acZ expression in thymo-
cytes from GATA_3+1l1ls1acZ mice by 
four-color flow cyfomeh1', 
Thymus cell suspcnsions were loaded 
with the B-galactosidase substrate FOG 
and subsequently stained with anti-CD4, 
allti-CDS, in combination with anti-
C069, anti-TCRuB or anti-liSA antibod-
ies. Cells were analyzed for the expres-
sion of C04 and CDS, the indicated sub-
populations A-E were gated, and llnalyzcd 
for [aeZ expression and the fourth surface 
marker (C069, TCRc(B or liSA), The 
numbers indicate the percentage of /acZ 
expressing cells in the subpopulations 
analyzed. All samples are lymphocyte 
gated by forward and sideward scatter. 
Ovcrvie'v of the proportions of [(feZ 
expressing cells in the indicated thymo-
cyte subpopulations in GATA_3+lllhlacZ 
mice. The numbers are mean values ± SO 
(n=3). The background percentages of 
fl-galactosidase positive cells, as deter-
mined in wild-type control mice, was 
<1% in all subpopulations. 
expressed lacZ. Likewise) lacZ expression was found to be significantly downregulated in 
mature CD44+ and CD62L+ CD8+ cells (data not shown). The intensities of the fluorescence 
signals show that the lacZ expression levels per cell increased slightly during the maturation 
process ofCD4 SP cells, whereas CD8 SP cells displayed lower and more heterogeneous lacZ 
expression levels (figure IA). 
When the T cells leave the thymus, the proportions of GATA-3+ cells decreased to -20% 
of the CD4+ and to <I % of the CD8+ T cell popUlations in the spleen and lymph nodes. (21). 
For the CD4+ lineage cells in the spleen, we did not observe a clear correlation between 
GATA-3 and the expression of the HSA, CD69, CD44, CD62L or CD25 surface markers, 
which are instrumental to specify subpopulations of naiVe, activated or memOl), T cells (44) 
45). 
As summarized in figure I B) the proportions of GATA-3 expressing cells were low in 
CD3-TCRuB-CD69- DP cells (-19%), and increased at the onset of positive selection events, 
characterized by upregulation ofCD3 and TCRaf) surface expression and induction ofCD69. 
The proportions increased to ~86% at the stage of the last uncommitted subset of 
CD4+CD8!oCD69+cells, and remained high for the most mature thymic CD69-CD4+ subpop-
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ulation. By contrast, commitment to the CDS lineage \vas associated with downregulation of 
GATA-3 expression, resulting in <20% GATA-3+ cells within the mature population ofCD69-
CD8+ cells. 
TRANSGENIC EX 'PRESSION OF GATA-3 DRIVEN BY THE HUMAN CD2 LOCUS 
CONTROL REGION 
In order to modifY GATA-3 expression ill vivo, transgenic mice were generated in which 
the murine GATA-3 gene, 5' tagged with 3 HA epitopes, was expressed under the control of 
the human CD2 LCR (35). Two independent CD2-GATA-3 transgenic lines were established. 
No differences were found between the two lines in any of the performed analyses. The off-
spring did not manifest developmental defects or any increased sllsceptibilities to infectious 
disease or malignancies for over 9 months of age, with the exception of the observed thymic 
lymphomas discussed below. 
Expression of the CD2-GATA-3 transgene was evaluated by comparing total GATA-3 
levels in transgenic and non-transgenic littermates in intracellular flow cytometry experi-
ments, lIsing a mouse monoclonal antiserum specific for GATA-3. In the wild-type animals, 
the GATA-3 levels were low in DP cells, increased during positive selection in CD4!oCD8!o 
cells, and wcre high in CD4 SP cells (figure 2), consistent with our findings in the 
GATA-3+/JI/s/acZ mice (figure 1). 
In both transgenic lines, expression of the CD2-GA1I1-3 transgene resulted in elevated 
levels of GATA-3 protein in all stages of T cell development in the thymus, however there 
were major differences between the individual thymocyte subpopulations (figure 2). Due to 
the presence of the CD2-GATA-3 transgene, total GATA-3 protein levels were uniformly high 
in DP, CD41oCD81o, CD4+CD81o, and CD4+ cells. In CD8+ cells in the thymus and peripher-
al T cells, GATA-3 levels in the CD2-GATA-3 transgenic were close to those observed in 
Spleen 
coun,sL 
GATA-3 
CD4+ CDS+ 00 LA m 2J 
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FIGURE 2 
Exp.n~ssion of GATA-3 in thymus and spleen in 
wild-lnJc and CD2-GATA-3 transgenic mice. 
Cell suspensions were stained for surface CD3, 
CD4, and CDS expression, and subsequently for 
intracellular GATA-3 protein. The indicated T cell 
subpopuialions were gated and analyzed for 
GATA-3 expression. The results arc displayed as 
histograms of CD2-GATA-3 tnmsgcnic mice (bold 
lilies), together wit those of non-transgenic control 
mice {thin lilies). CD4-CD8- populations were gated 
on CD3- cells. CD4!oCDS!o cells and CD4+Cm;!o 
were gated 011 CD3+ cells. TIle numbers indicate the 
mean fluorescence intensities ill nontransgenic 
(llormal type) and CD2-GATA-3 transgenic mice 
(bold type). Data shown arc representative of6 mice 
examined within each group. 
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wild-type littennates. As CD2 surface expression in the individual T cell subpopuJations was 
comparable (data not shown), the observed modulated GATA-3 expression prome in the 
transgenic mice suggested the presence of post-translational regulation or an autoregulation 
mechanism by which GATA-3 protein levels regulate transcription of the endogenous 
GATA-3 gene (26, 46, 47). 
CD2-GATA-3 TRANSGENIC MICE HAVE DECREASED CD8+ T CELL NUlVIDERS 
IN THE PERIPHERY 
To analyze the effect of the CD2-GATA-3 transgene on T cell development, we exam-
ined the T cell populations in thymus, spleen and mesenteric lymph nodes from 2-3 month-
old CD2-GATA-3 transgenic mice and non-transgenic littermates by flow cytometty (figure 
3). In the CD2-GATA-3 mice the sizes of the main thymocyte subpopulations, as determined 
by CD4/CD8 analysis, were within the normal ranges, indicating that the enforced GATA-3 
expression did not dramatically impede thymocyte development (figure 3). No significant 
differences were detected between CD2-GATA-3 transgenic mice and normal littermates 
within the DN subpopulations, as defined by differential CD44 and CD25 expression (data 
not shown). However, the CD2-GATA-3 transgenic mice had fewer CD8+ T cells (~50% of 
control) in spleen and lymph nodes, when compared with non-transgenic littermates (ShO\vn 
for spleen in figure 3). The residual CD8+ T cells present exhibited a lower CD8 and a high-
er CD3 expression on the cell surface. The numbers of CD4+ T cells in the periphery were 
comparable in the two groups of mice. 
In conclusion, these resnlts indicated that forced expression of GATA-3 did not result in 
any adverse efrects on CD4+ T cell development in 2-3 month-old CD2-GATA-3 transgenic 
mice. By contrast, an inhibition of the maturation of CDS single positive cells was observed, 
occurring either in the thymus or shortly after leaving the thymus. 
Thymus 
C04L 
COB 
Spleen 
C04L 
CD3 
Spleen 
coaL 
CD3 
FIGURE 3 
Phenotype of CD2-GATA-J tnmsgenic mice. 
T cell development in the presence of the CD2-
GATA-3 transgene results in a reduced pool of 
peripheral CDS+ cells. FIO\y cytomctric analyses 
of the thymus and spleen of 2-month-old wild-
type and C'D2-GATA-3 mice. Single-cell suspen-
sions were stained with anti-CD3, anti-CD4 and 
anti-CDS antibodies. Results are displayed as dol 
plots of lymphocyte gate cells; perccntages of 
total cells within the indicated quadrants are 
givcn. Data showll are representatiYe of oyer 20 
mice examined within each group. 
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CD2-GATA-3 TRANSGENIC MICE DEVELOP THYlIHC LYMPHOMAS 
When the CD2-GATA-3 transgenic mice were followed up to 9 months of age, approxi-
mately 50% (26 out of 51) developed thymic lymphomas. Typically, these lymphomas were 
noticed as mice displayed respiratOlY distress at the age of 6-8 months, but in three cases such 
animals were observed at ~3 months of age. Tumor frequencies in the two independent trans-
genic lines were similar, while tumors were not seen in non-transgenic littennates. A 
Kapplan-:Meyer survival curve is plotted in figure 40. 
Flow cytometric analyses demonstrated that the tumors consisted of CD3+ CD4+ IYI11-
phoblasts showing variable levels of C08 coexpressioll, suggesting differentiation of DP 
tumor cells along the CD4 lineage. Several animals with a thymic lymphoma exhibited 
enlargement of spleen or lymph nodes. Lymphollla cells were also found to be present in the 
spleen, liver and lymph nodes, indicating that the thymic lymphomas metastasized to the 
periphely. Analysis of TCR{3 gene rearrangements using a J{31- and a .f{32-specific probe 
revealed that the lymphomas were monoclonal populations. The lymphoma cells displayed 
unique gene rearrangements in the TCR/310cus, indicating that the oncogenic event has taken 
place in a single T cell precursor (not shO\vn). Figure 4A shows an example of a thymic lym-
phoma (DP and CD4+ cells), with different metastases in lymph node (DP and CD4+ cells) 
and spleen (CD4+ cells only). Imlllunohistochemical examination of tumor tissue sections 
confirmed that the tumors mainly consisted oflymphoblasts, suppolied by a network ofMHC 
class II negative fibroblasts, while characteristic structures of epithelial cells expressing cor-
tical or medullar cell markers were absent (data not shown). 
Among CD2-GA'U1-3 transgenic mice that did not exhibit outward signs of illness, nor 
lllanifestcd a macroscopically visible thymic tumor at ~3 months of age, we found evidence 
for early stages of tumor development in 6 out of32 cases (- 19%). In flow cytometric analy-
ses of thymus cell sllspensions the DP or CD4+CD810 subsets contained atypical fractions of 
CD3+ Iymphoblastoid cells with high FSC characteristics, suggestive of tumor growth. In the 
example shown in tlgure 4BC, the Iymphoblastoid cells had a CD3+ CD4+CD81o phenotype 
and expressed very high levels of GATA-3 protein. 
GATA-3 ENHANCES TCRuB UPREGULATION DURING POSITIVE SELECTION 
As we observed a conelation between GATA-3 expression and TCRul3 or CD3 surface 
levels in GATA-J+llIlslacZ mice, we investigated these parameters in the thymocyte subpopula-
tions of the CD2-GATA-3 mice (figure SA). The expression of CD69 in the DP, CD41oCD81o 
and CD4+CD81o subpopulations was similar in CD2-GATA-3 and wild-type mice. 
By contrast, the prop0l1ions of TCRuf)hi or CD3hi cells were significantly increased in 
CD2-GATA-3 mice, particularly in CD69+CD41oCD8io subpopulation (Shown tor TCRuB 
expression in figure SA). In the more mature fmctions (CD4ioCD8+ and SP cells), the expres-
sion of CD3 and TCRap ,vere comparable between transgenic animals and wild-type Iitter-
mates. 
During the positive selection process CD3/TCRufl1o DP cells develop into 
CD3/TCRuflhi SP cells, which is accompanied by an increase in the average cell size (See 
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The dewloplllcnt of thymic lymphomas in CD2-GATA-3 
tnmsgenic micc. 
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spleen. The percentages of gated cells within the indicated 
CD4/CDS quadrants are showli. 
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Identification of an atypical GATA-3hiCD3+CD4+CDS!o Iymphoblastoid cell population in the thymus of a 
('[)2-GATA-3 transgenic mouse, indicative for a thymic lymphoma (TL2). Non-transgenic and tumor-free C1J2-
GATA-3 transgenic mice are shown as controls, Results are displayed as dot plots for CD4 and CDS. The given per-
centages of the gated CD4+CDS!o populations are of all thymocytes. 
Analysis of FSC, CD3 and GATA-3 expression in the gated thymocyte subpopulation shown in (B). The results are 
displayed as histograms of the CD2-GATA-3 transgenic TL2 mouse (hold lilies), together with those of a non-trans-
genic (dashed lines) and a tumor-free CD2-GATA-3 transgenic mouse (ihil1lilles). Cell suspensions '''ere stained for 
CD3, CD4, and CDS, and subsequently for intracellular GATA-3. All samples are lymphoc}1e/lymphoblast gated by 
fonvard and sideward scatter. 
(D) A total of 42 wild-type animals and 51 CIJ2-GATA-3 transgenic animals were followed for 9 months. Survival 
of tile animals is plotted in a Kapplan-i\leyer curve as fraction of the total number of animals. 
figure 5B, thin lines), However, in the CD2·GATA·3 transgenic mice cells, the cells within 
the DP subpopulutions had increased average forward scatter values, closer to those of nor-
mal SP cells (figure 5B), This finding suggested that in CD2·GATA·3 transgenic mice DP 
cells already have some morphological characteristics ofSP cells, Additional explanations for 
the increased cell size of ON cells would include an enhanced activation status of DP cells in 
the presence of high levels ofGATA-3, or altematively an effect ofGATA-3 on cell cycle pro-
gression in DP T cells. However, we did not find evidence for either of these two. \Ve h'liled 
to detect activated cells with high Th2 cytokille production in immunohistochemical analy-
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Thc CD2~GATA~3 h'ansgcllc cnhances TCRctP upregulation during positivc selection and induces cell death in 
CDS SP T cells in the thymus. 
Cell suspensions were stained for CD4, CD8 and CD69 expression, together with either CD3 or TCRnp. The indi-
cated T cell subpopulations (see also Hgure IA) were gated and analyzed for TCRnp expression, The results are dis-
played as histograms of CD2-GATA-3 transgenic mice (bold lilies), together with those of non-transgenic control 
mice (thin lines), The percentages shown are the fractions of the CD69+CD4!oD8!o cells that are in the indicated 
TCRnphi gate in wild-type mice (below marker) and CD2-GA7If-J transgenic mice (above markel; bold type). 
The effects of the CD2-GA7Il-J transgelle on the cell sizes of thymocyte subpopulations, Cell suspensions were 
stained for CD4 and CD8. The indicated 'f' cell subpopulations were gated and analyzed for FSC; the results are dis-
played as histograms of CD2-GATA-J transgenic mice (bold lines), together with those of non-tmnsgenic control 
mice (lfIinlilles). 
Thymus cell suspensions were stained for CD4, CDS and Annexin V. The CD4 and the CD8 SP T cell subpopula-
tions were gated and analyzed for FSC and Annexin V. The numbers indicate the percentage of gated CD4 or CDS 
SP thymocyles that arc Annexin V positive in the indicated mice. 
ses of tile thymuses ofCD2-GATA-3 mice. Flow c)10metric analyses of the thymic subpopu-
lations, using anti-CD4, anti-CD8 and To-Pro3, did not reveal differences in the cell cycle 
between CD2-GATA-3 transgenic animals and their wild-type littennates (data not shown). 
Also, the total size of the DP compartment in the thymus was similar in wild-type and CD2-
GATA-3 transgenic animals (figure 3), arguing against increased proliferation of DP cells. 
Taken together, the CD2-GATA-3 transgenic animals manifested an increased cell size of 
DP cells and an accelerated upregulation of the expression of TCRuB and CD3 on the cell 
surface, suggesting that enforced GATA-3 expression accelerated T cell maturation during the 
phase of positive selection. 
GATA-3 INHIBITS MATURATION OF CDS SINGLE POSITIVE T CELLS 
To investigate ,,,hether increased numbers of cells that had committed to the CD8 line-
age died in the thymus in CD2-GATA-3 transgenic mice, we analyzed the thymic SP com-
partment in more detaiL We found that many cells ill the CDS SP sUbpopulation and to a less-
er extent also in the CD4 SP sUbpopulation had low FSC characteristics (figure 5B), sug-
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FIGURE 6 
Enforced expression of GATA-3 inhibits 
the maturation of CD691oHSAlo COB SP 
cells in the thymus. 
In four-color flow cytometry experiments, 
thynnls cell suspensions were stained for 
CD4 and CDS expression, together with 
anti-HSA and anti-CD69 or with anti-
CD62L and anti-CD44. The CD4 and CDS 
SP T cells were gated and analyzed for the 
expression of the indicated markers. The 
results are displayed as histograms of 
CD2-GATA-3 transgenic mice (bold lines), 
together with those of non-transgenic COll-
trol mice (thin lines). 
gesting that a major fraction of these cells were apoptotic. Indeed, the numbers of annex in V 
positive mature CD8 SP T cells, which had small forward scatter values, were significantly 
increased in CD2-GATA-3 mice, as compared to wild-type littermates (figure SC). In the CD4 
SP T cell subpopulation only a minor increase in the fraction of annexin V positive cells was 
observed, from -2% in nontransgenic to -6% in CD2-GATA-3 transgenic mice (figure SC). 
It has been rep011ed that final maturation of single positive T cells is accompanied by a 
downregulation of CD69 and HSA expression (33, 43). The enforced GATA-3 expression 
appeared to inhibit the final maturation of CD8+ cells, as a selective deficiency of CD6910 
HSAlo cells was observed, when CD2-GATA-3 transgenic and wild-type littermates were 
compared (figure 6). For CD4+ cells the enforced GATA-3 expression only mildly affected the 
final thymic maturation steps. In addition, in the CD2-GATA-3 transgenic mice an increase in 
the surface expression of CD44, a marker for activated or melllOlY T cells, was observed both 
in the CD4 and the CD8 SP popUlation (figure 6). This phenomenon was also seen in the 
mature CD4+ and CD8+ T cells in the spleen (see Chapter 4). Finally, the expression of 
L-selectin, CD62-L, a marker which is expressed at high levels on naiVe T cells and which is 
essential for homing to peripheral lymphoid organs (48), was comparable in transgenic and 
nOll-transgenic animals. Therefore, the decrease in peripheral CD8+T cell numbers in CD2-
GATA-3 transgenic mice cannot be explained by a reduced capacity ofthese cells to leave the 
thymus. 
The increase of annexinV positive cells and the decrease of mature CD691oHSAlo cells 
in the CD8 SP subpopulation, together with the low numbers of peripheral CD8+ T cells, indi-
cated that enforced GATA-3 expression resulted in a pal1ial differentiation arrest of CD8+ 
cells, associated with cell death in the thymus. 
DISCUSSION 
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In this report we have used two differeut mouse models to study the role of GATA-3 in 
thymic T cell difterentiation ill vivo. \Ve evaluated CATA-3 directed lacZ expression in 
GATA_3+hIlslacZ mice, and examined the eftects of enforced GATA-3 expression throughout T 
cell differentiation ill CD2-GATA-3 transgenic mice, in which GATA-3 transcription is driven 
by the CD2 LCR. 
Our findings implicate GATA-3 as a participant in the commitment process to the CD4 
versus the CDS lineage. First, we found that commitment to the CDS T cell lineage coincid-
ed with downregulation of GA7i1-3 expression. The most mature subpopulation of unCOlll-
mitted thymocytes, the CD4+CD8io subset, contained high numbers of GATA-3 expressing 
cells. During the maturation of CDS+ cells in the thymus, GATA-3 expression was gradually 
lost. By contrast, GATA-J expression remained high during maturation ofCD4 SP cells in the 
thymus. Second, enforced GATA-J expression iubibited the differentiation ofCD8 SP cells. 
The CDS SP fraction in the thymus contained increased numbers ofapoptotic cells and exhib-
ited a selective deficiency of mature CD69ioHSAio cells. In the spleen and lymph nodes the 
numbers ofCDS+ T cells were significantly reduced. And third, a major fraction ofthe CD2-
GATA-3 transgenic mice developed thymic lymphomas at the DP CD69+CD3+ stage, which 
appeared to differentiate along the CD4 lineage. 
The enforced expression of GATA-3 did not directly influence the CD4 versus CD8 lin-
eage cell fate decision, as in the CD2-GADl-3 mice the percentages ofCD4 and CD8 SP cells 
in the thymus were in the normal ranges. Although the molecular mechanisms underlying the 
developmental choice between CD4 and CDS T cell fates are not known, they are thought to 
depend on differences in signal strengths of the MHC class I-CD8 and MHC class II-CD4 
interactions. The influence ofsigllaling molecules on lineage commitment is supported by the 
finding of differentiation towards the CD4 lineage in a gain-of-function extracellular signal-
related kinase (Erk)-2 mutant, and in Csk or c-Chl deficient mice (49-51). Activated Notch 
transmembrane receptor or BcI-2 overexpression were shown to promote differentiation to 
the CD8 lineage, probably by rescue Ii"om apoptosis and development along the CD8 lineage 
of cells that have a very low affinity MHC-interaction, which would normally die by neglect 
(52-54). 
Our data point at a role for GATA-3 ill the maturation of the cells once commitment has 
occurred. There is a progressive decline of GADl-3 expression during CDS lineage mahlra-
tion, and the enforced GATA-3 expression impaired cell survival in the most mature CD8 lin-
eage cells. In this context, there is a striking parallel with ThllTh2 differentiation, where 
GATA -3 is expressed ill nalVe peripheral T cells, followed by a substantial increase during 
Th2 development and a gradual downregulation during Thl development (22, 23). The Th2 
phenotype is initiated by JL-4 signaling, and by the action of GATA-3 becomes stable over 
time and independent of extrinsic factors, such as IL-4 (24, 26, 55). It was recently shown 
that GATA-3 generates stability of Th2 commitment by chromatin remodcling of Th2-spe-
cif1c cytokine loci, associated with a positive autoactivation pathway, which is a recognized 
mechanism contributing to cell fate determination (26). Concomitantly, GATA-3 inhibits Th I 
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development by repressing IL-12RB expression and, as a result, JL-12 induecd IFNy produc-
tion (56). Assuming a parallcl role for GATA-3 in CD4/CD8 and Thl/Th2 development, we 
propose that GATA-3 is involved in thc stabilization of the distinct gene expression profiles 
in committed CD4 cells, while for the full maturation of CD8 T cells, GATA -3 expression 
needs to be down regulated. 
The finding by Ouyang et al. (26) that GATA-3 may, either directly or indirectly, acti-
vate its own expression, could explain the modulated pattern of GATA-3 expression levels 
during T cell development in CD2-GATA-3 mice. Possibly, the elevated levels that we 
observed in these mice, may partly result from upregulation of endogenous GATA-3. This 
positive feedback mechanism could also account for the high GATA-3 protein levels present 
in the thymic lymphomas (figure 4). In addition, GATA-3 levels may be subject to posttrans-
lational regulation, as indicated by the presence ofcaspase-mediated degradation of the close-
ly related transcription factor GATA-I in immature el)1hroid cells (46). A detailed analysis 
of GATA-3 protein and RNA levels at the various stages of T cell development in 
CD2-GATA-3 mice is currently in progress. 
It is clear that further experiments will be needed to identifY the critical target genes for 
GATA-3 in early T cell differentiation. Intriguingly, GATA recognition sequences are present 
in the Notch4 promoter region (57). If Notch genes would be regulated by GATA-3, this 
could explain the parallels that exist between the ill vivo function ofGATA-3 and Notch. Both 
genes are essential for the development of the fIrst stage ofT cell difJerentiatioll, and not for 
any other haematopoietic lineage (21, 28, 58). Apart Ii'om the accelerated TCRuB upregula-
tion in developing CD69+ thymocytes that progress from the DP to the CD4+CD8io stage, we 
did not see any dramatic effects on the surl:1ce expression of presumed GATA-3 target loci, 
such as TCRa, TCR{J, and TCR15 or CD8a. In this context, the variable levels of sur lace CDS 
on the thymic lymphoma cells with velY high GATA-3 expression levels would argue against 
a major function of GATA-3 in CD8a expression regulation. 
Our previous finding of low GATA-3 expression during the two waves of TCR gene 
realTangement, separated by a stage of high GA7II-3 expression, suggested a role of 
GATA-3 in the regulation of proliferation events associated with the essential coupling of 
V(D)J recombination activity to cell cycle (21). However, the absence of any detectable 
effects of the CD2-GATA-3 transgene on the cell cycle would argue against such an essential 
role for GATA-3. Nevertheless, all thymic lymphomas in the CD2-GATA-3 mice character-
ized so far appeared to have originated at the DP stage, in ,vhich all TCRa gene rearrange-
ments occur. Therefore, it remains possible that - in the presence of high levels of OATA-3 -
oncogenic events, such as trallslocations, are mediated by aberrant use of the V(D)J recom-
bination machinelY, as has been found in V(D)J-recombination driven thymic lymphoma in 
mice defIcient for the alax;cllelangieclasia gene (59). 
Alternatively, the oncogenic potential of GATA-3 could be related to the ability of 
GATA-3 to form a complex with the TAL-I and LMO transcription factors, which are impli-
cated in a large fraction of hnman T-cell acnte lymphoblastic leukemias (60). Normally 
TAL-I and LMO are not expressed in the T cell lineage, but expression is induced by translo-
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cation events. It was recently shown that forced expression of GATA-3 ill vitro potentiated the 
induction by the TAL-I and LMO transcription factors of retinaldehyde dehydrogenase 2, 
which inhibits apoptosis ofT cells by generating retinoic acid (60). 
Finally, enforced GATA-3 expression probably leads to increased basal transcription of 
the RAD50 gene, which is involved in chromosomal double-stranded break repair. Because 
of the localization of the RAD50 gene within the IL-4/IL-5/IL-/3 Th2 cytokine gene cluster, 
an incrcase of basal RAD50 transcription is observed in Th2 cells (24). It is possible that in 
the CD2-GATA-3 transgenic T cells the increase might be more extreme, thereby resnIting in 
destabilization of the MREII-RADSO-NBSI protein complex, which is essential for chro-
mosome stability (61). Fut1her characterization of the tUlllor cells, including identification of 
chromosomal trans locations, expression analysis of TAL-I, LMO, RADSO, NBS I and the 
RAG proteins should identify the possible involvement of any of these oncogenic pathways 
in the origin of the thymic lymphomas in the CD2-GATA-3 mice. 
In conclusion, this stndy adds to our knowledge of the function of GATA-3 in early T 
cell development, as we have established a correlation between GATA-3 expression and mat-
uration towards the CD4 versus the CD8 lineage. We propose that in early T cell 
development, expression of GATA-3 is essential for the maintenance of CD4 cell lineage fate 
commitment, but inhibits CDS differentiation. Inferred from the recent findings that 
GATA-3 acts a key regulator ofTh2 development by stabilizing patterns of gene expression, 
GATA-3 would then in early T cell development stabilize the unique gene expression profiles 
that are characteristic for the CD4 or the CDS lineage by chromatin remodeling. 
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ABSTRACT 
The transcription factor GATA-3 is essential for development of the T cell lineage and is 
a key regulator of di£lerentiation of naiVe CD4+ T cells into Th2 effector cells. To study the 
fUllctional role of GATA-3 during T cell mediated immune responses in vivo, we analyzed 
CD2-GATA-31ransgenic mice, in which GATA-3 is ectopically expressed in T cells under the 
control of the CD2 locus control region. Analysis of these mice revealed increased numbers 
of T cells exhibiting a CD44h1CD45RB'o memory phenotype in splcen and lymph nodes. 
Peripheral CD4+ T cells expressed elevated levels of the IL-I receptor family member 
Tl/ST2, indicating enhanced di£lerentiation along the Th2 lineage. Purified CD4+ T cells 
from CD2-GATA-3 transgenic animals could be induced to acquire the Th2 effector pheno-
type, but in vitro proliferation ofThl cells was hampered and IFNy production was reduced, 
when compared to wild-type CD4+ T cells. After immunization with TNP-KLH, CD2-
GADJ-3 transgenic mice showed rednced serum levels of antigen-specific IgG2a, while IgG I 
was within the normal range. T cells from CD2-GAIA-3 mice exhibited an increased recall 
response to TNP-KLH antigen in vitro. Enforced CATA-3 expression severely reduced the 
Thl-mediated delayed type hypersensitivity response to KLH. Collectively, these observa-
tions indicate that enforccd CATA-3 expression is sufJicient to selectively inhibit Thl 
responses and to induce memory T cell formation ill vivo. 
INTRODUCTION 
CD4+ T helper (Th) lymphocytes develop into two functionally distinct subsets that 
can be distinguished on the basis of their cytokine production profile (I, 2). Thl cells are 
characterized by the production of interferon-y (IFNy) and tumor necrosis f.1ctor B (TNFB), 
whereas Th2 cells typically produce interleukin-4 (IL-4), IL-5, IL-IO and IL-13. Each subset 
mediates distinct effector fUllctions in vivo. Th I cells are predominantly involved in immune 
responses against intracellular pathogens, and are associated with autoimmune disease. Th2 
cells are of importance in the defense against extracellular pathogens, and are implicated in 
atopy and allergic diseases (3-5). 
Both Th I and Th2 cells are derived ii-om a common naive precursor (4-6). Signaling 
pathways initiated by cytokines playa dominant role in driving the dinerelltiation of ac.tivat-
ed naive CD4+ T cells into either eftector phenotype (2,7). For instance, IL-12 induces the 
diffcrentiation of naiVe Th cells to the Th I eflector phenotype (S-II), which requires induc-
tion of the IL-12 rcsponsive transcription factor Stat4 (12-14). On the other hand, IL-4 directs 
the difterentiation towards the Th2 e£lector phenotype (IS-IS). Th2 differentiation is mediat-
ed by Stat6 activation through IL-4 receptor engagement (19-21). In response to chronic anti-
genic stimulation ill vivo, progressive polarization of the cytokine responses ultimately leads 
to the commitment ofT helper cells to mutually exclusive Th phenotypes, which are thought 
to be maintained independently of extrinsic fc1ctors (22, 23). 
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Retroviral transfection of purified naIve CD4+ T cells in vihn with a constitutively acti-
vated form ofStat6 was shown to suppress IFNy production and IL-12Rfl2 chain expression, 
and to induce the expression ofTh2-speeific cytokines (24). Stat6 also induces the expression 
of the transcription factors GATA-3 and c-Maf(24), which have been shown to be selective-
ly expressed in a Th2-specific fashion (25-27). Recent experiments using Slal6-deficient cells 
have shown that, although lL-4 and Stat6 signaling may initially direct Th2 development, 
GATA-3 and c-Maf are capable of inducing the development of stable Th2 commitment, 
independent of Stat6 (28). The essential role of Stat6 in Th2 differentiation can be replaced 
by chromatin remodeling using pharmacological histone deacetylase- and cytosine methyla-
tion-inhibitors (29). It has been demonstrated that CD4+ T cell commitment to a pat1icular Th 
phenotype is associated with the induction of DNAse I hypersensitive sites in the loci of 
eftector cytokine genes. III vih'o differentiation into Th 1 cells induces chromatin remodeling 
ofthe IFNy locus and, conversely, the differentiation into Th2 cells induces remodeling of the 
IL-4/IL-5/1L-13 locus (30). The introduction of GATA-3 into ill vilJ'O-cultured T cells was 
shown to generate Th2-specitic DNAse I hypersensitive sites independently of Stat6, impli-
cating GATA-3 in the process of chromatin remodeling (28). 
The GATA-3 transcription factor is of critical importance for development of the T cell 
lineage (31). During T cell deifferentiation, GATA-3 gene expression is required for the 
development of tile earliest T cell progenitors (32, 33). GATA-3 levels are low during the two 
phases of TCR gene rearrangement, but are high in the fraction of rapidly proliferating cells 
that demarcates these two periods of TCR rearrangement (32). GATA-3 expression remains 
high in CD4+ thymocytes, but progressively declines in CD8+ thymocytes. GATA-3 is detect-
ed in naiVe CD4+ T cells and expression levels increase substantially during Th2 differentia-
tion (26, 27). GATA-3 expression has been shown to be indispensable for Th2 development, 
and is down regulated in response to IL-12-mediated Stat4 activation (27, 34). GATA-3 
strongly transactivates the lL-5 promoter, but appears to have only limited effects on IL-4 
gene transcription (27, 35, 36). Retroviral introduction ofGATA-3 during ill vilro Thl differ-
entiation of naiVe CD4+ T cells, resulted in an inhibition of IFNy production, independently 
of IL-4 (34, 37), and a down regulation of IL-12Rfl2 (34), which normally accompanies Th2 
differentiation (38). 
The manipulation ofStat6 and GATA-3 expression in Thl and Th2 polarization cul-
hires of wild-type or specific cytokine-deficient cells in vitro have added significantly to our 
understanding of the molecular basis of Th lITh2 differentiation. However, limited data are 
available on the role of OATA-3 during immune responses in animal models, pat1ly because 
the embryonic lethality of GAIA-3 deficiency in mice precluded il1l'il'o studies (39). Analysis 
of transgenic mice with T cell-specific expression of a dominant-negative mutant of 
GATA-3 indicated that inhibition of GATA-3 activity reduced the key features of asthma, 
including Th2 cytokine levels, eosinophilia and IgE production (40). 
In order to study the function of GATA-3 during T cell differentiation, we generated 
transgenic mice in which the expression of CATA-3 is under the control of the human CD2 
locus control region (see Chapter 3). In these mice, the enforced GATA-3 expression inhibit-
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ed the maturation of CDS single positive cells in the thymus and induced the development of 
thymic lymphomas of double positive cells, which appeared to differentiatc along the CD4 
lineage. These observations supported a role for GATA-3 in the regulation of CD4/CD8 lin-
eage commitment. 
To investigate how the enforced expression of GATA-3 affected T helper cell differenti-
ation, we analyzed T cell-mediated immune responses ill vh'o in CD2-GATA-3 transgenic 
mice. The observations of a selective deticiency of antigen-specific IgG2a production and 
severely reduced delayed-type hypersensitivity responses in these mice showed that enforced 
GATA-3 expression inhibited the differentiation ofThl cells in vivo. 
MATERlALAND METHODS 
MICE 
The CD2-GATA-3 mice are described in Chapter 3 and were crossed on an FVB back-
ground. To determine the genotype of the mice, tail DNA was analyzed by Southern blotting, 
as described in Chapter 3. 
FLOW CYTOMETRIC ANALYSES 
The preparation of single-cell suspensions, mAb incubations and three- or tour-color 
cytometry have been described previously (41). The following mAb were purchased limn 
Pharmingen (San Diego, CAl: FITC-conjugated anti-CD3E, PE-conjugated anti-CD4 (L3T4), 
anti-CD24/heat stable antigen (HSA), anti-CD25 (clone 3C7), anti-CD62L and anti-CD69, 
CyChrome-conjugated anti-CD4 (L3T4), anti-CD8 and anti-CD44, biotinylated anti-CD4 
(L3T4), and anti-CD8, APC-Iabeled anti-CD3E and anti-CD4. Anti-CD45RB (MB23G2) was 
a purified mAb conjugated to biotin, according to standard procedures. SecondalY antibodies 
used were PE-, TriColor-, or APC-eonjugated streptavidin (Caltag Laboratories, Burlingame, 
CAl. The Th2-selective surh1ee marker T1/ST2 (3EIO, rat IgG I, kindly provided by A.J. 
Coyle, Cambridge, MA) was detected by secondary goat-anti-rat IgG-PE (Jackson 
Immunoreseareh) (42). 
For intracellular detection of GATA-3 protein, cells were fixed and penneabilized using 
paraformaldehyde and saponin, as described (43) and subsequently incubated with the Hg-3-
31 anti-GATA-3 MoAb (Santa Cmz, Dan Diego, CAl and FITC-Iabeled anti-mouse IgG I 
(Phanl1ingen) as a second step. For three-color analysis, 0.5-1 x 105 events were scored using 
a FACScan analyzer (Becton Dickinson, Sunnyvale, CAl. For four-color analysis, 105 - 2x I 06 
events were scored using a FACS Calibur dual laser instrument (Becton Dickinson). 
SERUM Ig DETECTION AND IN VIVO IM1\'lUNIZATIONS 
Total sennn Ig levels were detennilled by subclass-specific sandwich ELISA, as 
described previously (44). Immunizations were done i.p. with 100 rIg TNP-KLH precipitat-
ed on alum. Serum levels of TNP-specific Ig subclasses were determined by ELISA, using 
TNP-specific standards (igGI, IgG2a and IgG2b) or TNP-speeific reference serum samples 
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(IgM and IgG3), as described (45). 
PURIFICATION OF CD4+ T CELLS AND IN VITRO CULTURES 
Single cell suspensions from spleen were incubated with biotinylated mAb to CDS 
(YTS-169), CDllb/Mac-1 (MlnO), CD40 (FOK-45.5), B220 (RA3-6B2) and IgM (M41), 
followed by streptavidiu-conjugated microbeads (Miltenyi). Using a Vario-MACS magnetic-
activated cell sorter, CD4+ T cells were purified according to the manufachlrer's instruction 
to purity >95%. The CD4+ l' cells were culturcd for up to 5 days in thc presence of IL-2 (50 
Ulml) on 96 well plates prc-coated with 10 Ilg/mi anti-CD3 (145 2CII) mAb. Culture super-
natants were harvested and cells were assayed for proliferation using standard tritiated thymi-
dine incorporation methods. 
Purified CD4+ l' cells were polarized into Till and Th2 effector cells in a total volume 
of200 III for 4 days in the presence of 5 Ilg/mi anti-CD28 (37.51) and 50 IU/mIIL-2 on 96-
well plates, which were pre-coated with 10 Ilg/mi anti-CD3. (145 2CII) (32). Thl-polariz-
ing cultures included 5 ng/ml r1L-12 (R&D Systems, Minneapolis, MN) and 10 mg/ml ncu-
tralizing mAbs to JL-4 (l1B11). Th2 polarized cells were cultured in the presence of 10-50 
ug/ml rIL-4 and 10 Ilg/mi neutralizing mAbs to IFNy (XMO 1.2). Aner 4 days of polarization 
cultures, the cells were thoroughly washed and transferred to new anti-CD3 coated 96-well 
plates, and cultured in the presence of IL-2, without addition of further cytokines or neutral-
izing antibodies. Default or non-polarizing cultures were performed as described above for 
the Th I and Th2 polarization culhlres, but in the absence of exogenously added cytokines or 
anti-cytokine antibodies. For the intracellular OATA-3 staining experiments (figure 3A), 
CD4+ cells ,,,ere culhlred in plates that were coated with 100 ng/ml anti-CD3E, but otherwise 
the 1'111 and Th2 culture conditions were identical to those described above. 
To measure DNA synthesis, after 2-3 days of cuihlre, cells were pulsed with [3H]tbymi-
dine for ~ 16 hours, harvested and counted using standard methods. After three days of res-
timulation, culture supernatants were harvested to determine cytokine production, using 
IFNy-, IL-4- and IL-5- specific ELISA systems, as previously described (46). 
DTH RESPONSES 
DTH responses were performed essentially as described by Cua et a!. (47). In short, 
mice were immunized i.p. with 100 IIg KLH in 250 I" PBS and on day 6 they were chal-
lenged with 150 IIg of KLH in 25 I" PBS in the len hind footpad. The right hind footpad was 
in injected with a vehicle control (25 I" PBS). Responses were quantified 24 and 48 hours 
after the challenge, by measuring the difterence in footpad thickness between the KLH- and 
the PBS-injected footpads. 
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RESULTS 
INCREASED EXl'RESSION OF MEMORY T CELL SURFACE MARKERS ll'I' 
CD2-GATA-3 TRANSGENIC MICE 
95 
To analyze the effect of enforced GATA-3 expression on Till and Th2 differentiation, we 
investigated peripheral T cell differentiation and function in CD2-GATA-3 mice, using 
non-transgenic littennates as controls. In these experiments, no essential differences were 
observed between two independent CD2-GATA-3 transgenic lines investigated. 
We characterized the T cell populations in spleen and mesenteric lymph nodes in 2-
3 months old CD2-GADl-3 mice by three or four color flow cytometlY, The sizes of the CD4+ 
T populations in CD2-GATA-3 mice were within normal ranges, but CD8+ T cells were 
reduced in number, to ~50% of normal. This decrease in size of the peripheral CD8+ T cell 
population was associated with increased cell death and impaired mahlration of CD8 single 
positive T cells in the thymus (see Chapter 3), 
As GATA-3 is involved in the stabilization of the Th2 phenotype and the maintenance of 
Th2 cytokine expression, \vhich are important features of T helper memory, we wanted to 
assess whether the enforced expression ofGATA-3 had an effect on the development ofmem-
01)' T cells. Antigen activation induces the expression of CD44 and decreases CD45RB 
expression on the cell surface of T cells. As this profile of cell surface marker expression is 
maintained, even after cells have revel1ed to a quiescent state, it can be used to define anti-
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Single-cell suspensions from splcen (A) and mesenteric lymph nodes (B) from 3 month-old CD2-GATA-3 transgenic 
mice and nontransgenic Iittemmtes were stained for CD4 and CDS, together with CD44, CD45RB or CD25. Surface 
CD4/CD8 profiles are shown as dot plots, in which the percentages oftolallymphocytcs within the indicated CD4+ 
and CDS+ gates are given. Total CD4+ and CDS+T cell populations were analyzed for the indicated markers. Results 
arc displayed as histograms of CD2-GATA-3 transgenic mice (bold lines) and those of non-transgenic littennalcs 
(thin lines), For CD45RB and CD25, the percentages ofpositivc cells are indicated above the marker line in bold 
(CD2-GATA-3 transgenic mice) and below the marker line (noll-transgenic littenuales). Data shown are representa-
tive of at least 6 mice examined in each group. 
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gen experienced T cells (48). As shown in figure lAB, in CD2-GATA-3 transgenic mice both 
the CD4+ and the CD8+ T cell populations contained elevated propm1ions of CD44hi and 
CD45RBio cells. This was found in the spleen and in the lymph nodes, and pointed to the 
presence of either recently activated or memmy T cells (48). The expression levels of CD69 
and IL-2Ra (CD25), which are markers of recently activated T cells (49), were low in CD2-
GATA-3 mice and non-transgenic littennates (Shown for CD25 in figure lAB), arguing 
against the presence of major fractions of recently activated T cells in CD2-GATA-3 mice. It 
has been shown that the propOitions ofT cells with a memOlY phenotype increases with age, 
probably as a result of progressive antigen experience (50, 51). When we compared CD44 
expression at two difterent ages, 2 months and 6 months, \ve indeed found that the conver-
sion to the CD44hi memmy T cell phenotype increased with age, both in CD2-GATA-3 trans-
genic mice and in control mice (data not shown). 
Taken together, these results indicated that in the CD2-GATA-3 mice both the CD4+ and 
the CD8+ T cell population contained an increased compartment of cells with a memory phe-
notype. 
ENFORCED EXl'RESSION OF GAIA-3 RESULTS IN INCREASED NUlVffiERS OF 
TI/STZ POSITIVE CD4+ T CELLS IN THE PERIPHERY 
To investigate whether CD4+ T cells in CD2-GATA-3 mice exhibited preferential polar-
ization towards Th2 development in vivo we evaluated surface expression ofTlIST2 (figure 
2). This marker, which is an orphan receptor that belongs to the IL-l receptor family, is 
specifically expressed on the surface ofTh2 cells (42, 52, 53). In non-transgenic controls we 
found Tl/ST2 expression on 5.1 % ± 1.3 and 1.1 % ± O. I (IF5) ofCD4+ T cells in spleen and 
mesenteric lymph nodes, respectively. In four-color labelings with CD4, CD8, CD44 and 
TIIST2, it was shown that in non-transgenic mice TlIST2 expression was largely confIned to 
the CD44high fi·action of activated/memmy CD4+ T cells (figure 2). 
The CD2-GATA-3 transgenic animals showed a significant increase in the propor-
tions of Tl/ST2+ cells: 31 % ± I and 23% ± 2 (IF3) in spleen and mesenteric lymph nodes, 
respectively. This increase could not be attributed solely to the increased proportion ofCD4+ 
T cells with a CD44high activated/memory phenotype, as Tl/ST2 was also found to be 
expressed on naYve CD4+ T cells with a CD44iow surface profile (figure 2). 
\Vhcn we analyzed Tl/ST2 expression in the thymic subpopulations, we found induction 
of Tl/ST2 on a small Ibction of the CD4 single positive cells in CD2-GATA-3 transgenic 
mice: 6.0% ± 1.0 (n~3), compared with 0.4% ± 0.05 in non-transgenic mice (n~5). In con-
trast, Tl/ST2 expression, which is reported to be absent on the surface ofCD8+ cells (42, 52), 
was not signilicantly induced on these cells in these SP thymocytes «0.5%). Low expression 
ofTI/ST2 was observed on CD8+ T cells in spleen (3.0% ± 0.8) and lymph node (1.7% ± 0.6) 
Ii-om CD2-GATA-3 transgenic mice (Shown in figure 2 for spleen and lymph node). 
In summary, these data indicate that enforced expression of GAlIl-3 resulted in signifi-
cantly increased numbers of peripheral CD4+ T cells with a Th2 polarized phenotype, not 
only in the CD44hi activated/melllOlY T cell compartment, but also in CD4410 nai've T cells. 
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Single-cell suspensions from spleen (A) mId mesenteric lymph nodes (B) from 2-3 month-old CD2-GATA-3 trans-
genic mice and nontransgenic littennates were stained for CD4, CDS, CD44 and TlIST2. CD4+ and CD8+ T cells 
were gated and analyzed for CD44 and TI/ST2 expression. Data tIrc displayed as dot plots, and the percentages of 
gated cells within the indicated TlIST2+ quadrants are shown. 
INHIBITION OF Thl DEVELOPMENT IN VITRO IN CD2-GATA-3 MICE 
The Tl/ST2 positive CD4+ T cells did not reflect ill vivo activated cells with high-level 
Th2 cytokine production, as we could not detect the presence of lL-4, IL-5 or IL-IO by flow 
cytometric intracellular cytokine stainings. To investigate whether the differentiation poten-
tial of CD4+ T cells into Th I and Th2 effector phenotypes was altered in the CD2-GATA-3 
mice, we perfonned ill vitro cell culture experiments on purified CD4+ T cells from spleen 
and lymph nodes. These cells were stimulated with anti-CD3E mAbs, either under Th I polar-
izing conditions (in the presence oflL-12 and anti-lL-4 mAbs) or under Th2 polarizing con-
ditions (in the presence ofIL-4 and anti-IFNy mAbs) for 4 days. Subsequently, the cells were 
washed and restimulated with anti-CD3, mAbs for 3 days. 
\Ve evaluated the GATA-3 expression by intracellular flow cytomett)', using a mouse 
monoclonal antisera specific for GATA-3 (figure 3A). The mean fluorescence intensities of 
GATA-3 expression were higher in the culhlres ofCD2-GATA-3 transgenic mice, when com-
pared to those of the nontransgenic littennates, both in the Till and in the Th2 cultures. 
Therefore, we conclude that the trallsgene is expressed both in Th I and in Th2 cells. 
In default (non-polarized) cultures, CD2-GATA-3 trausgenic CD4+ T cells produced sig-
nificantly lower levels ofIFNy and highly increased levels ofIL-5 and lL-IO as compared to 
wild-type CD4+ T cells, whereas IL-4 production was similar (figure 3B and data not shown). 
In Thl -polarized cultures, the production of IFNy was significantly reduced and the produc-
tion oflL-5 was strongly enhanced in the CD2-GA7//-3 transgcnic CD4+ T cells, when com-
pared to those from non-transgenic littennates (figure 3B and data not shown). In the Th2-
polarized cultures, the CD2-GATA-3 transgenic CD4+ T cells produced normal amounts of 
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FIGURE 3 
The effect of cnforced GATA~3 expression in CD4+ T cell cultures under Tltl and Th2 conditions. 
Expression ofGATA-3 in CD2-GATA-3 transgenic (bold lines) and nOll-transgcnic (thin lines) purificd CD4+ T cells 
that were activated under 1111 or Th2 conditions as indicated. Cell sllspcnsions were stained for surfhce CD4 and 
CDS and subsequently for intracellular GATA-3 protein. Flow cytometry results arc displayed as histograms of 
CD4+CDS- cells. 
Cytokine production in supernatants of7-day cultures of purified CD4+ T cells under def..1.ult, TIIl and Th2 condi-
tions, as indicated (Open bars: wild-type mice; closed bars: CD2-GATA-3 transgenic mice). 
Cell viability after 7 days of culture under Th I-priming or TI12-priming conditions of purificd CD4+ T cells of the 
indicated mice. Cell suspcnsions were stained for surface Cf)4 and CDS and propidiulll iodide (PI). Results are dis-
played as histograms of CD4+CDS- ceUs. The pcrccntages of viable (Pr) cclls arc indicated 
Proliferation, dctcnnined by [3Hjthymidine incorporation, in response to stimulation with ,lIlti-CD3, and IL-2 of 
purified CD4+ cells of the indicatcd mice, underThI and 1112 conditions. Data are given as mcan yalues ± SD (Open 
bars: wild-type mice; closed bars: CD2-GATA-3 transgenic mice). 
Data are representative of three experiments. 
IL-4 (not shown), but higher levels of fL-1 0 (figure 3B). 
The reduced IFNy production by CD2-GATA3 transgenic CD4+ T cells cultured under 
Thl-polarizing conditions could either result fi·om an inhibitOlY effect ofGATA-3 on the dif-
ferentiation of narve cells into Th I cells, or by an inhibition of the amount of IFNy produced 
by differentiated Thl effector cells. To distinguish between these possibilities, we assessed 
cell viability and proliferation in the T cell culhlres. \Vhen analyzed by flow cytometty using 
propidium iodide, CD4+ T cells from CD2-GATA-3 transgenic mice showed increased cell 
death under Th1 culture conditions at day 7, as compared with non-transgenic littennates 
(figure 3C), When [lH]thymidine incorporation was assessed at day 7, we observed a specif-
ic inhibitOlY efieet of enforced GATA-3 expression on cell proliferation in Thl cultures (fig-
ure 3D). By contrast, the presence of the CD2-GATA-3 transgene enhanced viability and pro-
liferation of CD4+ T cells in the Th2 cultures (figure 3CD). 
Collectively, these observations demonstrate that the presence ofthe CD2-GATA-3 trans-
gene inhibited the proliferation of1'h cells under Th 1 polarizing conditions. Furthermore, the 
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enforced GAlIl-3 expression did not SUppOlt signiticant proliferation and differentation of 
Th2 eflector cells in the Thl envirolllllent, as in these cultures JL-4 and IL-I 0 production was 
low. 
ENFORCED GATA-3 EXPRESSION INHIBITS SWITCHING TO IgG2A IN AN 
ANTIGEN-SPECIFIC L'lMUNE RESPONSE 
Serum levels of individual Ig isotypes are generally dependent on the ThllTh2 balance. 
lL-4 primes mouse 8 lymphoc)1es for switching to IgG I and IgE, while switching to these 
subclasses is inhibited by IFNy (54). Conversely, IgG2a responses are induced by IFNy and 
suppressed by JL-4. We analyzed total Ig serum levels, as well as the Rroduction of antigen-
specific Ig isotypes during a humoral immune response, as these reflected the in vivo T helper 
cell polarization. 
Total serum Ig levels were determined in 2-3 month-old CD2-GATA-3 transgenic mice 
and non-transgenic litlermates by ELISA. Semm levels of IgG I were significantly higher in 
the CD2-GATA3 transgenic animals, while the levels of all other isotypes were similar in the 
two groups of mice (figure 4A). Notably, no effect of the presence ofthe CD2-GATA-3 trans-
gene on Th2 driven total serum IgE levels was observed. 
In order to analyze Ig class switching in a T cell-dependent response in vivo, mice were 
immunized i.p. with TNP-KLH, which was precipitated on alum. CD2-GATA-3 transgenic 
mice expression showed a significantly decreased TNP-response for the INFy-dependent 
IgG2a isotype on day 7 (figure 48). The levels of all other Ig isotypes elicited in this 
response were comparable between transgenic animals and wildtype littennates. The 
decrease ofTNP-specific IgG2a was not due to delayed kinetics of the response. On day 14, 
the TNP-specific IgG2a levels were still low, while TNP-specific IgG I levels were somewhat 
elevated in the CD2-GATA-3 transgenic mice. The day 14 levels for TNP-specific IgG I, 
IgG2a and IgG2b were 2550 ± 270, 76 ± 15 and 403 ± 51 Jlg/m! (mean values ± SEM) for 
the CD2-GATA-3 transgenic mice and 1940 ± 530, 360 ± 120 and 550 ± 80 Jlg/ml for nOll-
transgenic Iittennates, respectively. 
Concomitantly, the levels ofTNP-specific IgM were elevated in the CD2-GATA-3 trans-
genic mice, both on day 7 (139 ± 14 Ulml in the CD2-GATA-3 mice and 68 ± 10 U/ml in non-
transgenic mice) and on day 14 (74 ± 9 Ulml and 49 ± 3 Ulml, respectively). 
In conclusion, the observed increase in TNP-specific IgM production and the suppres-
sion of TNP-specific IgG2a production indicated that GAlIl-3 expression is sufficient to 
inhibit IFNy-mediated antigen-specific class switching. In the CD2-GAlIl-3 transgenic mice 
an increased class switching to IgG I was observed in the total senllll levels, but not in the 
antigen-specific response. 
ENFORCED GATA-3 EXPRESSION SUPPORTS MEMORY T CELL FORMATION 
Our ill vil1v experiments showed that CD2-GAlIl-3 transgenic Th2 cells had an 
enhanced capacity to proliferate and survive il1 vih'o (figure 3). \Ve next tested the antigenic 
recall response ;11 vitro after previous immunization with a TNP-KLH. CD4+ T cells were 
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Expression of the CD2-GATA-3 tralls-
gene affccts Ig class switching iu .'iI'o, 
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IgM 19G3 closed symbols: ClJ2-GATA-3 transgenic 
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mice, n=12). 
For Th cell dependent responses, senlm 
conccntrations of TNP-specific Ig were 
determined 7 days after i.p. injcction of 
TNP-KLH (opcn symbols: non-trans-
genic mice, n=6, closed symbols: 
CD2-GATA-3 transgenic mice, n=6). 
Pre-immune levels were <10 V/ml for 
Ig~'f, <2 Ulml for IgG3, <10 mglml for 
IgGI, IgG2a and IgG2b. Levels were 
dctennincd by ELISA. 
111 vitro recall response of splcnic Til 
cells, 4 weeks after TNP-KLH immu-
nization. Data shown are mean values for 
4 wild-type mice (opcn squares), and 2 
mice of each indcpcndent transgcnic 
CD2-GATA-3 line (closed symbols). 
purified from spleens of immunized CD2-GATA-3 transgenic mice and controllittermates 4 
weeks after Lp. injection with TNP-KLH precipitated on alum and stimulated in vitro using 
wild-type irradiated APCs, which had been pre-incubated with KLH for 4 hours. Proliferative 
responses were determined by [3H]thymidine incorporation and showed that CD2-GATA-3 
transgenic mice had enhanced ill vih'o recall responses (figure 4C). HO\vever, CD4+ T cells 
from CD2-GATA-3 transgenic mice did not show increased proliferation when polycionally 
stimulated with anti-CD3£ or ConA (data not shown). 
ENFORCED GATA-3 EXPRESSION DIMINISHES DELAYED TYPE HYPERSEN-
SITIVITY RESI'ONSE TO KLH 
To directly test whether enforced GATA-3 expression suppresses Thl-dependent immune 
responses ill vivo, we assayed delayed type hypersensitivity (DTH) responses to the protein 
antigen KLH. Two-month-old mice were primed by i.p. injection of 100 ~lg KLH, and chal-
lenged on day 6 by injection of25 ~ll PBS alone and 25 III PBS containing 150 ~lg KLH in 
the left and right hind footpad, respectively. Twenty-four hours after the injections, footpad 
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thickness was measured and the difference between the two footpads was calculated (figure 
5). The KLH-induced footpad swelling was signiticantly reduced in CD2-GATA-3 transgenic 
animals, as compared to the wild type littennates. This reduction of footpad swelling did not 
reflect delayed kinetics of the DTH response, as also at 48 hours after the injections footpad 
swellings were still essentially absent in the CD2-GATA-3 transgenic mice. 
These observations demonstrate that GATA-3 expression has a severe inhibitol), effect 
on the Th I-mediated DTH response ill vivo. 
DISCUSSION 
Prior studies using Th I and Th2 polarization cultures of wild-type and specific cytokine-
deficient cells ill vitro have idcntified GATA-3 as a master switch in Th2 development (26-
28,34,37). GATA-3 does not only induce the expression ofTh2-specific c)10kines, but also 
acts as a repressor ofThl differentiation. Introduction ofGATA-3 by retroviral infection into 
naive T cells strongly inhibited IFNy production, independently of IL-4 expression (34, 37). 
Our analysis of the CD2-GATA-3 transgenic mice support the findings that GATA-3 
expression inhibits Th I development. The enforced GATA -3 expression inhibited Th I-medi-
ated responses in vivo, including antigen-specific IgG2a production and DTH responses to 
protein antigen. In our Thl/Th2 polarization cultures, cnforced GAlil-3 expression under 
Till-inducing culture conditions resulted in a reduction in cell survival, proliferation and 
IFNy production and an enhanced IL-5 production. The additional rmdings of increased 
Tl/ST2-expression in CD4+ T cells and elevated total IgG I serum levels suggest that the 
presence of the CD2-GATA-3 gene drives T cells prefereutially towards dilIerentiation along 
the Th2 pathway. Therefore, we conclude that GATA-3 plays a dual role ill vivo in the differ-
entiation of narve T helper cells into Th2 cells, as it both represses Th I differentiation and 
induced Th2 difierentiation. 
Our results also indicate that enforced expression of GATA-3 enhanced memory cell for-
mation. In CD2-GATA-3 transgenic micc, the peripheral T cell compartment contained a high 
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propmiion of cells with a memmy cell surface profile, defined as CD44h;CD45RBlo and neg-
ative for CD25 and CD69. The ratio ofna"ive versus memory-phenotype cells decreased with 
age, as normally seen in wild-type mice. Furthermore, T cells from CD2-GATA-3 mice exhib-
ited an increased recall response to TNP-KLH antigen ill vitro. Finally, the selective increase 
of the total levels of the IL-4 dependent isotype IgG I in the semm would also be consistent 
with increased Th2 memory formation. 
In CD2-GATA-3 transgenic mice the expression of the Th2-spccific T IIST2 marker with-
in the CD44hi memory Th cell population in spleen and lymph nodes was increased by a fac-
tor -6 and ~20, respectively. Therefore, it is conceivable that in these mice the CD4+ memo-
ly T cell compartment mainly consists of committed Th2 cells. The increased proliferation 
and cell survival of CD2-GATA-3 transgenic CD4+ T cells in the in vitro Th2 polarization cul-
h.ues could either reflect the presence of high propOIiions of memory Th2 celis, or be the 
result of efficient proliferation and further differentiation ofna ... ve GATA-3 expressing CD4+ 
T cells. Conversely, the increased cell death and limited proliferation of CD2-GATA-3 CD4+ 
T cells in the Th I polarization cultures could be a result of reduced survival of the memory 
Th2 cells in a Thl environment, or reduced proliferation ofnai"ve GATA-3 expressing CD4+ 
T cells. These two possibilities are not mutually exclusivc, but they both imply that the Thl 
environment, i.e. the presence of IL-12 and anti-IL-4 antibodies, inhibits the survival of 
GATA-3 expressing CD4+ T cells. Therefore, we conclude that IL-12 or lL-4 signaling not 
only rcgulate differentiation ofna ... ve cells into Thl and Th2 effector cells (26-28, 32, 34), but 
also affect proliferation and survival of GATA-3 expressing CD4+ T cells. This would also be 
suppolied by the finding that CD2-GATA-3 transgenic CD4+ T cell populations, despite their 
large fractions of CD44hi T I IST2+ cells, did not produce significant amounts of IL-I 0 in our 
Th I polarization cultures (in contrast with the high levels of lL-I 0 in default and Th2 polar-
ization cultures). 
GATA-3 therefore appears to facilitate the differentiation process of dividing effector 
cells to memory cells. We propose that GATA-3 regulates the fate decision of activated CD4+ 
T cells, by reducing activation-induced cell death, in favor ofTh2 memory cell formation. In 
this context, GATA-3 does not simply act as a survival factor supporting cell proliferation, 
because survival alone docs not appear to be sufficient for mel1lOlY cell formation, as was 
shown by the absence of increased memory formation in BcI-2 transgenic mice (55). Further 
experiments are required to define GATA-3 targets that are involved in Th2 memory cell for-
mation. 
Gne of the molecules involved in Th2 memmy might be Tl/ST2, as it is normally specif-
ically expressed in the Th2 lineage within the compmiment of CD44hi activated/memory T 
cells (figure 2). In CD2-GATA-3 transgenic mice Tl/ST2 was not only expressed in the eOI11-
pmiment of CD44hi activator/memory T cells, but also in CD4410 naIve T cells. Enforced 
expression of GA1II-3 may induce TI/ST2 cell surface expression in CD4+ T cells even 
before they had encountered antigen. This would argue for a direct regulation of T J IST2 tran-
scription in T cells by GATA-3, independent of the process of stable polarization to the Th2 
lineage after TCR stimulation. The recent identification of three GATA elements in the mill-
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imal GATA-responsive TIIST2 promoter in mast cclls (56) would support this hypothcsis of 
a dircct regulation of TJlST2 exprcssion by GATA-3, indcpendent ofTh2-specific c)10kines. 
Collectively, the observations reported to date provide evidence for a key role of 
GATA-3 in nearly all major fate decisions during T cell development. The lack of even the 
earliest CD44+CD25- DN T cell precursor subpopulation in the absence of GATA-3 shows 
that this factor is required for commitment to the T cell lineage (32,33). Our findings in the 
transgenic mice with enforced expression of GA1Il-3 under the control of the CD2 promoter 
implicatcd GATA-3 in CD4 versus CDS lineage development (sec Chapter 3), in Th2 differ-
entiation and in memory T cell formation. In case of the Th liTh2 fate decision, it has been 
shown that GATA-3 can support the differentiation of one cell lineage while inhibiting the 
development of the other (34). In this context, GATA-3 parallels the transcription factor pax-
5, which was recently shown to play an essential role in B-lineage commitment by suppress-
ing aiternative lineage choices (57). 
In conclusion, this study shows that enforced expression of GATA -3 inhibits Th I func-
tion in vivo. At the same time, the effects on allergy associated Th2 differentiation were lim-
ited, as we did not observe elevated total serum IgE levels (figure 4) or increased eosinophilic 
bronchoalveolar inflammation in an ovalbumin-induced model for allergic asthma (B.L., 
unpublished resuits). Therefore, our findings could possibly be useful whcn considering 
enhancement ofGATA-3 activity as a potential therapy for diseases that renect an unbalanced 
activity ofThl cells (58). This would require the development of strategies to manipulate the 
activity of GATA-3 in patients with specific autoimmune diseases. 
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ABSTRACT 
SJA/9 mice mount humoral immune responses to protein antigen and helminth parasites 
that are characterized by low IgE levels. IgE levels of SJAl9 mice can be restored either by 
injection of thymocytes obtained from congenic SJL mice or by infusion of recombinant 
ILA prior to or during the immune response. Therefore, we examined the capacity of SJAl9 
CD4+ T cells to diOerentiate into IL-4-producing effector cells. SJAl9 CD4+ T cells can be 
induced efllciently to differentiate in vitro into ILA-producing cells, yet they £1i1 to do so in 
vivo during the response to either polyclonal goat anti-IgD or TNP-KLH. Instead, CD4+ T 
cells purified from SJAl9 mice after these rcsponses, produce large amounts of IL-IO. This 
altered CD4+ T cell differentiation is not due to a defect in lL-4R-mediated signals, as both 
IL-4 receptor-mediated activation of STAT-6 and IL-4-induccd proliferation are normal in 
SJAl9 CD4+ T cells. In addition, we show that neutralization of IL-I 0 levels during the ill 
vivo rcsponse to TNP-KLH results in abrogation of the differentiation of SJAl9 CD4+ T cells 
into an IL-IO-producing phenotype. However, the in vivo neutral1zatioll of IL-l 0 could not 
rescue the IgE response of SJAI9 mice, indicating that the production ofIL-1 0, in itself, was 
not responsible for the low IgE responses in SJA/9 mice. We conclude that the differentiation 
of CD4+ T cells into mature effector phenotypes is dysregulatcd in SJAl9 mice, resuIting in 
both an attenuated differentiation into IL-4-producing cells and an enhanced difterentiation 
into IL-l O-producing cells. 
INTRODUCTION 
SJAl9 mice were derived limn breeding thc BALB/c immunoglobulin (Ig) H chain allo-
type (Ig') into the SJL background (I). SJAI9 mice are characterized by the absence ofa sig-
nificant IgE response to helminth parasites, such as Nippostrollgylus brasiliensis, or to pro-
tcin antigens which induce strong IgE responses in both BALB/c and SJL mice (2, 3). This 
defective response is Ig isotype-specific, as IgG 1 responses to Nippostrol1gylus brasiliensis 
and tri-nitro-phenol conjugated to Keyhole Limpet hematocyanin (TNP-KLH) are normal 
(4). When stimulated ill vitro with LPS and IL-4, SJAl9 B cells produce levels of IgE com-
parable to those produced by SJL and BALB/c B cells, indicating that there is no intrinsic 
defect in SJ/V9-derived B cells to class-switch to IgE in response to IL-4 (5-7). The antigen-
specific IgE response of SJAl9 mice could be reconstituted by adoptive transfer of unprimed 
SJL-derived T cells, suggesting that a T cell-intrinsic defect might be responsible for the 
absence of IgE responses in SJAl9 mice (2, 4, 8). Moreover, the infusion of recombinant 
IL-4 during the first week of the immune response to Nippostrol1gylus brasiliensis or TNP-
KLH completely restored the IgE response in SJAl9mice (4). These data indicatc that a defi-
cient IL-4 production by Th2 cells might be responsible for the low IgE levels observed dur-
ing humoral immune responses in SJfV9 mice. However, the presence of a functional, IL-5-
producing Th2 population in these mice was suggested by the observation of a normal of 
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blood eosinophilia during the response to Nipposlrollgylus brasiliensis in SJAJ9 mice, which 
could be blocked by thc infusion ofIL-5-neutralizing antibodies (4). 
CD4+ T helper (Th) lymphocytes can differentiate into two functionally distinct subsets 
which can be distinguished based on thcir cytokine prodnction profilc (9,10). Thl cells are 
characterized by the production of IFNy and TNFB, whereas Th2 cells typically produce 
IL-4, IL-5, IL-9, IL-IO and IL-13. Each of these helper T cell subset mediates distinct effec-
tor functions ill vivo. For instance, Thl cetls are involved in immune responses against intra-
cellular pathogens, and are associated with autoimmune disease. Th2 cetls on the other hand 
are important in the defense against extracellular pathogens, and are implicated in atopy and 
allergic diseases (11-13). The ability of CD4+ T cells to differentiate into Th2 or Th I cells is 
critical in conferring a sllsceptible or resistant phenotype to Leishmania major infection in 
mice, reflecting the ill vivo relevance of polarized Th cell responses (14-16). 
Both Th I and Th2 cells are derived from a common naIve precursor (12, 13, 17). 
Cytokine-induced signaling pathways are essential in driving the differentiation of activated 
naIve CD4+ T cells into either mature effector phenotype (10, IS). IL-12 induces the difIer-
entiat ion of naIve Th cells to the Th I eftector phenotypc (19-22), by activating the transcrip-
tion factor Stat4 (23-25). IL-4 directs CD4+ T cell difterentiation towards the Th2 eftector 
phenotype (26-29), which is mediated by Stat6 activation (30-32). Differentiated effector Th 
cells negatively regulate the activity orthe other effector subset. For instance, the production 
of IFNy by Thl effector cells inhibits Th2 cell differentiation and proliferation (33, 34), 
whereas the Thl cells themselves have lost responsiveness to IFNy at the receptor level (35, 
36). The production of cytokines by Th I cells is indirectly inhibited by the prodnction of 
IL-IO by Th2 efIector cells (37). 
As the natural occurring defect in IgE responses of SJAJ9 mice was shown to be T-cell 
dependent and could be reconstituted by infusion ofrIL-4, we analyzed the difIerentiation of 
SJAI9 CD4+ T cells into eftector phenotype. In this study, we show that while SJAl9 CD4+ T 
cells have no intrinsic defect in Th2 polarization, they are not able to fully differentiate into 
IL-4-producing effector cells in vivo following imlllunization protocols that normally elicit 
Th2-mediated responses. This low IL-4 production is accompanied by an enhanced IL-IO 
production by SJAl9 Th cells, indicating that the difIerentiation ofCD4+ T cells in SJAl9 into 
efIector cells is dysregulated. 
MATERIALS AND METHODS 
MICE 
SJA/9 and SJL mice were bred and maintained under specific pathogen Ii·ee (SPF) con-
ditions at the Erasmus Center of Animal Research, Rotterdam. All experiments with live ani-
mals were performed according to the regulations of the institutional animal care and use 
committee. 
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T CELL PURIFICATION 
CD4+ T cells were purified by negative selection from spleen and lymph nodes as 
described (38). In brief, single cell sllspensions were prepared tiom spleens and mesenteric 
and lingual lymph nodes. Erythrocytes were depleted by standard ammonium-chloride lysis. 
Cell suspensions werc labeled with biotinylated monoclonal antibodies (mAb) to CD40 
(FGK45.5), CDllb/Mac-1 (MI170), B220 (RA3 6B2), IgM (M41) and CDS (YTS I 69). After 
thorough washing, cells were incubated with streptavidin-coated microbeads (Nfiltellyi 
Biotec GMBH, Bergisch Gladbach, Germany). Cells were then separated using a vario-
MACS (Miltenyi) cell purification protocol according to the manufacturer's instructions. The 
negative cell fraction was collected and purity was confirmed by flow cytometry. Purity of 
CD4+ T cclls was routinely -95 % CD4+. 
CD4+ T CELL CULTURES AND l'OLARIZATION 
Purilied CD4+ T cells were cultured at 10' cells/well for up to 4 days in t1at bottom 96-
wells culture plates (NUNC, Nalge-Nunc Int., Denmark), which had been pre-coated with 5 
llg/ml anti-CD3E mAb (145 2cll), in the presence of 10 Ulml r1L-2 (a kind gill of Dr. 
Besemer). Culture medium was RP~lI 1640 (Bio\Vhittaker, Verviers, Belgium), containing 
5% heat-inactivated FCS (BioWhittaker), 25 n11V1 HEPES buffer (GibcoBRL, Life Tech LTD, 
Paisley, Scotland), 100 lV/ml penicillin (GibcoBRL), 100 mg/ml streptomycin (GibcoBRL), 
hnM pyruvate (Sigma, Zwijndrecht, The Netherlands) and 50 llM 2-ME (Sigma). 
Proliferation of CD4+ T cells was measured by adding 0.5 [lCi [3H]-thymidine per well and 
incubating the cultures for another 16 hours. Th I and Th2 polarization cui hires were per-
formed by culturing the cells as described above in the additional presence of 5 [lg/ml anti-
CD28 mAb (37.51) and exogenously added cytokines and anti-cytokine mAbs. Thl polar-
ization was induced by adding in 5 ng/ml recombinant IL-12 (R&D Systems, Minneapolis, 
MN) and 40 llg/ml anti-IL-4 mAb (lIBII). Th2 polarization was induced by the addition of 
10 ng/ml recombinant IL-4 (aftlnity-purified fi·om culture supernatants of plasmacytoma 
transformant of the X63-Ag8-653 cell line carrying the IL-4 cDNA (39)) and 40 llg/ml anti-
IFNy mAb (XMG 1.2). After 4 days of culture, cells were washed and restimulated ou anti-
CD3E (145 2cll; 5 llg/ml) pre-coated 96 well plates in the absence of any exogenously added 
cytokines. Culture supernatants were collected at day 2 of the restimulated cell culture. 
Cytokine (IL-4, IFNy) concentrations in supernatants of replicate cultures were determined 
using a sandwich ELISA system as descibed before (40). Differences are considered and 
refelTed to as significant ifp.::;O.05 according to Shldent's {-test 
SEQUENCE ANALYSIS 
1L-4 eDNA was amplified from mRNA extracted from purified, polyclonally activated 
CD4+ T cells by RT-PCR, using the lL-4- specific primer pair: 5' GGG ATT TGT TAG CAT 
CTC TTG AT 3' aud 5' ATAAGT TAAAGC ATG GTG GCT CA 3'. SubsequentIL-4 cDNA 
sequence analysis was performed with Dye terminator reagents (PE biosystems) using the 
ABI377 t1uorescent cycle sequencer (PE biosystems) according to the manufacturer's 
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instructions. 
CT.4S IL-4-SPECIFIC BIOASSAY 
CT.4S cells (a kind gift ofDt: D. Oray) were maintaincd in the prescnce ofrlL-4 (41). 
SJL and SJA/9 T cell culture supernatants were titrated in two series of triplicate serial dilu-
tions using 96 well round-bottom plates (Ill though 11128). The samples were pre-incubated 
I hour at 37°C with the following monoclonal antibodies: S4B6 (IL-2 specific; 40 llg/ml), 
2A5.1 (lL-iO specific; 40 Ilg/mI), and either the IL-4-specific mAb II B II or isotype control 
mAb (Il-Oal specific) OLII3 (both at 40 rlg/ml). CTAS cells were added at lOS cells/well. 
The plates arc incubated 24 hours at 37"C, at which tinle ['H)-thymidine was added at 0.5 
rlCi/well and cells were incubated for another 18 hours at 37°C, [lH)-thymidine incorpora-
tion was measured by scintillation counter (B-plate counter, Beckman, Mijdrecht, The 
Netherlands). IL-4-speeifie CTAS proliferation was calculated by subtracting the IlBll-vaI-
ues from the OLl 13-values. 
FLOW CYTOMETRlC ANALYSES 
Single-cell suspensions were harvested from tissue culhlre plates and stained for analy-
sis by flow cytometl), as described previously (42). Thc following mAb were purified and 
conjugated to FITC or biotin according to standard procedures: anti-CD4 (OKI.5), anti-B220 
(RA3 6B2), anti-CD25 (PC6I), anti-CD44 (POP-I), anti-CD45RB (MB2302) and anti-
CD62L (Mcl-I4). As secondar)' antibodies wcre used: PE- or Tricolor-conjugated strepta-
vidin (CaJtag Laboratories, Burlingame, CA). Stained cells were analyzed using a FACScan 
analyzer (Becton Dickinson, Sunnyvale, CA). 
ANTI-IGD mIMUNIZATION 
Polyclonal goat IgO raised against mouse IgD (Nordic, Tilburg, The Netherlands) was 
reconstitutcd at 4 mg/ml in PBS. Oroups of 5 mice were injected intravenously (Lv.) in the 
lateral tail vain with 200 pI (800 rIg) goat IgO reconstituted in PBS or with saline control. 
Serum was collected at days a (prior to injection), days 4, 7 and II. Total serum IgE Icvels 
were determined using a sandwich ELISA system as previously described (43). 
TNP-KLH IMMUNIZATION 
Immunizations were performed by intra-peritoneal (Lp.) injection of with 10 ~lg 
TNP-KLH precipitated on alum. Sera were collected on days 0 (prior to immunization), 14 
and 28. Serum levels of TNP-specific immunoglobulin (Ig) subclasses were determined by 
ELISA, using TNP-specific standards, as previously described (40, 43). 
ALGINATE-ENCAPSULATION AND INJECTION OF HYBRIDOMA CELLS. 
GLl 13 and 2A5.1 hybridoma cells were harvested fi'om culture during logarithmic 
grO\\1h phasc. Cells were counted, and 2x 106 hybridollla cells were resuspended in 500 rt! of 
PBS. Cells were thcn encapsulated in alginate as dcscribed (44). Alginate-encapsulated cells 
werc injected i.p. using a 210 needle (2xI06/mouse). 
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DTH RESPONSES TO KLH 
Delayed-type hypersensitivity (DTH) responses were performed essentially as 
described (4S). Groups of6 mice were immunized i.p. with 100 rIg KLH. On day 6, the mice 
were challenged by subcutaneous injection of ISO llg KLH in 30 rt! PBS (S llg/lll) in the left 
hind footpad and 30 rll of PBS in the right hind footpad. Footpad thickness was measured at 
days 0 (prior to injection), I and 2 using an engineer's micrometer (NIihltoyo Digimatic, 
Veenendaal, The Netherlands). Day I values were nsed to calculate specific swelling by cal-
culating the ratio of left versus right hind footpad thickness. 
ELECTRIC MOLBILITY SHIFT ASSAYS (EMSA) 
CD4+ T cells purified from spleen and lymph nodes were incubated with a dilution 
series of rIL-4 for I hour at 37°C. Cells were washed and cell extracts were prepared by 
resuspending the pellet in a lysis buffer containing NP-40 (O.S%; Boehringer, Petersburg, 
VA), NaCI (ISO rIM; Fischer Scientific, Chicago, IL), PMSF (0.4 mM), Leupeptin (I llg/ml), 
Pepstatin (I rlg/ml), Apoprotinin (3 llg/ml), DTT (Di-thio-trcitol, Imlvl) (all Boehringer). 
Protein content of the cell lysate was measured using standard Bradford techniques. DNA 
binding of activated Stat factors present in the lysate was analyzed by incubating cell lysate 
containing S rIg of total protein for 30 minutes with a O.S ng of a [32PJ-labeled dsDNA probe 
containing a single GAS element (interferon-gamma activated site) as previollsly described 
(46). Reaction mixtures were separated on a O.llx TBE S% poly-aclylamid (PAA) gel. PAA 
gcls wcre dried and exposed to X-ray film. 
RESULTS 
SJAl9 CD4+ T CELLS CAN BE INDUCED TO PRODUCE IL-4 IN VITRO 
SJAJ9 mice have an T cell-intrinsic defect resulting in low IgE responses which can be 
reversed by infbsion ofriLA early during the innnune response (4). These data raise the pos-
sibility that SJN9 CD4+ T cells have a reduced potential to differentiate into IL-4-produCing 
effector cells. In order to investigate the potential of SJN9 CD4+ T cells to differentiate into 
[LA-producing cells, we purified CD4+ T cells from SJN9 and SJL spleens and lymph nodes 
and cultured them under Thl- and Th2-inducing conditions for 4 days, and rcstimulated the 
polarized Th cells. Cytakine levels were determined on T cell culhue supernatants harvested 
at day 2 after restimulation of the polarized Th cells. As shown in figure I, Th2-polarized 
SJAl9 CD4+ T cells produced high levels ofJL-4 upon restimulation, comparable to the lev-
els produced by SJL CD4+ T cells. In addition, IFNy production by Till-polarized CD4+ T 
cells ,vas comparable between the two strains of mice (figure 1). Therefore, it appears that 
SJN9 CD4+ T cells have a normal potential to differentiate into IL-4- and IFNy-producing 
cells ill vitro. 
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FIGURE I 
Cytokine production by ill ~'ilro polarized CD4+ T ccUs. 
Cytokine production as detected by sandwich ELISA in culture 
supernatants from purified splenic SJAi9 (black bars) and SJL 
(white bars) C04+ T cells culturcd in the presence of recomb i-
nant lL-12 and lL-4-neutralizing monoclonal antibodies ('TIll ') 
or in the presence of recombinant JL-4 and fFNy-neutralizing 
monoclonal antibodies ('Th2'). Values (nglml) represent mcan 
± I SO of 4 replicate cultures. Diflerenccs arc considered and 
referred to as significant ifpSO.05 according to Student's t-test. 
IL-4 PRODUCED BY SJA/9 T CELLS IS BIOACTIVE 
We show that ill vitro Th2-polarized SJAl9 CD4+ T cells produce similar levels of [L-
4 as compared to SJL CD4+ T cells. Also, infusion ofr[L-4 during Nippostl'OlIgyllls brasiliell-
sis iufection restores the [gE response in SJAI9 mice (4). We therefore tested the possibility 
that the SJAl9 IL-4 protein is not functional. To this end, we first derived the cDNA sequence 
from the SJAl9 IL-4 mRNA. The nucleotide sequence for the SJAl9 [L-4 eDNA was identi-
cal to the published murine IL-4 cDNA sequence (not shown) (47). [n addition to the cDNA 
sequence, the specific bioactivity of the SJAl9 IL-4 protein was determined. IL-4-containing 
supernatants from SJAl9 and SJL CD4+ T cell cultures were tested for induction oflL-4-spe-
cific proliferation of CTAS cells. Dilution series of these CD4+ T cell culture supernatants 
were added to cultures of eTAS cells, both in the presence and in the absence of neutralizing 
antibodies to IL-4. Units of IL-4-activity (l unit equals half-maximal IL-4-induced CTAS 
proliferation) in the Th cell culture supernatants were compared to ELISA values for total 
IL~4 protein content of these supernatants. Thus, the specific IL-4 bioactivity was determined 
to be 20.7 units/ng for SJAl9 IL-4 and 19.2 units/ng for SJL IL-4. Taken together, these 
results show that SJAl9 lL-4 is encoded for by a non-mutated mRNA and that the SJAl9 IL-
4 protein has full bioactivity, as compared to SJL IL-4. 
SJAl9 CD4+ T CELLS PRODUCE LOW LEVELS OF IL-4 WHEN RE-STIMULAT-
ED AFTER THE IN VIVO RESPONSE TO ANTI-IgD 
SJA/9 T cells are capable of producing IL-4 ill vitro and the SJA/9 [L-4 protein has full 
bioactivity. Still, IgE levels during humoral imlllune responses can be restored by infusion 
of rIL-4, indicating a possible defect in IL-4 production by SJAl9 CD4+ T cells ill vivo. 
Therefore, we wanted to analyze IL-4 production by purified CD4+ T cells during the 
immune response to polyclonal Goat anti Mouse IgD (GALVI-IgD), a response which is char-
acterized by high IL-4 production ill vivo (48). CD4+ T cells, purified at day 7 of the anti-IgD 
response, were polyclonally restimulated in vitro, and cytokine production was measured by 
ELISA. In this ex vivo stimulation, SJAl9 CD4+ T cells produced significantly lower levels 
of IL-4 and significantly higher levels oflFNy as compared to SJL CD4+ T cells (figure 2A). 
These low levels of ex vivo IL-4 production by SJA/9 CD4+ T cells might reflect a decreased 
Th2 polarization ill vivo or a decreased induction of IL-4 gene expression ex vivo. 
Interestingly, SJAl9 CD4+ T cells purified from GAM-IgD immunized animals dis-
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CD4+ T celis, purified from splecn at day 7 of the GM1-lgD response were restimulated ill vitro on immobilized 
CD3E-specific mAb. (A) Lcvcls oflL-4 (pg/ml) and lFNy(ngfml) in SJN9 (black bars) and SJL (white bars) Th cell 
culture supernatants harvcstcd at day 4 of ex vim rcsti.l1lulation. Values are mean cylokinc concentration ± I SD of 
four replicate culturcs. (B) Prolifcration (in Ixl04 cpm) ofSJAJ9 (black bars) and SJL (white bars) C04+ T cclls at 
day 3 of the il1l'itro rcstimulatioll. Values (lxl03 cpm) arc mean cpm values ± I SO of three replicate cultures. (C) 
Flow c}1ometric analysis of cell size (forward scallcr) and CD25 expression in SJN9 (fat curve) and SJL (thin curye) 
CD4+ T cells at day 2 of the ill vitro restinllliation. Control plots deriyed from unstimulated SJAl9 cells arc repre-
sented by a dotted eurvc. (D) Flow cytometric analysis ofCD25 expression on C062Lhi and CD62Lio CD4+ T cell 
subsets ofSJN9 (A and C) and SJL (B and 0) micc, at day 2 of the il1l'ilro restimulation. (E) Sennn values of total 
Igi'vl HlgfIlll), IgG I (~lg/ml) and IgE (ng/mI) in SJAl9 (black bars) and SJL (whitc bars), determined by isotype-spe-
cific sandwich ELISA at day 7 of the GAM IgD response. Values are mean Ig-isotype serum ± I SO of groups of 
five mice cacho 
played significantly lower proliferation during this ex vivo culture as compared to SJL CD4+ 
T cells. No diflerences ,vere observed between in two strains in the in vitro proliferation of 
CD4+ T cells purified fi'om saline injected control animals (figure 2B), To confirm these 
results, the cells from the ex vivo cultures were analyzed on expression of activation markers 
using flmv cytoll1etry. Analysis of CD4+ T cells stimulated ill vitro, revealed a significantly 
decreased number of CD25-expressing CD4+ T cells fi'om the GAM-IgD-imlllunized SJA!9 
mice (22.3%) as compared to GAM-IgD-immunized SJL mice (44.2%) or saline injected 
SJA/9 (58.0%) or SJL (50.5%) mice (figure 2e). In addition, cell size analysis indicated an 
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absencc of blast-like cells in ex vivo polyclonally stimulatcd SJAI9 CD4+ T cells, only when 
they were purified ti0111 GAM-IgD treated animals (Figure 2C). Takcn together, these data 
suggest that the activation of SJAl9 CD4+ T cells by polyclonal stimulation ill vitro is less 
pronounced shortly after the ill vivo response to GAM-IgD. 
To distinguish betwcen activated (CD25+) and resting (CD2Y) naIve (CD45RBhi, 
CD4410 and CD62Lhi) and antigen-experienced Th cells (CD45RBlo, CD44hi and CD62Uo), 
CD4+ T cells were stained for expression ofthe cell surface markers CD45RB, CD44, CD62L 
and CD25 (shown for CD62L vs. CD25 in figure 2D). Levels of CD25 expression on anti-
gen-experienced CD4+ T cells (CD62Uo) were comparable between GAM IgD treated SJL 
and SJA/9 mice (3.7% and 3.9%, respectively). Conversely, expression of CD25 on naIve 
(CD62Lhi) CD4+ T cells was reduced on CD4+ T cells purified from GAM-IgD immunized 
SJAl9 mice (17.7%; dot-plot C) as compared to GAM-IgD immunized SJL (59.5%; dot-plot 
D) or saline-injected SJAl9 (45.8%; dot-plot A) and SJL (43.3%; dot-plot B) mice (fIgure 
2D). Therefore, it seems likely that the low proliferative response of SJA/9 CD4+ T cells to 
polyclonal activation ex vivo could mainly be attributed to the nalVe subset ofTh cells. 
\Ve next analyzed immunoglobulin (Ig) serum levels to determine the magnitude and 
the nature of the humoral immune response to the anti-IgD illllllunizatioll. Isotype-specifie 
sandwich ELISA revealed that SJA/9 mice produced significantly lower levels of IgE iu 
response to GAlvI-IgD immunization as compared to SJL mice, whereas senllll levels oflgM 
and IgG I were comparable between the two strains (figure 2E). 
In sUllllllmy, we show that SJAI9 CD4+ T cells have a potential to differentiate into IL-
4~prodt1cing cells ill vitro comparable to that of SJL CD4+ T cells. However, the ill vivo dif-
ferentiation of SJAl9 CD4+ T cells into IL-4-producing cells is impaired during the GAM-
IgD-induced rcsponse. In addition, SJAl9 CD4+ T cells purified from GAM-IgD immunized 
animals were only partially activated in response to polyclonal stimulation in vitro. This 
impaired activation seemed to be mainly restricted to CD4+ T cells with a naiVe phenotype. 
SJAI9 CD4+ T CELLS PRODUCE LOW IL-4 AL'I'D mGH IL-1O AFTER TNP-KLH 
IMMUNIZATION 
It is possible that the low ex.vivo IL~4 production and impaired proliferation to poly-
clonal activation of SJAl9 CD4+ T cells purified during the GAM-IgD response is unique to 
this type of stimulation. Alternatively, it could be reflective of a more general characteristic 
ofSJAl9 Th cell-mediated imlllune responses. To distinguish between these possibilities, we 
analyzed SJA/9 and SJL responses to immunization with the protein antigen TNP-KLH. 
CD4+ T cells were purified at day 28 following immunization with TNP-KLH, and restimu-
lated ill vitro on anti-CD3 coated plates. Under these conditions, SJAl9 CD4+ T cells pro-
duced significantly smaller amounts of IL-4 as compared to SJL CD4+ T cells, similar to 
those produced by Th cells purified from untreated SJA/9 or SJL mice (figure 3A). In addi-
tion, SJAl9 CD4+ T cells produced significantly higher levels of IL-I 0 as compared to SJL 
CD4+ T cells. CD4+ T cells purified from both strains produced equal levels of IFNy. 
In the GAM-IgD responses, SJAl9 CD4+ T cells were only partially activated by poly-
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clonal in vitro restimulatioll. This phenomenon seemed to be restricted to the naiVe subset of 
CD4+ T cells. Therefore, we analyzed both polyclonal and KLH-specific activation ofCD4+ 
T cells purified from TNP-KLH immunized mice. The proliferation of poly clan ally restimu-
lated SJAl9 CD4+ T cells was strongly decreased as compared to their SJL counterparts (fig-
ure 38). [n contrast, no differences were seen between the proliferation of SJA/9 and SJL 
CD4+ T cells when they were cultured with KLH-pulsed spleen cells derived li"Olll either 
SJAl9 or SJL mice (figure 38). This result indicates that the KLH-specific SJAl9 CD4+ T 
cells proliferate normally in response to antigen. 
To check for potential altered kinetics of the [gE response in SJA/9 mice, total [gE 
serum levels were determined at various days during the TNP-KLH response (figure 3C). The 
JgE levels of SJA/9 mice were significantly lower than those of SJL mice at days II and 14 
after initial immunization. The kinetics of the response, hmvever, were similar between the 
two strains of mice. 
Taken together, these data indicate that the low proliferation of ill vitro polyclonally 
stimulated Th cells seen in SJA/9 mice is not reflective of an intrinsic proliferative defect of 
antigen-experienced CD4+ T cells purified from the SJA/9 mice. Rather, the naIve (non-anti-
gen-experienced) fraction of the CD4+ T cells seems to have a low proliferation in response 
to ex vivo polyclonal activation, but only after a recent immune response. The high produc-
tion of [L-I 0 ill vitro by polyclonally stimulated SJA/9 CD4+ T cells purified from immu-
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FIGURE 3 
It, )'ilro analysis of the CD4+ T cell effector func-
tions after the TNP-KLH response. 
(A) Ex )';1'0 cytokine production Hnd (B) prolifera-
tion of CD4+ T cells and (C) fotal IgE serum yalues 
during the response to TNP-KLII. 
CD4+ T cells \vere purified at day 28 of the primary 
immune response from TNP-KLH and saline immu-
nized animals und re-stimulated Oll immobilized 
C03e-spccific mAb illl'i1ro. (A) Culture sllpcmatants 
from both groups (as indicated) were harvested at day 
4, and IL-4 (ng/ml), IFNy(nglml) and IL-IO (00) pro-
duction by SJAi9 (black bars) and 51L (white bars) 
C04+ T cells was measured by sandwich ELISA. 
Values are mean ± I SD of four replicate cultures. (B) 
Polyclonal (immobilized C03e-specific mAb) and 
antigen-specit1c (KLH-pulsed spleen cells from SJAl9 
and SJL mice) proliferation of SJAl9 (black bars) and 
SJL (white bars) CD4+ T cells on at day 3 of the ill 
vitro restimulation. Values (Ix! 03) are mean cpm val-
ues ± 1 SO of three replicate cultures (C) Total SJAl9 
(solid dimnollds) and SJL (open diamonds) IgE serum 
values were measured by isolype-specifie sandwich 
ELISA on days 0, 4, 11, 14, 18 and 26 of the TNP-
KLH response. Values are mean IgE serum leyeIs ± I 
SO of groups of 5 mice each. 
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nized mice might indicate an altered differentiation ofSJAl9 CD4+T cells during the immune 
response. 
SJAl9 CD4+ T CELLS HAVE FUNCTIONAL IL-4 RECEPTOR SIGNAL TRANS-
DUCTION 
During the generation of immune responses in SJAl9 mice, CD4+ T cells tend to dif-
ferentiate into a population of helper T cells characterized by high IL-l 0 and low IL-4 pro-
duction. III vitro, however, SJAl9 CD4+ T cells can be polarized efficiently into IL-4 pro-
ducing cells. These observations could be explained by a diminished activation of Stat6 in 
response to ILA (which is a limiting factor ill vivo but not ill vitro) in SJA/9 CD4+ T cells. 
Therefore, we wanted to analyze lL-4 receptor (IL-4R)-mediated signal transduction in 
SJA/9 CD4+ T cells. To this end, CD4+ T cells were purified from SJA/9 and SJL spleens, 
and incubated with a dilution series of recombinant IL-4. STAT-6 activation in whole cell 
extracts was analyzed by electrophoretic mobility shift assays (EMSA) (46). In addition, 
IL-4-induced proliferation of CD4+ T cells was measured using standard [3H]-thymidine 
incorporation methods. No differences were observed in either recombinant IL~4~dependent 
STAT-6 activation (figure 4A) between SJL and SJAl9 CD4+ T cells, or in IL-4-induced pro-
liferation between SJL and SJA/9 CD4+ T cells (figure 4B). These results indicate that there 
are no differences in IL-4-induced signal transduction leading to STAT-6 activation and cel-
lular proliferation between SJAl9 and SJL CD4+ T cells. 
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FIGURE 4 
IL-4 responslveness of CD4+ T cells. 
Stat-6 activation (A) and proliferation ofCD4+ T 
cells (ll) in response to an rIL-4 dilution series. 
(A) Stat-6 activation in response to a dilution 
series of rIL-4 was analyzed in SJAi9 and SJL 
whole celllysatcs by EI\-lSA using a [32P]_labeled 
dsDNA probe containing a single GAS clement. 
(B) Proliferation of SJAi9 (solid diamonds) and 
SJL (open diamonds) CD4+ T cells in the pres-
ence ofa dilution series ofrlL-4. Values are mean 
values oflhree replicate cultures ± I SD. 
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IN VIVO NEUTRALIZATION OF IL-IO DOES NOT RESCUE THE IgE RESPONSE 
TO TNP-KLH IN SJAl9 MICE 
CD4+ T cells which are purified from recently imlllunized SJAl9 mice, produce high 
amounts ofIL-lO when restimulated ex vivo. Therefore, we wanted to examine the role ofthis 
cytokine in both CD4+ T cell differentiation and in the IgE response of SJAl9 mice ill vivo. 
To this end, SJAl9 and SJL mice were transplanted with alginate-encapsulated hybridoma 
cells. These cells produce monoclonal antibodies (mAb) specific for IL-IO (2A5.1) or, as an 
isotype-matched control, for j3-Gal (GL-113). This method was shown to be effective inneu-
tralizing senllllieveis ofIL-4 and ofIL~6 when mice were transplanted with alginate~encap~ 
sulated hybridoma cells producing the IL-4-specific mAb lIB 11 and the IL-6-specitk mAb 
20F3, respectively (49). Alginate-encapsulated hybridoma cells (2xl06) were injected i.p. 3 
days prior to the TNP-KLH immunization. At the time of TNP-KLH immunization, semm 
levels of rat IgG I were between 1 and 5 [{g/ml, and remained constant for approximately 
three weeks (data not shown). Serum levels of total and TNP-specific inlllluriogiobulin iso-
types were determined prior to inllllunization and at days 14 and 28 of the response. 
Total IgE levels li'om both strains of mice were relatively low during the TNP-KLH 
rcsponse. SJAl9 mice treated with the control antibody GLlI3 had significantly lower IgE 
responscs as compared to SJL mice treated with GLI 13 (figure 5A). In SJAl9 mice, treatment 
with IL-I O-neutralizing mAb (2A5.1) had little effect on total IgE responses as compared to 
GLl13-treated SJAl9 mice. Total IgE levels in SJL mice treated with 2A5.I mAb were non-
significantly enhanced as compared to GL 113-treated SJL mice. In addition, 2A5. I -treated 
SJAl9 mice had similar levels ofTNP-specific IgE as compared to those treated with GL 113 
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FIGURES 
Neutralization of IL~10 during the TNP-KLH response ill 
vil'o. 
Total IgE CA) and TNP-specific IgE and IgG2a (B) levels and 
ex vitro proliferation of CD4+ T cells (C) during the immune 
response to TNP-KLH under neutralization oflL~IO. 
Mice (5 per group) were transplantcd i.p. with 2x.106 alginate 
encapsulated hybridoma cells, producing mAb specific for 
IL-1O (2A5.1) or jl-Gal (GLlI3), and a TNP-KLH immuniza-
tion was perfonned. (A) SJA/9 (black bars) and SJL (white 
bars) totallgE senllll levels (depicted as mean ± I SO) were 
dctcnnined at day 14 of the TNP-KLH response by sandwich 
ELISA. (B) SJAl9 (black bars) and SJL (white bars) TNP-sjle~ 
cHIC IgE and IgG2a Senltll values (depicted as mcan ± I SD) 
were measured 011 day 14 of the respollse by TNP-specific 
sandwich ELISA. (C) CD4+ T cells were purified and reSllnHl-
lated ill vitro on immobilized CD3e-specific mAb in the 
absence (marked as anti-C03) or presence of IL-1O neutraliz-
ing mAb (marked as anti-CD3/2A5. I). AI day 3 of the culture, 
proliferation was measured by [3H]-thymidinc incorporation. 
Values Ox103) arc mean cpm values ± J SO of three replicate 
cultures. 
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(figure SB). TNP-specific IgE levels were non-significantly reduced in SJL mice treated wilh 
2AS.I mAb as compared 10 GLll3-trealed SJL mice. No significant differences in TNP-spe-
cHic IgE responses were observed between SJL and SJA/9 mice. 
TNP-specific IgG2a serum levels were elevated in 2AS.I-treated SJA/9 mice as com-
pared to GLll3-lreated animals, whereas levels were comparable bel ween 2AS.I and GLI I 3-
treated SJL mice (figure SB). TNP-specific IgG2a levels were significantly eubanced in 
SJAl9 mice as compared SJL mice only wilhin the 2AS .I-Ireated groups. TNP-specific IgG I 
levels could not be measured accurately, due 10 Ihe inlerference of the rat IgG I mAb (GLI 13 
or 2AS.I) with the ELISA assay (dala not shown). 
C04+ T cells were purified on day 28 of the response from all groups of animals, and 
their ability to proliferate in response to polyclonal stimulation in vitro was determined. CD4+ 
T cells purified from SJAl9 mice treated with GLll3 show a significantly decreased prolif-
eration to polyclonal restimulation in vih·o as compared to GLIl3-treated SJL mice (figure 
4C). The ill vitro proliferation of SJAI9 CD4+ T cells was reslored by neutralizing IL- lOin 
the cultures (figure 4C). The ill vitro proliferation of CD4+ T cells purified fi·om SJAI9 mice 
which had been treated ,,,ith 2AS.l in vivo, was only slightly reduced as compared to cul-
tures ofCD4+ T cells purified from ill vivo 2AS.I-treated SJL mice. Interestingly, ill vihn neu-
lralizalion of IL-IO in Ihe cultures of 2AS.I-treated SJAl9 C04+ cells did not enhance the 
proliferation, suggesting Ihallhese cultures did nol contain IL-IO-producing T cells. 
Taken together, these data indicate that the ill vivo treatment on SJN9 mice with IL-lO-
neutralizing antibodies could prevent the differentialion of C04+ T cells into IL-I O-produc-
ing cells, but could not restore the IgE response of the SJAl9 mice to levels comparable to 
that of the SJL strain of mice. 
SJAl9 MICE ELABORATE NORMAL DTH RESPONSES TO PROTEIN Al'lTIGEN 
SJA/9 mice elaborate altered Th cell-dependent i1ll1llune responses in vivo. Specifically, 
differentiation of CD4+ T cells inlo IL-4-producing cells is affected. To determine whelher 
the Th I compartment in SJAI9 mice is funclional, we induced a typical TllI-medialed 
immune response in SJAI9 and SJL mice, the delayed-Iype hypersensitivity (OTH) response 
to the protein antigen KLH. Mice were injected i.p. with 100 I'g KLH. At day 6, mice were 
rechallenged by injection of ISO I'g KLH in 30 mg PBS in the left-hind footpad and 30 I'g 
PBS in Ihe righI-hind footpad. Footpad thickness was measured at 24 hours after the chal-
lenge, and KLH-specific swelling was calculated by determining the ratio of left versus right 
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FIGURE 6 
DTH responses. 
SJAl9 and SJL mice were challenged subcutaneous in the left-hind toot-
pad with 150 ~tg KLH at day six after initial KLH immunization (i.p. 100 
~tg ). Right hind footpads were injected with equal volumes (30 ~tl) of 
PBS. Footpad thickncss of SJAl9 (solid diamonds) and SJL (open dia-
monds) right and left hind footpads were detemtined at 24 hours after 
challenge and left versus right hind tootpad ratios were calculated. 
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hind footpad thickness. No differences were observed between SJA/9 and SJL mice in spe-
cific footpad swelling in response local challenge with KLH (figure 6). These results indicate 
that the Th I compartment in SJAl9 mice is fully functional as compared to SJL animals. 
DISCUSSION 
SJAl9 mice display defective IgE but normal IgG I responses to hehninth parasites and 
protein antigens (2-4). IgH class switching of activated B cells to the IgE isotype is largely 
dependent on IL-4 (6, 50, 51). The isotype-speeific defect ofSJAl9mice could, therefore, be 
reflective of a specific defect in IL-4-responsiveness. It has been shown, however, that SJA/9 
B cells are capable of IgE production when stimulated ill vitro with rIL-4 and LPS (5-7). 
Also, congenic SJL thymocytes have been shown to revert the IgE response to 
NippoStrollg),llIs brasiliellsis and TNP-KLH (2, 4, 8), indicating that the SJAl9 defect in IgE 
responses resides within the T cell compartment. In addition, infusion of rlLA early during 
the immune response also restored the IgE rcsponse ofSJAl9 mice (4), indicating the possi-
bility of a defective JL-4 production by SJA/9 CD4+ T cells to be the responsible factor. 
Here we show that SJAl9 CD4+ T cells can be induced to produce IL-4 ill vitro efti-
ciently (figure I), but produce only modest amounts of IL-4 when restimulated ex vivo fol-
lowing the immune response to polyclonal anti-IgD goat serum (figure 2), or to TNP-KLH 
(figure 3). These results indicate that the T cell defect responsible for the defective IgE 
responses ofSJAl9 mice does not result from their capacity to produce IL-4, but from the ill 
vivo induction of SJA/9 CD4+ T cells to become IL-4-producing effector cells. CD4+ T cells 
purified from SJAl9 mice after an immune response produce high levels of IL-IO and low 
levels of IL-4 as compared to congenic SJL CD4+ T cells (figures 2, 3), which could explain 
the inhibition of in vitro proliferation in response to polyclonal activation. 
It seems likely that the antigen-experienced subset of SJAl9 CD4+ T cells is responsi-
ble for the high IL-IO production. SJAl9 CD4+ T cells purified from non-immunized animals 
proliferate normally and do not produce IL-IO in response to polyclonal activation ill vitro. 
Also, polyclonal, but not antigcn-specific proliferation is strongly decreased in SJiV9 CD4+ 
T cell cultures from previously immunized animals (figure 3D). Finally, the defective induc-
tion ofIL-2Ra upon polyclonal ex vivo stimulation is Im:gely confined to the naive (CD62Lhi) 
CD4+ T cells (figure 2C) (52). Taken together, these findings indicate that during the response 
to GAM-IgD or TNP-KLH, antigen-experienced SJA/9 CD4+ T cells differentiate into a pop-
ulation of CD4+ T cells producing low amounts of IL-4 and high levels of IL-I 0, suggesting 
a dysregulation of CD4+ T cell difierentiation in SIAl9 animals. 
Th-derived production of IL-I 0 may be accounted for by IL-I O-produciug Th2 cells, or 
by regulatOlY T cells I (Tr-I), a regulatory subset of Th effector cells which produce IL-I 0 
but no IL-4 (53). The ill vivo cQuIlterp3li of these il1 vitro generated Tr-l cells, are contained 
within the CD45RBIow subset of CD4+ T cells (54). It has been reported that the differentia-
tion of these IL-IO-producing CD4+ T cells is dependent on the presence ofIL-IO (53, 55). 
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We show that during the immune response to GAM-IgD or TNP-KLH, SJiV9 CD4+ T 
cells differentiate into IL-IO-producing CD4+ T cells to a higher extent than do SJL CD4+ T 
cells. The IL-IO production after ex vivo re-stimulation of SJiV9 CD4+ T cells could be 
derived from both Th2 and Tr-l cells. Neutralizing IL-I 0 during the ill vivo immune response 
inhibited the suppression of the proliferation in response to polyclonal activation ill vitro (fig-
ure 3). This indicates the impOliance of IL-IO for the differentiation of SJA/9 CD4+ T cells 
into the IL-IO-producing phenotype. These data suggests that at least pmi of the IL-IO-pro-
ducing cells in SJiV9 CD4+ T ceUs might be Tr-l cclls. Importantly, however, ncutralization 
of IL-I 0 during the immune response did not result in increased levels of TNP-specific 19E. 
Therefore, the SJA/9 CD4+ T cells were are incapable of producing sufficient amounts of 
IL-4 to induce isotype-switching to IgE, even when the differentiation into an IL-I O-produc-
ing phenotype was inhibited. So, IL-I O-producing SJiV9 CD4+ T cells do not actively inhib-
it the differentiation ofSJiV9 CD4+ T cells into IL-4-producing cells. More likely, some reg-
ulatOlY mechanism acting on SJiV9 CD4+ T cell differentiation is responsible for both their 
propensity to differentiate into an IL-l O-producing phenotype and their lack of difierentiation 
into an IL-4-producing phcnotype. 
There are a number of possible explanations for the dysregulated SJiV9 CD4+ T cell 
differentiation. IL-4-induced STAT-6 activation in SJiV9 CD4+ T cells might be diminished, 
leading to a deficiency in inducing Th2 difterentiation in response to ILA. However, we show 
that IL-4-dependent activation of STAT-6 and IL-4-induced proliferation is similar between 
CD4+ T cells derived fi'oll1 SJiV9 and SJL mice. Moreover, SJiV9 CD4+ T cells can be 
induced to differentiate into IL-5 producing Th2 efiector cells ill vivo (4). Also, we show that 
SJiV9 CD4+ T cells can readily be differentiated ill vitro into IL-4-producing Th2 cells. 
It remains possible that IL-4 gene expression is specifically affected in SJiV9 CD4+ T 
cells, independent of the expression of other Th2 c)10kine genes, such as IL-5 and IL-I3. We 
show that Th2 polarized SJiV9 CD4+ T cells are capable of producing IL-4 to similar levels 
as SJL CD4+ T cells. However, a putative defect in IL-4 production by SJiV9 CD4+ T cells 
might be too subtle to detect under these optimized conditions in vitro. Under physiological 
conditions, not all the factors essential for the optimal induction IL-4 gene transcription might 
be available to SJiV9 CD4+ T cells, resulting in an IL-4-specific defect in cytokine produc-
tion by these cells. For instance, an absence of factors essential for the induction ofc-Maf, a 
transcription factor acting on the IL-4 promotor specifically (56), could account for such a 
defect in induction of 1L-4 gene transcription. These issues remain to be addressed in fuhlre 
studies. 
The SJA/9 strain was originally derived from breeding the BALB/c ill1lllunoglobulin H 
chain allotype (lg') into the SJL background (I). It can be anticipated, however, that SJiV9 
and SJL mice differ on additional chromosomal loci, which could contain genes important for 
the regulation ofTh-mediated immune responses. Such differences might then account for the 
observed difJerences in CD4+ T cell differentiation and the subsequent regulation of the 19E 
response. A more detailed genetical analysis of the SJiV9 and SJL strains could therefore be 
an interesting approach to determine these genetic loci that putatively affect Til cell difTeren-
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tiation. 
In conclusion, we show that CD4+ T cells derived from SJA!9 mice -which are charac-
terized by a specific defect in the induction of IgE responses- fail to differentiate into IL-4-
producing Th2 effector cells ill vivo. This defective differentiation into an IL-4-producing 
phenotype is associated with a preferential ill vivo differentiation into an IL-IO-producing 
phenotype. The acquisition of an IL-IO-producing phenotype in itself is not responsible for 
the impaired induction of an JgE response. The molecular mechanisms responsible for the 
dysregulated differentiation ofSJAJ9 CD4+ T cells remain to be elucidated and could be vel)' 
informative on the regulation of Th cell differentiation into IL- I O-producing phenotypes. 
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ABSTRACT 
Recent studies have suggested that signaling initiated by the activation of antigen recep-
tors and signaling activated through cytokine receptors may be regulated by a common set of 
inhibitOlY proteins. SOCS-3, which has previously been demonstrated to inhibit cytokine sig-
naling, is induced upon T cell receptor (TCR) ligation. Overexpression of SOCS-3 can inhib-
it transcription driven by the IL-2 promoter in response to T cell activation. This inhibitOlY 
activity correlates with the suppression of calcineurin dependent dephosphOlylation and acti-
vation of the transcription factor NFATp. Infection of primary murine T cells with a retmvirus 
encoding SOCS-3 blocks their ll..-2 production in response to activation. Interestingly, SOCS-
3 was found to co-immunoprecipitate \vith the catalytic subunit of calcineurin. These studies 
suggest that SOCS-3 may regulate T cell function as part of a negative feedback loop. 
li'llTRODUCTION 
Regulation ofT cell activation is critical for the maintenance of immune homeostasis 
and the prevention of autoimmune disease (1). This homeostatic regulation can be imple-
mented at several levels. Regulation of T cell activation at the level of cell-cell interaction 
involving negative regulatory receptors such as CTLA-4 and Fas are well characterized (I). 
:Mucb less is known about the negative regulation ofT cell activation through TCR mediat-
ed signaling pathways. :tYlechanisms involved in this rcgulation include recruitmcnt of the 
inhibitOlY protein tyrosine kinase, Csk (2), and protein tyrosine phosphatases such as SHP-I 
and SHP-2 (3, 4). Interestingly, the SHP-I and SHP-2 phosphatases also regulate cytokine 
receptor signaling (5). There are many similarities between TCR mediated signaling and 
cytokine receptor mediated signaling. Early events in both cases involve clustering of recep-
tor subunits and the activation of tyrosine kinases. The most well studied tyrosine kinases 
activated by cytokine receptors are the janus kinase (JAK) family (6), whereas TCR ligation 
leads to activation of the Src family kinases Lck and FYll, followed by activation of ZAP70 
(7). Activated tyrosine kinases proceed to phosphorylate receptor chains and associated scat:' 
folding proteins, which then bind ftllther downsti'eam eflectors. One of the most well-char-
acterized dowllstream effectors of TCR mediated signal transduction is calcineurin, a calci-
um dependent serine/threonine phosphatase that dephosphorylates, and activates the tran-
scription factor NFAT upon TCR ligation (8). Important downstream effectors of cytokine 
receptor activation include the signal transducer and activator of transcription (STAT) fami-
ly of transcription factors (6). 
In addition to protein tyrosine phosphatase recruitment, another mechanism in the reg-
ulation of cytokine signaling involves members ofthe SOCS gene family (9-11). CIS, SOCS-
I and SOCS-3 have all been shown to inhibit cytokine signaling by interfering with the 
JAK -STAT pathway (12). The existence of parallels between cytokine receptor mediated sig-
Chapter 6 130 
naling and signaling through the TCR has led to interest in the potential involvement of 
SOCS t:1mily members in TCR mediated signaling. CIS has been shown to be induced by 
TCR stimulation and to enhance TCR mediated MAP kinase activation, possibly through its 
interaction with protein kinase C (PKC)-0 (13). While the effects of SOCS-l on TCR sig-
naling remain unclear, SOCS-l has recently been shown to inhibit the activation ofNFAT in 
293T cells expressing CD8 and Syk (14). Whether SOCS-3 plays a role in the regulation of 
TCR mediated signaling has not previously been reported. In this report, we show that SOCS-
3 is induced in T cells upon TCR ligation and can inhibit TCR mediated activation of the 
IL-2 promoter when overexpressed. Furthermore, SOCS-3 is shown to interact with cal-
cineurin and inhibit the activation of NFATp in response to calcium signaling. Our results 
suggest a role for SOCS-3 in the regulation ofNFATp activity in T cells. 
MATERIALS AND METHODS 
NORTHERN BLOT ANALYSIS 
RNA was extracted using an RNeasy Mini Kit (Qiagen, Valencia, CAl. A total of 5 [lg 
of total RNA was denatured for 5 min at 68¥C, separated by electrophoresis in 1% 
agarose/formaldehyde gel and transferred to nylon membrane. SOCS-3 eDNA Ii'agment was 
labeled using Rediprime (Amersham Pharmacia, Piscataway, NJ). 
CELL CULTURE AND TRANSFECTION 
Jurkat cells were grown in RPMI 1640 supplemented with 10% heat inactivated FCS. 
Jurkat cells were transfected by elecroporating 2x I 07 cells in 400 rtlmedia at 250 V and 960 
[IF. Stably transfected cells were selected by resistance to I mg/ml G418 (Gibeo BRL, 
Gaithersburg, lvID). 293T cells were grown in OM EM supplemented with 10% heat inacti-
vated FCS. 293T cells were transfected by the calcium phosphate method. CD4+ T cells were 
isolated from spleens andlor lymph nodes of C57BL/6 mice by negative selection. Briefly, 
single cell suspensions containing no red blood cells "lere incubated with rat anti-mouse 
mAbs (Pharmingen, San Diego, CAl against B220, MAC-I, and CD8 at 20 I,g/ml each. Aner 
washing, suspensions were incubated with anti-rat IgG DYllabeads (Oynal, Lake Success, 
NY). Antibody coated cells were removed using a magnetic concentrator (Oynal). Remaining 
cells were cultured in RPMI 1640 supplemented with 10% heat inactivated FCS, 50 I,M 
B-mercaptoethanoi, 1 mivl sodium pymvate, 0.3 ~{g/ml glutamine, 0.1 mM non-essential 
amino acids and 20 U/ml human IL-2. 
INTRACELLULAR CYTOPLASMIC STAINING 
Cells were fixed in 4% para formaldehyde in PBS, penneabilized with staining buffer 
(PBS with 1% BSA and 0.2% NaNJ ) containing 0.1 % saponin (Sigma, st. Louis, MO), 
blocked with normal rat IgG, and stained with PE conjugated rat anti-IL-2 (Pharmingen, San 
Diego, CAl. Cells were analyzed on a FACScan. 
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ELECTROPHORETIC MOBILITY SHIFT ASSAY 
Probe used was derived from the distal NFAT binding site from the human fL-2 pro-
moter, and its sequence is 5'-GGA GGA AAA ACT GTT TCA TAC AGA AGG CGT-3' 
Double stranded oligonucleotides were prepared and labeled by filling in recessed ends with 
Klenow enzyme (New England Biolabs, Beverly, MA). Nuclear extracts were prepared as 
previously described (15). Binding reactions were carried out in a 20 ml volume containing 
10 mM Tris pH 7.5, 50 mM NaCI, ImM EOTA, IrlM l3-mercaptoethanol, 300 ng of poly-
dIdC, and 1% Ficoll. Probe was incubated with 5 rIg nuclear extract for 20 minutes at room 
temperature, after which reaction mixture was rUll on a prenm 5% polyacrylamide gel for 2 
hours at 200 V. Gel was dried onto What man paper and autoradiographed. 
IMMUNOPRECIPITATION AND WESTERN BLOTTING 
Cell extracts were made using lysis bufter consisting of 0.5% Nonidet P-40, 50 111M Tris 
(pH 8.0), 200 mM NaCI, 50 mM NaF, 0.5 ruM NaV04, 20mM Na4P'O" 10% glycerol, 0.1 
mM EOTA, 0.4 mM PMSF, and IInM OTT. Extracts were precleared with normal mouse IgG 
or normal rabbit IgG before incubation with NFATp antisera (Santa Cmz Biotechnology, 
Santa Cmz, CA) or HA antisera (Santa Cruz Biotechnology). Immune complexes were cap-
tured with Protein A sepharose, washed with lysis bufter, washed with PBS, and resolved by 
SOS-PAGE. Proteins were transferred to nitrocellulose membrane. Antisera used in western 
blotting included NFATp (Santa Cmz Biotechnology), HA (Santa Cruz), and Xpress 
(Invitrogen, San Diego, CAl. 
GST PRECIPITIONS 
Plasmid encoding GST-SOCS3 fusion protein was constmcted by cloning SOCS-3 into 
the BamHI site ofpGEX-3X (Amersham Phannacia, Piscataway, NI). GST and GST-SOCS-
3 proteins were harvested from bacterial cultures after 3 hours of induction with 0.2 mM 
IPTG at 30°C. Bacteria were lysed using lysozyme, followed by addition ofsarcosyl and son-
ication. Extracts were incubated with glutathione-agarose beads. Beads were washed and 
stored at 4°C. Precipitation experiments were performed by incubating cell extracts with 
beads coupled to 15 rIg GST or GST-SOCS-3 and washing beads with lysis buffer described 
above, washing beads with PBS, and resolving associated proteins by SOS-PAGE. 
RETROVIRAL INFECTIONS 
Infections were performed as previously described (16). Briefly, retrovimses were gen-
erated by transient transfection of 293T cells with pCL-Eco, and either pMIG or pMIG-
SOCS-3. 48 and 72 hours after transfection, retrovirus containing medium was harvested 
from plates of transfected cells and used for infection. Infections were performed by incu-
bating cells in retrovirus containing media in 24 well plates. Plates were spun at 2500 rpm at 
32YC for 90 minutes, after which retrovirus containing media was removed and fi'esh T cell 
media was added. 
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RESULTS 
TCR-MEDIATED T CELL ACTIVATION REGULATES SOCS-3 EXPRESSION 
Several cytokines, including IL-2, IL-3, IL-6, leukemia inhibitory t:1ctor, gro,,1h hor-
mone, and leptin can inducc SOCS-3 mRNA (9, 17), To examine the effects ofTCR stimula-
tion on SOCS-3 exprcssion, RNA from purified murine T cells stimulated with CD3-specific 
antibodies (nCD3) was analyzed by Northern blotting. SOCS-3 mRNA levels were increased 
by stimulation with aCD3, reaching peak levels after 8 hours of stimulation and remaining 
elevated for at least 24 hours (figure I). SOCS-3 induction by TCR ligation is less rapid and 
of much greater duration than induction by the other stimuli listed above. SOCS-3 can also 
be induced with nCD3 in polarized Th I and Th2 cell populations (data not shown). 
liP®! ~ SOCS3 
EtBr 
FIGURE 1 
Changes in SOCS-J mlli,,\A lel'els 011 TCR Uglltioll. 
RNA was isolated from splenic T eells ofC5711Ll6micc stimulat-
ed with plate bound nCD3 for the amount of time indicated. The 
RNA was then sUbjected to Northem hlot analysis with probe spe-
cific tor SOCS-3 (top panel). Ethidium bromide staining of Ri'l"A 
gel is shown to demonstrate equal loading ofianes (bottom panel). 
INHIBITION OF JL-2 PROMOTER ACTIVITY BY SOCS-3 
To investigate the effects of SOCS-3 expression on signaling downstream of the TCR, 
Jurkat cells were cotransfected with a luciferase reporter driven by the proximal lL-2 pro-
moter and either SOCS-3 or a vector control. SOCS-3 inhibited the activation of the IL-2 
promoter by PMA and ionomycin (t1gure 2A). Fut1her cotransfection experiments utilizing a 
luciferase repOlier driven by 3 copies of the distal NFAT/AP-I site fi'om the JL-2 promoter 
revealed the ability of SOCS-3 to inhibit transcriptional activation driven by this element 
(figure 2B). In contrast, SOCS-3 had no effect on the PMNionomycin induced activation of 
a third luciferase reporter driven by multimerizedAP-l binding sites (figure 2C). The results 
of these transient transfection experiments suggest that SOCS-3 suppresses NFAT-dependent 
transcriptional activation. Furthermore, as P!vlA and ionomycin bypass the initial tyrosine 
phosphorylation events involved in T cell activation, the mechanism of SOCS-3 in blocking 
gene induction by NFAT lies downstream of the tyrosine kinases lek and ZAP70. 
SOCS-3 INHIBITS NFATr DEPHOSPHORYLATION 
To further study the efiects of SOCS-3 on NFAT function, JUt'kat cells constitutively 
expressing SOCS-3 were generated. JUt'kat cells expressing SOCS-3 were deficient in their 
ability to produce IL-2 as compared to lurkat cells transfected with vector alone when stim-
ulated with PMA and ionomycin (figure 3A). When Jurkat cells expressing SOCS-3 were 
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FIGURE 2 
SOCS-3 sllppresses NFAT 
mediated transcriptional 
activation. 
(A) Jurkat cells were trans-
fceted with an IL-l-Luc 
reporter (20 ~Ig) and eithcr 
pcDNA3 or pcDNA3-S0CS-3 
(10 ~Ig). 12 hours aficr trans-
feetion, cells were culhlred 
with or without PMA 
(l OOn~·f) and ionomycin 
(2tl~\'f) for 8 hours, after which 
cells were harvested and ana-
lyzed for luciferasc activity. 
TransfectiollS were repeated 
as abovc using a 3:A1\TFAT-Luc 
reporter (B) ond 0 3XAP-l-
Luc reporter (e). 
stimulated with uCD3, the pattern of tyrosine phosphOlylation seen in whole cell extracts was 
similar to that observed in cells transfected with empty vector (data not shown), again sug-
gesting that SOCS-3 does not interfere with the activation of tyrosine kinases through the 
TCR. To determine if the overexpression of SOCS-3 altered NFAT activation in these cells, 
NFAT activity was investigated directly by electrophoretic mobility shift assay (EMSA). 
A. 
B. 
c. 
Vector SOGS3 
Vector SOGS3 
------
+ + PMNlono 
t +- NFATp 
;;: 
Vector SOCS3 
------
+ + lono 
., II ~4 .,1 := ~~:~~ 
FIGURE 3 
SOCS-3 inhibits l\'FATp activation. 
(A) Intracellular cytoplasmic staining for IL-2. Jurkat cells sta-
bly transfectcd with pcDNA3 or pcDNA-SOCS3, as indicated, 
wcre left unstimulated (thin line) or stimulated for 20 hours 
with PMA and ionomycin (thick line). After stimulation sam-
ples were fixed, penneabilized, and staincd with PE conjugat-
ed ral anti-murine lL-2 (Phanningen) for onalysis by flow 
cytomctry. (D) Examinotion of l\Tf'AT activation by EMSA. 
Nuclear extracts were prepared from stably lransfcctcd Jurkot 
cells unstimulated or stimulated for 4 hours with PMA (100 
ni\l) and ionomycin (2 mM). Extracts were assayed for binding 
to the distal NFAT binding site of the human lL-2 promoter. (C) 
Analysis of NFATp dcphosphorylation. Stably transfectcd 
Jurkat cells wcre unstimulated or stimuloted with ionomycin (2 
mM) for 2 minutes. WJlOie cell extracts wcre analyzed by 
immunoblot for NFATp. 
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NFAT binding to its distal binding site from the IL-2 promoter in response to four hour cul-
ture in the presence of PM A and ionomycin was reduced in nuclear extracts from lurkat cells 
expressing SOCS-3 (figure 38). These data demonstrate that overexpression of SOCS-3 can 
inhibit NFAT activation and IL-2 production in Jurkat cells. 
Possible explanations for the decrease in NFAT activation observed by EMSA include 
lower total levels ofNFAT, reduced nuclear entry ofNFAT, or inhibition ofNFAT DNA bind-
ing activity. Total levels ofNFATp in the cells were analyzed by immunoblotting. No signif-
icant differences in levels of NFATp were seen between lurkat cells transfected with 
SOCS-3 and those transfected with empty vector (data not shown). Because the nuclear entry 
ofNFAT depends on dephosphOlylation of multiple serine/threonine residues in response to 
sustained increases in intracellular calcium, the dephosphorylation ofNFATp induced by a 2 
minute stimulation with ionomycin was examined. Dephosphorylation ofNFATp leads to a 
10-20 kD decrease in its apparent molecular weight by immunoblot (I8, 19). NFATp was 
immunoprecipitated from stimulated or unstimulated stably transfected lurkat cells and ana-
lyzed by immunoblotting for a decrease in apparent molecular weight. Less emcient dephos-
phOlylation ofNFATp was observed in Jurkat cells expressing SOCS-3 when compared with 
Jurkat cells transfected with empty vector (figure 3e). This result suggests that SOCS-3 inter-
feres with the activation ofNFATp by inhibiting its dephosphorylation. 
INTERACTION OF SOCS-3 WITH CALCINEUIUJ'I 
NFAT dephosphOlylation by the cellular phosphatase calcineurin is activated by 
increases in intracellular calcium concentration (20). Stimulation of the TCR leads to tyro-
sine phosphOlylation of receptor components, the recruitment of molecular scaffolds, and, 
among other events, the recruitment and activation of phospholipase C (PLC)y, which in turn 
leads to increased intracellular calcium levels. Ionomycin bypasses PLCy, directly increasing 
the intracellular calcium concentration. The observation that SOCS-3 inhibited NFATp 
dephosphOlylation induced by ionomycin raised the possibility that SOCS-3 could interact 
with NFATp or calcineurin. 
To determine whether SOCS-3 interacts with these molecules, whole cell extracts from 
293T cells transfected ,vith calcineurin, NFATp, or empty vector were incubated with agarose 
beads coupled to glutathione S-transferase (GST) or a GST-SOCS-3 fusion protein. Although 
there is a slight interaction between calcineurin and beads coupled to GST, a much stronger 
interaction was observed between calcineurin and beads coupled to GST-SOCS-3 (figure 
4A). The association of calcineurin with beads coupled to GST-SOCS-3 was also much 
stronger than that seen between NFATp and beads coupled to GST-SOCS-3 (figure 4A). The 
reverse interaction of SOCS-3 with calcineurin was tested by trallsfecting 293T cells with 
combinations of SOCS-3, calcineurin, and empty vector. SOCS-3 co-imlHunoprecipitated 
with calcineurin only in cells which had been transfected with both (figure 48). 
The ability of SOCS-3 to associate with calcineurin led to the question whether 
SOCS-3 affects the phosphatasc activity of calcineurin. Calcillcurin phosphatase activity 
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(A) Agarose beads coupled to GST 
or GST-SOCS-3 were incubated 
with extracts from 293T cells 
llntransfcctcd or lransfecled with 
HA tagged Calcineurin or HA 
tagged NFATp. Proteins associated 
with the beads were analyzed by 
immunoblot f'Or HA. Extract lanes 
represent 10% of total input. (il) 
293T cells were untransfcctcd or 
lransfectcd with HA taggcd cal-
cineurin, Xpress tagged SOCS-3, or 
both, as indicated. Whole cell 
extracts were ill1ll1unoprecipitated 
with antisera to HA (top prmel) or 
Xpress (bottom panel), and 
immunoblotted for Xpress. 
towards an ill vih-o labelled RIIK peptide was similar in extracts from Jurkat cells stably 
transfected with SOCS-3 and extracts from Jurkat cells transfected with empty vector (data 
not shown). Further phosphatase assays utilizing 293T cell extracts demonstrated that recom-
binant GST-SaCS-3 does not inhibit the dephosphorylation of the RIIK peptide by cal-
cineurin (data not shown). These experiments demonstrate that SOCS-3 does not affect the 
phosphatase activity of calcineurin towards all substrates. 
SOCS-3 INHIBITS IIA PRODUCTION IN PRIMARY CD4+ T CELLS 
As the initial observation of SOCS-3 mRNA modulation by uCD3 was made in primary 
murine T cells, the ability of SaCS-3 to alter NFAT dependent responses in these cells was 
examined. CD4+ T cells isolated from lymph nodes of C57BLl6 mice were infected with 
retroviruses encoding either SOCS-3 and green fluorescent protein (GFP) or GFP alone. 
Three days after infection, the cells were stimulated for 4 hours with PMA and ionomycill, 
and analyzed for IL-2 production by intracellular cytoplasmic staining. \Vhile there was a 
T~ "k:]PMIG_soeS3 
. ~ " 
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FICURE 5 
Intracellular Cytoplasmic Staining for IL-2 in primary T cells. 
CD4+ T cells were isolated from lymph nodes of C57BLi6 mice and 
stimulated wilh plate bound nCD3 and nCD28. 24 and 48 hours after 
stimulation, cells were transduced with either p~\'nG or p.MIG-SOCS-3 
retrovll-uses. Five days after stimulation, cells were stimulated with 
PNlA (100 11M) and ionomycin (2 ~lM) for 4 hours. Subsequently, stim-
ulated (thick lines) and unstimulated (thillIiJles) cells were stained with 
CyChrome conjugated nCD4, facd and stained for intracellular IL-2 
as in figure 2A. 
Cells expressing both CD4 and OFP by flow c)1ometry wcre analyzed 
for intracellular IL-2 content. 
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marked activation ofIL-2 synthesis in cells expressing GFP alone, this activation was great-
ly reduced in cells also expressing SOCS-3 (figure 5). The failure of T cells expressing 
SOCS-3 to synthesize IL-2 resembles that seen ill T cells from transgenic mice expressing a 
domiuant negative NFAT (21). 
DISCUSSION 
The data presented demonstrate a role for SOCS-3 in the regulation ofTCR mediated 
signal transduction. Expression of SOCS-3 suppresses the activation of the fL-2 promoter in 
activated T cells. Further analysis revealed the ability of SOCS-3 to suppress transcription 
driven by the NFAT/AP-I element of the IL-2 promoter with no effect on transcription driv-
en by AP-I alone. SOCS-3 is shown to interact with calcineurin and to inbibit activation of 
NFATp by preventing its calcium dependent dephosphorylation. 
The preponderance of studies on the sacs gene family have addressed their role in 
cytokine signal transduction, although other functions are beginning to emerge. CIS and 
SOCS-3 have so far been implicated in TCR mediated signaling (13). In the case ofcytokine 
signaling, both CIS and SOCS-3, in addition to SaCS-I, are negative regulators of 
JAK-STAT signaling (12). In contrast, CIS and SOCS-3 have opposing effects on TCR medi-
ated signals, with CIS being a positive regulator associated with PKce and SOCS-3 being a 
negative regulator associated with calcineurin. As the SH-2 domain and sacs box motif are 
well conserved among the sacs f.11l1i1y (22), difierences in function between family mem-
bers, such as that seen between CIS and SOCS-3 in T cells, may help to elucidate the role of 
other regions oCthe proteins which are not conserved within the family. 
The inability of SOCS-3 to block calcineurin phosphatase activity towards an RllK 
peptide substrate leaves open the question of the mechanism of SOCS-3 in the inhibition of 
NFATp activation. One possibility is that SOCS-3 alters the interaction between NFATp and 
calcineurin. It is also possible that SOCS-3 simultaneollsly associates with calcineurin and a 
serine/threonine kinase, bringing a kinase capable of phosphorylating NFATp to the 
NFATp/calcineurin complex. In support of this possibility, SOCS-3 has been shown to inter-
act with the Pim family of serine/threonine kinases (B. Vuong and P. Rothman, unpublished 
data), and Pim family kinases can phosphOIylate NFAT ill vitro (23). 
Clinically, the activation ofNFAT can be blocked by the dmgs CyclosporinA or FK506, 
which act in conjunction with immunophilin receptors to bind to and inhibit the phosphatase 
activity of calcineurin (24). Side effects of these drugs have generated interest in obtaining 
more specific inhibitors of NFAT activation. Synthetic peptides based all the calcineurin 
binding site ofNFAT are interesting candidates and have already been shown to block NFAT 
activation in cell lines (25, 26). The experiments above demonstrate that SOCS-3 inhibits 
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the activation ofNFATp without grossly effecting calcineurin phosphatase activity, suggest-
ing that synthetic peptides based on sequences within SOCS-3 may also be of interest in this 
regard. 
Increases in SOCS-3 mRNA levels in T cells activated through the TCR were also 
observed, suggesting the involvement of SOCS-3 in a classical feedback loop ofTCR medi-
ated signal transduction. A recent repOlt showing the ability of SOCS-3 to inhibit IL-2 sig-
naling in lymphocytes adds an interesting dimension to the 1001', as IL-2 cooperates with 
TCR mediated signals to stimulate T cell proliferation (27). SOCS-3 may have a dual role in 
regulating T cell responses, inhibiting the activation of both NFAT by calcineurill and JAKI 
by the IL-2 receptor. 
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The transcription factor GATA·3 plays a key regulatory role at two points in T cell dif-
ferentiation. GATA·3 has been shown to be indispensable for development of the T cell line· 
age, and plays an essential role in the differentiation into Th2 cells. Targeted deletion of the 
GAlIl-3 gene results ill early embryonic lethality and is associated with neural abnormalities 
as well as anemia and abdominal hemorrhages (1). Rag2-1- complementation analysis 
revealed contribution of GATA·3·/· emblyonic stem (ES) cells to all hematopoietic lineages 
except the T lymphocyte lineage (2). The thymocytes present in the GATA·3·/·/Rag2·/· 
chimeras had the Rag2-1- genotype, as determined by Southern blotting analysis, and were as 
a consequence blocked at the CD25+CD44- double negative (DN) stage ofT cell differentia· 
tion. Therefore, it was concluded that development of GATA·3·/· T lymphocytes was blocked 
at or before the DN progenitor stage (2). In addition, targeting GATA·3 mRNA by an anti· 
sense approach in fetal thymic organ cultures (FTOC) inhibited generation of thymocytes 
from fetal liver progenitors but not from fetal thymic cells (3). Taken together, these data indio 
cate a crucial role for GATA-3 in early T cell development, but it is unclear in which devel-
opmental stage(s) GATA·3 is essential. F1II1hennore, the level ofGATA·3 gene expression in 
the subsequent stages of T cell development is unknown. The ouly data available are from a 
Northern blot analysis of various T cell lines, which revealed expression of GATA-3 in cell 
lines derived fi'om fetal prothymocytes (CD25'CD44+) and in thymic T cell lines but not in 
cell lines derived from fetal prethymoc)1es (CD25'CD44+1.) (4). 
In order to identifY the stages of T cell development that are dependent on GATA·3 
expression ill vivo, we generated ES cells in which the GATA-J locus was targeted by an in-
frame insertion of a laeZ reporter gene, containing a nuclear localization signal (nls). Using 
these ES cells, we generated chimeric mice and subsequently obtained gennline transmission 
of the laeZ rep0l1er. In heterozygous GAlIl-3+/II/sl(1CZ animals \ve analyzed the proportion of 
lacZ-expressing cells at the various stages of T cell development and differentiation. 
Flowcytometric measurement of lacZ activity in developing GATA_J+/llfslacZ T cells provided 
a powerful means of detennining the levels of GATA-J genetrabscription. In fact, it has been 
shown that observed patterns of laeZ expression in neural tissues correlated to a high degree 
with previously characterized patterns of GATA-3 gene transcription (5). In addition, 
GATA-3-deficiellt ES cells (GATA_3I1co/nfslacZ) were generated next to the GATA_3+1nf_~facZ cells_ 
The presence of the lacZ reporter gene in these two types of ES cells allowed us to specifi· 
cally trace the fate of individual GATA_3I1fo/1I1sfacZ and GATA_3+llIfsfacZ ES cell-derived T cell 
progenitors in the thymus of ES cell chimeric mice. 
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7.2. GATA-3 IN EARLY THYMIC T CELL DIFFERENTIATION 
To investigate the contribution of GATA_3+IIIMacl and GATA_3I1collifs/acZ ES cells to carly 
T cell progenitors, we generated chimeric mice by injection orES cells of both genotypes into 
wild-type blastocysts. In this in vivo competition analysis we confirmed the contribution of 
CATA _3+llIlslacZ ES cells to the T cell lineage from the earliest T cell progenitors onwards. In 
contrast, no contribution to the T ceillincage ,vas observed when GATA_3I1eol/lfs!acZ ES cells 
were injected. Therefore, we show that in the absence of GATA-3, T cell development is 
blocked from the earliest thymic (CD25-CD44+ DN) stage onwards. Using GATA-3-/- ES cells 
in Rag-2-I- complementation studies, we observed a contribution of GATA-3-1- ES cells to the 
8 cclllincage but not to the T cell lineage (A.K. and R. W.I-I, unpublished observations) con-
firming previously published results (2)_ The finding, that GAD!-3-/- ES cells do not con-
tribute to even the earliest detectable thymic progeuitors implies that GAD!-3-/- progenitors 
either do not reach the thymus or die upon arrival within the CD25-CD44+ stage_ As we could 
trace our ES cell-derived progenitors by the expression of lacZ activity, we could define the 
developmental block of GATA-3-/- T cell precursors more accurately than in the Rag-comple-
mentation studies (2). From these latter experiments, it was only clear that the developmen-
tal block of GAD!-3-/- cells was at or before the DN stage, as chimerism was not determined 
within the 4 subpopulations of the DN Ii-action (2)_ 
Detailed analysis of lacZ expression during T cell difierentiation in the thymus revealed 
a complex pattern of GATA-3 gene transcription (figure I). GATA-3 gene expression is low 
during phases of TCR gene rcarrangemcnt (CD25+CD44- DN and DP cells). Expression of 
GATA-3 was strongly induced after B-selection (transition from CD25+CD44- to CD25-
CD44- DN stage). In addition, upon successful completion of TCRa gene rcarrangement at 
the DP stage of T cell development and the initiation of positive selection, GATA-3 was 
strongly induced to reach a maximal expression level at the CD4+CD8io CD69+ stage, at 
which the T cells make the CD4/CD8 lineage commitment decision. 
Thymus r-----------------~~=-----------------~ .. 
CD4-CDB-
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FIGURE I 
-TeRn 
Levels of GATA-3 transcription during T cell differentiation. 
Spleen 
GA7)1-3 gene expression levels at various stages during T cell ditlercntiation, represented as the fraction of IneZ" 
cells in the GATA_3115I1acZJ+ thymus_ Phases during '''hich TeR gene rearrangements occur are indicated. 
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At the CD25+CD44- ON and the CD69- DP stages T lymphocytes arc small, resting cells 
reatTanging their TCR{3 and TCRn gene loci, respectively. The low levels ofGATA-3 expres-
sion detected at these stages ofT cell differentiation correlated to cell size, indicating that the 
residual GATA-3-expressing cells at these mahuational stages might already have completed 
TCR gene rearrangement and have initiated cellular proliferation. \Ve therefore conclude that 
GATA-3 transcdption seems to be inhibited during phases of TCR gcne rearrangement. The 
observed pattern of CATA-3 transcription during early T cell development might be compat-
ible with two alternative, but not necessarily mUhlally exclusive, potential roles for GATA-3 
in T cell differentiation. First of all, GATA-3 might be involved in TCR enhancer-dependent 
gene transcription of TCR{3 and TCRn genes. An incompatibility of the processes of TCR 
gene rearrangement and cnhancer-dependent TCR gene transcription could then explain the 
observed regulation of GATA-3 gene transeriptiOlL Alternatively, GATA-3 might be involved 
in the induction of cellular proliferation immediately after the successful realTangement of 
TCR genes. The incompatibility of TCR gene reatTangement with the process of cellular pro-
liferation could then explain the strict regulation of GATA-J gene transcription (6). 
thymIc lymphoId progenitor 
(CD2S"CD44') 
UIHIIJ 
TCRiJlocus 
FIGURE 2 
pro·T cell (CD2S'CD44') 
U;./12 
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double·posltlve T cell 
Model for GATA-3 in early T cell differcnnalioll. 
early pre·T cell (CD2S'CD44·) 
We hypothesize a role for GATA-3 both in enhancer-dependent chromatin remodeling at the TCRfi and TCRa loci 
prior to the induction of gene rearrangement, and in enhancer-dependent high-level transcription after gene 
rearrangement of the TCR loci. See text for details. 
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The presence ofGATA-3 binding sites has been described in the TCRa, TCR{J and TCRo 
enhancers. Binding of GATA-3 to the TCRa and TCR{J enhancer sites induces TCRa and 
TCR{J enhancer activity (7-11). Targeted deletion of the TCR{J enhancer results in a partial 
block ofT cell development at the pre-T cell stage (12). The regulation of chromatin remod-
eling at the TCR{J locus by the TCR{J enhancer was shown to be critical for T cell differenti-
ation (13). T cell development in mice homozygous for a targeted deletion of the TCRa 
enhancer (Ea) region is arrested at the DP stage, associated with a lack of TCRa gene 
rearrangement. Expression of germline or mature (rearranged) TCRa transcripts is depend-
ent on Ea (14). Therefore, we assume a dual function for the TCR gene enhancers during T 
cell development. Firstly, the TCR enhancers regulate chromatin accessibility at the TCR loci 
prior to the induction ofTCR gene rearrangement, thereby facilitating the interaction of RAG 
proteins with the chromatin. Secondly, the TCR gene enhancers regulate high-level tran-
scription fimn the TCR loci after successful completion of the rearrangement process. 
It has been shown, that the chromatin structure at the TCR{J locus at the CD25+CD44+ 
pro-T cell stage is accessible for transcription h'lctors, as reflected by the production of 
germline transcripts (15, 16). As expression of the Rag genes and TCRy gene rearrangements 
can already be detected at this stage, it can be assumed that Rag proteins are present and func-
tional (17-19). The low level of Rag proteins at this stage and a putative difference in affini-
ty for Rag proteins between the TCRf3 and TCRy recombination signal sequences could then 
explain why TCR{J gene rearrangement only occurs at the CD25+CD44- early pre-T cell 
stage. 
Upon successful rearrangement of the TCR genes, high-level transcription of the newly 
rearranged loci will be induced. This is also regulated by the TCR enhancers. The differen-
tial regulation of chromatin structure at the TCR loci during phases ofV(D)J recombination 
versus phases of high-level transcription might reflect a difterent context of transcription fac-
tors at the TCR enhancer. Binding ofGATA-3 could playa role in either function of the TCR 
enhancer (figure 2). The observed enhanccd levels ofTCRa~ expressed at the cell surface of 
CD2-GA7iJ-3 DP T cell immediately after the successful realTangement of the TCRa gene 
(DP CD69+) would indicate a role for GATA-3 in TCR enhancer-dependent high-level tran-
scription of the TeR genes. Based on our observations, we cannot draw conclusions about a 
role for GATA-3 in TCR enhancer-dependent chromatin remodeling at the TCR loci prior to 
phases of V(D)J recombination. In this context, the function of GATA-3 in early T cell 
development may well parallel its function in the regulation of the IL-4/IL-5/IL-13 locus, 
where GATA-3 acts by inducing chromatin remodeling during cellular prolifcration (20, 21). 
The observed levels of GATA-3 transcription would indicate that TCR enhancer-dependent 
transcription of the TCR genes is absent during TeR gene rearrangement. Residual activity 
of the proximal promotor of the TCR genes might still result in low-level transcription ofthe 
locus during these stages, resulting in the production of gennline transcripts. 
The alternative explanation for the observed stringent regulation of GATA-3 gene tran-
scription during phases of TCR gene rearrangement hypothesizes a role for GATA-3 in the 
induction of cellular proliferation after the successful completion of TCR gene rearrange-
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ment. This hypothesis seems reasonable, as other OATA-3 family members have been impli-
cated in cell-cycle regulation as well. GATA-I was shown to affect the regulation of cell cycle 
in a study, in which overexpression of GATA-I dysregulated terminal elythroid differentia-
tion associated with an enhanced cellular proliferation, implicating GATA-l in the regulation 
of proliferation versus differentiation (22). Also, GATA-J-I- megakaryocytes are retarded in 
their difierentiation and display enhanced proliferation (23). Using GATA-2-1- ES cells and 
GATA-2-1- yolk sack-derived hematopoietic progenitor cells, it was shown that GATA-2 is 
indispensible for the expansion of lllultipotent progenitors, but is not required for erythroid 
or myeloid terminal differentiation (24). In addition, activity of estrogen-inducible GATA-2 
has been shown to promote proliferation and block terminal differentiation in chicken pri-
mary erythroblasts (25). Together, these data implicate a role for GATA-factors in cell fate 
decisions by the induction of proliferation at the expense of potential differentiative devel-
opmental steps. 
CD2-GATA-3 transgenic mice developed T cell lymphomas from 3 months of age 
onwards. The T cell lymphomas consisted of Iymphoblasts of a DP, CD4+CDSlo or CD4 SP 
phenotype. Regardless the coreceptor expression protile, the T cell lymphomas expressed 
high levels ofCD3E on the cell surface, as well as high levels ofGATA-3. These T celllym-
phomas metastasized to secondary lymphoid organs (spleen, lymph nodes) and non-lymphoid 
organs such as the liver and kidneys. The observed lymphoma induction at the DP CD69+ 
Iymphoblastoid stage ofT cell development also argues for a role for GATA-3 in the induc-
tion of cell proliferation upon the completion of TCRa gene rearrangement. The oncogenic 
event might be a result of aberrant use of the Y(O)J recombination machinery, of complex 
formation of GATA-3 with the TAL-l and LMO transcription factors, which are associated 
with human acute lymphoblastic leukemias (26), or of an increased basal transcription of the 
RAD50 gene, resulting in destabilization of the MRElI-RAD50-NBSl protein complex, 
which is essential for chromosome stability (27). Future cytogenetic studies ofthe lymphoma 
cells in the CD2-GATA-3 transgenic mice should demonstrate the presence of translocations 
involving the TCR loci or the TAL-/ gene. 
7.3. GATA-3 IN CD4 VERSUS CD8 LL~EAGE COMMITMENT 
After the initiation of positive selection at the OP stage, T cells undergo lineage com-
mitment and differentiate into CD4+ SP or CDS+ SP T cells. We show that CD4+ SP T cells 
remain a high expression level of GATA-3, whereas CD8+ SP T cells markedly downregulatc 
GATA-3 expression levels during SP maturation. A more detailed analysis revealed that tran-
scription of GATA-3 is strongly induced directly after the initiation of positive selection 
(CD69+ DP cells). The highest expression of GATA-3 was observed at the CD4+CDS1oCD69+ 
stage of T cell development. This is the stage at which the CD4/CDS lineage commitment 
decision is made by differentiating T cells, which will continue to downregulate CDS expres-
sion and develop into C04 SP cells) or which will undergo coreceptor reversal induced by IL-
7R-mediated signals and develop into CDS SP cells (2S). As we show a progressive down-
regulation ofGATA-3 transcription during CDS SP mahlration from this point onward, it can 
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be assumed that switching off of CATA -3 transcriptiou is part of the genetic program of CDS 
differentiation. 
It seems unlikely that GATA-3 directly afiects the lineage commitment decision, as 
overall numbers of thymic CD4 and CDS SP populations are comparable between 
CD2-GATA-3 transgenic animals and littennate controls. Rather, the tinal mahlration ofCD8 
SP T cells is disrupted in CD2-CATA-3 transgenic animals, leading to low numbers of peri ph-
eral CD8+ T cells. Using the GATA _3+/n/s/ucZ mice, we show a progressive decline of 
CATA-3 transcription during CDS SP maturation. Therefore, it can be hypothesized that the 
downmodulation of GATA-3 expression is essential for the acquisition or implementation of 
the genetic program associated with final CD8 maturation. The enforced expression of 
CATA-3 during CD8+ SP T cell maturation in the CD2-CATA-3 transgenic animals might then 
intertere with this genetic program, ultimately resulting in the induction of programmed cell 
death due to a failurc to downmodulate OATA-3 levels. 
In this context, there is a striking parallel with Thl/Th2 differentiation, where CATA-3 
is expressed in naiVe peripheral T cells, followed by a substantial increase during Th2 
development and a gradual downregulation during Th I development (29, 30). The acquisi-
tion of the Th2 phenotype is initiated by IL-4-dependent Stat6 activation, but becomes inde-
pendent of extrinsic factors, such as IL-4 over time, as a result ofGATA-3 autoregulation (21, 
31-33). It was recently shown that OATA-3 generates stability ofTh2 commitment by chro-
matin remodeling of Th2-specific cytokine loci, associated with a positive autoactivation 
pathway, which is a recognized mechanism contributing to cell fate determination (21). 
Concomitantly, OATA-3 inhibits Till development by repressing IL-12R~ expression and, as 
a result, !L-12 induced IFNy production (34). Assuming a parallel role for OATA-3 in 
CD4/CD8 and Thl/Th2 development, we propose that OATA-3 is involved in the stabiliza-
tion of the distinct gene expression profiles in committed CD4 cells, while for the fullmatu-
ration of CD8 T cells, CATA-3 expression needs to be downregulated. 
REGULATION OF HELPER T CELL DIFFERENTIATION INTO 
THI AND TH2 PHENOTYPES 
7.4. lJ'ITRODUCTION 
On the basis of a large number of shldies using a variety of approaches, a generalized 
model for Th cell differentiation has emerged (figures 10, II of the general introduction; 
'reviewed in 35-38). In order to enter the genetic program leading to Th cell differentiation, 
the resting naiVe Th cell needs to receive concomitant activating and differentiation-inducing 
signals, derived from the TCR and from cytokine receptors, respectively (39). Upon activa-
tion, naive Th cells will enter the cell cycle (39). Full differentiation into Thl or Th2 effec-
tor cells requires several cell divisions (35). Cytokine-mediated signals resulting in the acti-
vation of Stat factors are essential for the induction of Th cell differentiation (40-45). 
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Regulation of the induction of Th2 diftercntiation occurs at various leyels of the cascade of events leading to the 
acquisition of an Th2 phenotype. Regulation ofthis process of cellular difierentiation is implemented at multiple lev-
els. See text for details. 
!L-12-dependent Stat4 activation induces the difterentiation into the Thl phenotype (40-42, 
46-49)_ IL-4-dependent Stat6 activation induces differentiation towards the Th2 phenotype 
(43-45, 50-53)_ Activated Stat factors differentially induce the Tid-specific transcription fac-
tor T-bet or the Th2-specific transcription factor GATA-3, which are thought be the key reg-
ulators ofTh cell differentiation of several genes (35, 36, 38, 54, 55). These transcription fac-
tors induce chromatin remodeling, regulating the accessibility of the cytokine loci, \vhich is 
essential for high-level expression of these genes. In addition, these transcription factors can 
act directly on the proximal promotor regions (20, 21,33,56). Eventually, expression ofindi-
vidual cytokine genes is dependent on the accessibility of the locus as well as the presence of 
both cell-type specific and activation-inducible transcription factors (35, 36, 38). 
Regulation of Thl versus Th2 differentiation is exerted at multiple levels. This is 
schematically depicted in figure 3 for Th2 difterentiation. First of all, expression of cytokille 
receptors determines the responsiveness of the Th cell to differentiation-inducing signals in 
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the micro-environment. Secondly, regulation of cytokine-induced signal transduction regu-
lates the sensitivity of the cell for these differentiation-inducing signals. Thirdly, the induc-
tion and cross-regulation of the critical transcription factors T-bet and OATA-3 determine the 
outcome of the difierentiation process. Fourthly, regulation at the induction of the target 
genes of these transcription factors provides a final level of regulation. 
7.5. CYTOKINE-DEPENDENT REGULATION OF Th SUBSET ACTIVITY IN 
SJA/9 MICE 
We investigated cytokine-mediated regulation ofT cell difierentiation in great detail in 
the SJ;V9 strain of mice, which is characterized by a specific Th2 defect. The Th cells from 
this mouse strain fails to produce sufficient IL-4 during the immune response, resulting in the 
observed IgE deficiency. The IL-5-dependent eosinophilia is normal in this strain, indicating 
a pm1ially functional Th2 compm1ment. Wc show that the CD4+ T cells of this strain acquire 
an alternative eft-ector phenotype during the immune response. SJA/9 CD4+ T cells acquire 
an IL-IO-producing phenotypc during illl'il'O respouses to anti-IgD and TNP-KLH precipi-
tated on alum, responses which are usually associated with strong Th2 differentiation. The 
observed IL-l 0 production, however, is not mechanistic in the deviated differentiation of the 
SJA/9 CD4+ T cells, as neutralization of IL-IO did not restorc the IgE response. Therefore, 
SJAl9 Th cells have a deficiency in their capacity to differentiatc into IL-4-producing cells. 
The IgE responses ofSJAl9 mice can bc restored by adoptive transfer of (con genic) SJL thy-
mocytes, indicating that the defective TL-4 production is caused by a T-cell intrinsic defect 
(57). The defect in SJA/9 Th cells does not reside in IL-4 receptor signaling, as IL-4-depend-
ent induction ofStat6 activation and cellular proliferation were comparable between SJL and 
SJAl9 CD4+ T cells. Also, the ShV9 IL-4 protein is fully bioactive as compared to SJL 
ILA protein. We therefore hypothesize an altered transcriptional regulation of the IL-4-genc 
in SJAl9 CD4+ T cells. 
7.6. ROLE OF SOCS-3 IJ.'I T CELL ACTIVATION 
Th2 development is also regulated at the level of IL-4R-mcdiated signal transduction, 
for instance by phosphotyrosine phosphatases, such as SJ-JP-l,2 and SHIP, and the adapter 
molecule SOCS-I (58, 59). This effect of SOCS-l on Jak-I-mediated Stat6 activation could 
be due to shielding of the critical phosphotyrosine in Jak-I, or alternatively, to targeting 
Jak-I for proteosomal breakdown. We went on to investigate the role of the SOCS family 
member SOCS-3 in T cell activation and differentiation. \Ve show that SOCS-3 mRNA lev-
els in peripheral T cells are regulated by TCR-mediated T cell activation. Interestingly, when 
introduced into a Jurkatt T cell line, SOCS-3 inhibited TCR-dependent NF-ATp activation, 
by direct interaction with the serine-phosphatase calcineurin. In this manner, SOCS-3 pre-
vented the calcium-dependent dephosphorylation, and subsequent nuclear translocation and 
induction of gene transcription, ofNF-ATp. As SOCS-3 directly affccts TCR-mediated sig-
nal transduction, it seems unlikely that SOCS-3 plays a role in the regulation of c}10kine 
receptor-mediated signal transduction. Rather, as SOCS-3 transcription is induced by TCR-
mediated signal transduction, SOCS-3 seems to be implicated in a classical negative feed-
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back loop of TCR-dependent l' cell activation. 
Interestingly, a positive regulatory role in T cell activation has been described for the 
family member CIS (60). ClS transcription was shown to be induced by TCR-mediated l' cell 
activation. Enforced expression of CIS in CD4+ T cells resulted in enhanced proliferative 
responses, increased cytokine production and prolonged survival ofTh cells in response to 
CD3 cross-linking. CIS was shown to bind PKC, resulting in enhanced MAP kinase and JNK 
activity (60). In addition, SOCS-l was shown to suppress CD31; and Syk-mediated NF-AT 
activation in the 2931' kidney cell line (61). 
Additional evidence for a role of SOCS-l in TCR-mediated signal tranduction was 
derived from SOCS-l-I- mice. Targeted deletion of SOCS-l was shown to induce the presence 
of a population oflarge blastoid DP thymocytes at day 4, whereas the DP population had dis-
appeared by day 10. At both timepoints, relatively large SP populations were present, indi-
cating a possible enhanced selection of DP l' cells, which could be the result of deregulated 
TCR-dependent NF-AT activation (62). 
Together, these data implicate SOCS family members in the regulation ofTCR-mediat-
ed T cell activation, in addition to their initially characterized role in the regulation of 
cytokine receptor signal transduction. As both GATA-3 and T-bet are induced by both TCR-
mediated and cytokine receptor-mediated signals, the SOCS family members might be 
involved in the regulation ofTh cell differentiation (figure 3). Additional experiments would 
be needed to fmiher analyze the functional role of SOCS family members in Th cell differ-
entiation. 
7.7. ROLE OF GATA-3 IN PERIPHERAL T CELL DIFFERENTIATION 
Using a cDNA representational difference analysis (RDA) between Thl and Th2 cells, 
GATA-3 was identified as a gene preferentially expressed in 1'112 cells (30). GATA-3 expres-
sion was shown to be downregulated during Th I differentiation, whereas it is induced during 
ThZ differentiation (29, 30). The role ofGATA-3 in Th cell differentiation has been analyzed 
using a variety of ill vitro assays. Forced expression of GATA -3 under control of the CD4 pro-
motor induced 1'112 cytokine gene expression in CD4+ l' cells afler ill vitro Thl differentia-
tion (30). In addition, retrovirally introduced GATA-3 inhibited IFNy production and induced 
IL-4 and IL-5 production during Thl difterentiation of naIve Th cells (63). Ectopic expres-
sion of GATA-3 by retroviral transfection of Thl cells after polarization and of Thl clones 
resulted in ThZ gene expression and chromatin remodeling at 1'112 gene loci (20). So, in these 
ill vitro assays GATA-3 seems to induce Th2 differentiation and to repress Th 1 diftcrentia-
tion. 
Very few data are available on the role of GATA-3 in Th cell difterentiation during ill 
vivo responses. In one study, an attempt was made to analyze the effect of transgenic expres-
sion ill vivo of the KRR dominant-negative fmm of GATA-3 on the Th2-mediated allergic 
response (64). The authors show a marked reduction of eosinophils in the broncho-alveolar 
lavage, an inhibition of OVA-specific IgE in serum and an inhibited lllllCliS production in the 
lungs of KRR mice. However, analysis of c)~okine productiou by isolated CD4+ l' cells 
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revealed an inhibition of the production of both Th I c)10kines (IFNy) and Th2 c)1okines 
(ILA, IL-5, IL-13), indicating that the Th cells in the KRR mice might have a more general-
ized defect in proliferation, differentiation or cytokine production. Fm1hermore, the study 
lacks the control of the expression of wild-type GATA-3 in a similar transgenic fashion (64). 
Therefore, this study only revealed limited information about the role of GATA-3 during ill 
vivo immune responses. 
In a more recent study, the KRR lllutation of GATA-3 was more thoroughly analyzed 
(65). The authors show that the KRR mutation heavily disrupts the acetylation of GATA-3, 
resulting in a strongly decreased transcriptional activity of wild-type GATA-3 in the presence 
of the KRR-Illutated GATA-3. Forced expression of KRR-GATA-3 under transcriptional con-
trol ofthe Lck distal promotor did not appear to affect thymic T cell differentiation. Peripheral 
T cell populations displayed an altered distribution over the secondmy lymphoid organs, 
resulting in enhanced numbers of CD4+ T cells in the spleen and in the circulation, whereas 
CD8+ T cell numbers were strongly reduced in the lymph nodes and in the circulation, indi-
cating a complex effect of enforced expression of KRR-GATA-3 on peripheral T cell homing. 
Finally, forced expression of KRR-GATA-3 was shown to prolong T cell survival and IL-2Ra 
expression as well as IL-2-induced proliferation (65). 
We investigated the role of GATA-3 during peripheral Th cell differentiation ill vivo. 
Using the GATA_3+/nfsfacZ chimeric mice, we characterized the regulation of GATA-3 gene 
transcription. During Thl differentiation, GATA-3 transcription ,vas dowllmodulated, where-
as GATA-3 transcription during Th2 differentiation was enhanced. Vle analyzed the function-
al role of GATA-3 during in vivo Th cell-mediated immune responses using the 
CD2-GATA-3 transgenic animals. OUf findings on the role of GATA-3 in vivo supp0l1 the in 
vitro observations suggesting that GATA-3 expression inhibits Thl devclopment (34, 63). 
First of all, the lFNy-dependent KLH-specific IgG2a production was strongly decreased in 
CD2-GATA-3 transgenic Illice. In addition, the Th I-induced DTH response to KLH in 
CD2-GATA-3 transgenic mice was significantly decreased. These results indicate a decreased 
induction of the Thl -dependent local inflammation. This could be the result of decreased Th I 
cell extravasation at the site of KLH challenge and a decreased production of cytokines 
(lFNy, TNFfl/LT, IL-3, GM-CSF) and chemokines (MIF, MCF) by the activated Thl cells. In 
addition, enforced expression of GATA-3 resulted in a reduced Th cell survival, proliferation 
and IFNy production of cells cultured in vitro under Thl-inducing conditions. The observed 
increased number of Tl/ST2-expressing CD4+ T cells and elevated total JgGI serum levels 
suggest that the presence of the CD2-GATA-3 gene drives differentiating Th cells preferen-
tially towards the Th2 pathway. However, the Th2-dependent total senlln IgE levels or 
eosinophilic bronchoalveolar inflammation in the mouse model of allergic asthma were not 
significantly different between CD2-GATA-3 transgenic mice and wild-type littermates. 
These data indicate that the putative increased differentiation of CD2-GATA-3 CD4+ T cells 
into Th2 cells did not result in enhanced Th2w dependent i..nunune responses in vivo. 
It is difficult to estimate the exact levels of GATA-3 protein present in the 
CD2-GATA-3 Th cells. First of all, GATA-3 protein levels might be regulated by post-tran-
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scriptional mechanisms. It has been shown that caspase-mediated cleavage of GATA-I pro-
tein plays a functional role in the negative regulation of erythroid development (66). GATA-
2, however, was insensitive to CD95L-induced caspasc activity in erythroid precursors. 
Snbstitution of a critical aspaliate residne at the major caspase cleavage site (EDLD at posi-
tion 125) of GATA-I rendered a caspase-insensitive form of the protein (66). It is unknown 
whether GATA-3 is also subject to caspase-mediated cleavage. Secondly, several post-trans-
lational modifications might afiect the functional activity of GATA-3. GATA-I and GATA-3 
have been shown to be subject to acetylation by CBP/p300 at multiple well-conserved lysine 
residues positioned in between and C-tenninally adjacent to the Zinc fingers (65, 67, 68). 
This post-translational modification ofGATA-3 has been repOlied to increase its activity (65, 
67,68). Also, GATA-I, GATA-2 and GATA-4 have been shown to be subject to phospho-
Iylation (69-71). Phosphorylation of GATA proteins has been shown to increase affinity for 
DNA and functional activity of the GATA proteins. Phosphorylation ofGATA-3 has not been 
repOlied yet. 
Finally, a transcriptional repressor, repressor of GAT A (ROG), has been reported to neg-
atively regulate transcriptioual activity of GATA-3 by a direct, physical interaction. ROG is 
lymphoid-specific and is induced in T cells by TCRRlllediated activation. A differential 
TCR-dependent induction of ROG between polarized Thl and Th2 cells was shown (72). 
Therefore, it could be possible that in CD2-GATA-3 CD4+ T cells significantly higher levels 
of ROG are induced upon activation than in wildRtype Th celis, thereby partially antagoniz-
ing the efiect of the enforced expression ofGATA-3. A more detailed analysis ofGATA-3 pro-
tein levels and the degree of post-translational modification of the GATA-3 protein would 
allow for a more accurate interpretation of the phenotype of the CD2-GATA-3 transgenic 
mouse model. 
Two possible mechanisms by which the enlorced expression of GATA-3 afiects Th cell 
differentiation need to be considered (figure 4). Firstly, GATA-3 might directly influence the 
cell-fate decision ofTh cell difierentiation, resulting in enhanced numbers ofTh2-differenti-
ating cells and reduced numbers of Th I Rdifferentiating cells. Also, ill vih'o analysis of the 
efiect of the introduction of GATA-3 into difierentiating Th cells by several groups would 
argue lor this role of GATA-3 (20, 21). Alternatively, the enforced expression of GATA-3 
might have no effect on the difierentiation decision ofTh cells, but might interfere with the 
execution of the genetic program associated with the Thl phenotype. This might then result 
in Thl cells which are compromised in their viability, in their proliferation capacity andlor in 
their efiector functions. \Ve observed increased cell death and decreased proliferation of 
CD2-GATA-3 CD4+ T cells cultured under Thl conditions. Either way, the net result would 
be an increased number of Th2 cells in the periphery, consistent with the observed increase 
in TI/ST2Rexpressing cells in CD2-GATA-3 transgenic lnice and the increased total serum 
levels of the IL-4-dependent IgG I. 
The increased Tl/ST2 expression might also be caused by a direct efiect of GATA-3 on 
Tl/ST2 gene expression, resulting in a non-Th2-specific Tl/ST2 expression. The identifica-
tion of three GATA elements in the minimal T I/ST2 promoter in mast cells (73) would sup-
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port this hypothesis of a direct regulation ofTl/ST2 expression by GATA-3, independent of 
the acquisition of a Th2 phenotype. 
The absence of an enhanced Th2 M dependent response ill vivo might also be attributed to 
the altered kinetics of the GATA-3 expression in CD2-GATA-3 Th cells. As we did not detect 
enhanced production levels of IL-4 by CD2-GATA-3 Th cclls, whereas we did observe 
strongly enhanced JL-IO production, it might be hypothesized that the increased expression 
ofGATA-3 early in the process ofTh cell differentiation alters the cell-fate decision of these 
cells. In addition to the observed suppression of Thl differentiation, the CD2-GATA-3 Th 
cells might acquire an IL-I O-producing phenotype, resulting in suppression ofTh2 difieren-
tiation and activity. 
7.8. GATA-3 IN MEMORY T CELL DEVELOPMENT 
Our results indicate that enforced expression of GATA-3 resulted in an enhanced mem-
ory Th cell formation. In CD2-GATA-3 transgenic mice relatively high numbers of peripher-
al T cells displayed a memOlY cell surface profile (CD44h1CD45RB10 and CD25-, CD69-). In 
addition to a phenotypical characterization, we also performed ill vitro recall responses. T 
cells from CD2-GATA-3 mice exhibited a significantly increased recall response to KLH. In 
CD2-GATA-3 transgcnic mice the expression of the Tll2-specific T1/ST2 marker within the 
CD44h1 Th cell population in spleen and lymph nodes was strongly increased. In addition, 
serum levels of total IgG I were significantly increased. Therefore, we conclude that CD2-
GATA-3 mice have a CD4+ memOl)' T cell compartment with strong Th2 characteristics. Our 
ill vitro data (increased proliferation in Th2 cultures and decreased proliferation in Thl cul-
tures) support of this notion. 
Two alternative explanations must be considered (tigure 4). Firstly, GATA-3 might facil-
itate the differentiation process of dividing effector cells to memOlY cells. GATA-3 would 
then regulatc the cell-fate decision of activated CD4+ T cells, possibly by reducing activation-
induced cell death in favor of (Th2) memory cell formation. In this model, GATA-3 does not 
simply act as a survival factor supporting cell proliferation, because survival alone does not 
appear to be sufficient for memory cell formation, as was shown by the absence of increased 
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memOlY formation in BcI-2 transgenic mice (74). 
Alternatively, GATA-3 might be responsible for a higher level of cell division of acti-
vated T cells, leading to a higher number of Th2 effector cells. An increased survival and 
acquisition of a memory phenotype by these eft-ector cells could then be caused by the 
cytokines present in the local microenvironment in the CD2-GATA-3 transgenic mice. In the 
case of so-called homeostatic proliferation, sustained cell division of naIve T cells has been 
shown to be accompanied by a phenotypical and functional acquisition of a memOlY pheno-
type (75, 76). Other GATA family members have also been shown to induce proliferation at 
the expense of terminal difierentiation, and we have hypothesized this role for GATA-3 in 
early T cell development and SP T cell maturation in the thymus as well. 
7.9. CONCLUDlL'IG REMARKS AND FUTURE DIRECTIONS 
In conclusion, our data implicate GATA-3 in nearly all major fate decisions during T cell 
development (figure 5). The lack of even the earliest CD44+CD25- DN T cell precursor sub-
population in the absence of GATA-3 shows that this factor is essential for devclopment of 
the T cell lineage. It remains to be elucidated whether GATA-3 is essential for commitment 
of pluripotent precursors to the T cell lineage. Our fmdings in transgenic mice with enforced 
expression of GATA-3 under the control of the CD2 locus conlrol region implicate GATA-3 
in CD4 versus CDS lineage development, in Th2 versus Thl diflerentiation and in memory 
T cell development. The mechanism by which GATA-3 regulates cell fate decisions during T 
cell differentiation may be different between subsequent developmental stages. At the COI11-
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mitment to the T cell lineage and the induction of memory formation, GATA-3-ll1ediated reg-
ulation of cell fate decisions may well involve the induction of proliferation. How induction 
of proliferation would guide the difterential induction of one out of two potential cell fates 
remains to be elucidated. It is a possibility that the induction of proliferation is mechanistic 
in effecting a cell-fate decision. It has been observed, for instance, that the initiation of IL-4 
gene transcription in na'ive Th cells requires at least three cell divisions, whereas IFNy gene 
transcription can ah'eady be detected after one cell division (77). In this sense, the induction 
of proliferation could be favorable for thc induction of Th2 dilIerentiation. In addition, tbe 
induction ofGATA-3 during Th2 differentiation has also been correlated to changes in chro-
matin stmchlre at the Th2 cytokine locus (33), a process which is also strictly dependent on 
entry of cell cycle. The alternativc explanation would be, that the induction of ccllular pro-
Iifcration by GATA-3 is a parallel effect of GATA-3 activity and independent of GATA-3-
regulated cell f:1te decisions. The mechanism by which GATA-3 induces cell fate decisions 
might then involve the regulation of chromatin accessibility at relevant genetic loci. This has 
been shown to occur at the Th2 cytokine locus by the introduction ofGATA-3 into naiVc and 
Tbl-polarized CD4+ T cells. Also, in early T cell development, GATA-3 might act in this 
manner on TCR gene loci, regulating accessibility of these loci for RAG proteins. 
In case oftbe Thlffh2 fate decision, it has been shown that GATA-3 can support tbe dif-
ferentiation of one cell lineage while inhibiting the formation of the other (34). In this con-
text, GATA-3 parallels the transcription factor pax-5, which was recently shmvn to play an 
essential role in inducing B-lineage commitment by suppressing alternative lineage choices 
(78). Interestingly, pax-5 and GATA-3 have been implicated in respectively the B- and T-lym-
phocyte-specific transcription of Rag2 (79, 80). Rag expression is essential for somatic 
rearrangement of the antigen receptor genes, and induction of Rag expression might be the 
halhnark of commitment to B- and T-lymphocyte lineages. In this sense, GATA-3 might be 
the equivalent factor in determining T lymphocyte lineage commitment as pax-5 has been 
shown to be for B lymphocyte development (81, 82). A more detailed analysis of GATA-3 
target genes and an analysis of the effect of ectopic GATA-3 expression on commitment to 
other hematopoietic lineages are needed to substantiate this potential function of GATA-3 in 
the T cell lineage. In addition, generation of knockout mice with conditional or inducible 
mutations in the GATA-3 gene could be Vel)' informative to further study the role of 
GATA-3 in T cell differentiation. 
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SUMMARY 
T cell development is a tightly regulated process of cellular differentiation. The unique 
thymic microenvironment facilitates efticient development ofT cells in an ordered sequence. 
of aiternating differentiative and proliferative phases. Thymocytes which have successfully 
rearranged their TCRa and TCR(3 genes COll1ll1it to either the CD4 (helper T cell) or the CD8 
(cytotoxic T cell) lineage. Mature T cells exit the thymus and circulate as naiVe T cells in the 
periphery. Upon activation, naIve T cells will differentiate into one of the various effector 
phenotypes, such as the Th I, Th2 and Tr-I phenotypes, which are characterized by produc-
tion ofIFNy, ITA and IL-IO, respectively. Eventually, activated T cells differentiate into 
memOlY cells or enter apoptosis. 
This thesis is focussed around the question how cell fate decisions during differentiation 
ofT lymphocytes arc regulated. This issue is addressed using several approaches. Firstly, the 
presence and functional role of the transcription factor GATA-3 is analyzed throughout 
thymic and peripheral T cell differentiation. Secondly, the regulation of peripheral T cell dif-
ferentiation by cytokines and adapter proteins which act on the cytokine signaling pathway is 
studied. 
The transcription t:1ctor GATA-3 is essential for development of the T cell lineage and 
for T cell differentiation into the Th2 phenotype. We wanted to analyze the role of GATA-3 
in T cell differentiation in vivo. Targeted insertion of a IneZ reporter gene into the GATA-3 
locus allowed us to analyze GATA-3 gene transcription levels during T cell difierentiation in 
the mouse. These analyses revealed a modulated pattern with strict down-regulation at phas-
es of TCR gene rearrangement, insulated by proliferative phases in which GATA-3 transcrip-
tion was higher. In addition, GATA-3 gene expression was progressively downregulated dur-
ing CDS single positive maturation, \vhereas most CD4 cells maintained GATA-3 expression. 
In peripheral T cells, a significant proportion of CD4+ T cells expressed GATA-3, whereas 
GATA-3 expression was absent in CDS+ T cells. 
\Ve have also generated chimeric mice, by injecting IneZ-expressing emblyonic stem 
cells into wild-type blastocysts, and followed these cells during T cell development. In this 
ill vivo competition assay, GATA-3-dcficient cmbryonic stem cells did not contribute to even 
the earliest detectable progenitor stage of the T cell lineage, whereas GATA-3+1- ES cells did. 
Subsequently, we modified GATA-3 gene transcription levels troughout T cell differen-
tiation using transgenic mice, in which the GATA-3 gene was placed under transcriptional 
control of the CD2 locus control region. We observed no effect of the modified GATA-3 gene 
transcription levels in vivo on TCR{3 and TCRu gene realTangement. Neveliheless, enhanced 
levels of TCRa(3 membrane expression were observed after the initiation of positive selec-
tion. Maturation of CD8 single positive thymocytes was impaired and associated with a 
markedly increased induction of apoptosis. As a result, pcripheral CD8+ T cell numbers were 
strongly decreased in CD2-GATA-3 transgenic mice. 
Within 9 months, -50% of the CD2-GATA-3 animals developed thymic lymphomas, 
mainly of a CD4+CD8+ Iymphoblastoid phenotype. In each case, the lymphoma cells dis-
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played a single TCRf3 gene rearrangement, indicating that the oncogenic event had taken 
place in one T cell precursor. Metastases of these monoclonal lymphomas were observed in 
the spleen, lymph nodes, kidney and liver. 
In the CD2-GATA-3 transgenic mice, the numbers of peripheral CD4+ T cells were with-
in normal ranges, but an increased proportion of these cells was positive for the Th2-specif-
ic markcr T 1/ST2. Th I-mediated responses ill vivo were significantly reduced. Analysis of ill 
vitro Th I-polarized transgenic CD4+ T cells revealed a decreased IFNy production, an 
increased IL-5 production and an increased induction of apoptosis. III vitro Th2-polarized 
transgenic CD4+ T cells produced similar amounts ofIL-4 and increased amounts oflL-5 and 
IL-IO, when compared to wild-type CD4+ T cells. In addition, peripheral CD4+ T cells in 
CD2-GATA-3 transgenic animals displayed an increased size and function of the mel110lY 
subset. 
Taken together, these fIndings show that GATA-3 regulates several important cell-fate 
decisions during T cell differentiation. First of all, GATA-3 is indispensable for development 
of the T cell lineage from the earliest thymic progenitors onwards. During T cell difJerentia-
tion in the thymus, GATA-3 enhances the membrane expression of TCRaB. In addition, 
enforced expression of GATA-3 inhibits the maturation of CD8-committed T cclls. In the 
periphery, GATA-3 plays an impOJ1ant role in the negative regulation ofThl differentiation. 
The increase of the size and function ofthe memory compartment in CD2-GATA-3 transgenic 
mice implicate GATA-3 in the induction ofTh memory development. \Ve propose a model in 
which GATA-3 regulates T cell fate decisions at the CD4/CD8 and the Th I/Th2 commitment, 
as well as in memory cell development versus the induction of activation-induced cell death 
(AlCD). In this model, GATA-3 acts by positively regulating one differcntiation pathway 
(CD4, Th2 and memory development) whilst negatively regulating its alternative choice 
(CD8, Thl and AICD, respectively). 
In addition, we analyzed the regulation of peripheral T cell difierentiation by cytokine~ 
mediated signals. First we studied the regulation ofTh2 differentiation by cytokines in SJAl9 
mice. The SJAJ9 strain of mice has a T cell-intrinsic defect which results in low IgE respons-
es. We show that SJAl9 CD4+ T cells do not acquire an ILA-producing phenotype during ill 
vivo Th2 immune response,s. Instead, SJAI9 Th cells produce large quantities ofIL-IO when 
restinmlated in vitro, indicating a possible deviation of the SJAI9 Th cell difierentiation into 
a Tr-l phenotype. 111 vivo neutralization ofiL-IO did not rescue the IgE response. The defect 
in SJAl9 Th cells could not be attributed to a defect in IL-4-induced activation of Stat6. We 
therefore hypothesize that the Tb2 defect in SJA/9 mice is due to an altered transcriptional 
regulation of the IL-4 gene. 
Secondly, we studied the role of the saCS-3 adapter protein in the regulation ofTh cell 
differentiation. Members of the sacs family of adapter proteins have been implicated in the 
negative regulation of cytokine-mediated signal transduction, indicating a regulatory role for 
sacs family members in ThllTh2 differentiation. We analyzed the effect of SaCS-3 on T 
cell activation and diftcrentiation in Jurkat T cells. \Ve show, however, that SOCS-3 is 
involved in negative regulation of TCR-mediated activation of the transcription fhctor 
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NF-AT by a direct interaction with calcineurin. As SOCS-3 transcription is induced by 
TCR-mediated T cell activation, we conclude that SOCS-3 is involved in a classical negative 
feedback loop on T cell activation, with probably equal effects on Thl and Th2 cells. 
In SUllllllaty, our findings implicate GATA-3 as a key regulator of cell fate decisions dur-
ing T cell differentiation, by supporting commitment to the T cell lineage, diflcrentiation into 
CD4 T cells, Th2 cells and memory T cells. We also show, that the cell-fate decision in 
Thffh2 differentiation is not directly regulated by SOCS-3 or the genetic markers implicated 
in the Th cell intrinsic defect of SJAl9 mice. 
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SAMENVATTING VOOR LEKEN 
INLEIDING 
Het immuunsysteem is belangrijk voor de bescherming van ons lichaam tegen infecties 
door ziekteverwekkers zoals bacterien, virussen, sehimmels en parasieten. Delen van deze 
ziekteverwekkers, de zogellaall1de antigenen, worden herkend door de cellen vall het 
immuunsysteem. Het immuunsysteem wordt gevormd door vele verschillende SOOl'ten witte 
bloedcellen, die allemaal hun eigen functie hebben. T en B cellen hebben de unieke eigen-
schap dat ze op hun eeloppervlak receptoren hebben, die antigenen specifiek kunnen herken-
nell. Deze antigeen-receptoren kunnen signalen doorgeven l1aar het inwendige van de eel, 
met als gevolg, dat de cellen, die de juiste antigenen herkennen, gaan delen en uitrijpen tot 
effectorcellen. Geactiveerde killer T cellen kunnen virus-geinfeeteerde cellen doden. 
Geactiveerde helper T cellen kUllllen signaalstoffen (cytokines) maken die andere witte 
bloedcellen activeren en die B cellen helpen uit te rijpen. B cellen kUllllen uitrijpen tot plas-
mace lien, die antistofien maken die in het bloed klllmcn circuleren en het antigeen kunnen 
neutraliseren. 
T cell en ontwikkelen in een speciaal nabij het h8lt gelegen orgaan, de thymus, of weI de 
zwezerik. Tijdens de uitgroei ill de thymus maken de T cellen hun antigeenreceptor, de T cel-
receptor (TCR). Deze TCR mag geen antigenell herkennen die afkomstig zijn van de eigen 
lichaamscellell, want dan zouden deze T cellell een anveerreactie tegen het eigen lichaam 
kunnen aansturen. Daarom worden in de thymus die T cellen geselecteerd, die een TCR 
hebben die weI functionecl is, maar niet lichaamseigen antigenen herkent. Slechts een klein 
gedeclte van de T cellen die in de thymus uitgroeien worden uiteindelijk goed genoeg bevon-
den, en verlaten de thymus als rijpe T cellen. 
Infecties door verschillende soorten ziektekiemen worden door het afweersysteem met 
een verschillende reactie beantwoord. Er bestaan dan ook verschillende typen helper T cellen, 
die zorg dragen voor het aanshlren van deze verschillende soorten afweerreacties. Het meest 
bekend zijn de type-I helper T cellen (Thl) en de type-2 helper T cellen (Th2). Thl cellen 
zijn belangrijk voor de afweer tegen ziekteverwekkers die zich in cellen van het lichaam 
huisvesten. Th2 cellen zijn van belang voor de afweer tegen ziekteverwekkers die niet de 
lichaamscellen ingaan, maar zich tussen de cellen in de weefsels bevinden. Bij het eerste con-
tact met een ziekteverwekker zijn de helper T cellen nog niet uitgcrijpt tot een van de ver-
schillende typen. Het soort ziekteverwekker bepaalt de uitrijping van de helper T eel tot het 
juiste type. Het is van groot belang dat het lichaam tegen iedere infectie de juiste somi 
afweeneactie heef!. Het proces van uitrijping van naive helper T cellen tot Th I ofTh2 cellen 
noemen we helper T eel differentiatie. Een proces, waarbij een niet-gespecialiseerde eel zich 
ontwikkelt tot cen van meerderc mogelijke gespecialiseerde ceJtypen, noemen we in het algc-
meen differentiatie. Zo is de he Ie ontwikkeling van T cellen in de thymus en in het bloed een 
opeenvolging van fasen van cellulaire difierentiatie en fasen van celgroei. 
Cellen die differelltieren, verwerven hierbij nieuwe functies en nieuwe kenmerken, maar 
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ze verliezen ook bepaalde funk ties en kemnerkell. Een naive T eel is eell rustende eel, die 
maar weinig eytokines aamuaakt. Na differentiatie tot Th2 eel gaat deze eel eell bepaalde set 
van cytokines maken, die llodig zijn am zijn speeialistisehe funetie uit te voeren. Een Th I eel 
maakt een andere set eytokines, die voor zijn speeifieke funetie belangrijk zijn. 
De veranderingen, die gepaard gaan met differentia tie van eellen, zijn gebaseerd op het 
gebruik van eell nieuwe set genen. Een gen is een stukje erfelijk materiaal (DNA) waarap de 
informatie voor de aanlllaak van eell eiwit is geeodeerd. Het DNA van het gen wordt vertaald 
in RNA (transeriptie). Dit RNA wordt weer vertaald in het eiwit (translalie). In iedere eel is 
het DNA aanwezig voor aile menselijke eiwittell. Taeh heeft iedere eel sleehts een gedeelte 
van al deze eiwitten nadig. Daarom is er in de eel een strikte regulatie, welke genen mogen 
worden afgelezen en welke !liet. Deze regulatie van de transeriptie van genen wordt verzorgd 
door de transeriptiefaetoren. Dit zijn eiwitten, die bepaalde stukjes DNA herkennen en ervoor 
zorgen dat een gen wei of juist Iliet wordt vertaald in RNA en eiwit. Op deze manier reguleren 
transcriptiefactoren de differentiatie van een eel: in aanwezigheid van bepaalde transcrip-
liefaetoren ontwikkelt de naive helper T eel zieh tot Th I eel, te"vijl in de aanwezigheid van 
andere transcriptiefaetoren de naive T eel zich tot Th2 eel onhvikkelt. 
Het onderzoek dat in dit proefsehrift wordt besehreven geeft meer duidelijkheid over de 
manier waarop de T eel differentiatie wordt gereguleerd. Hiertoc is er onderzoek gedaan naar 
de rol van de transeriptiefaetor GATA-3 in de T eel ontwikkeling. Bovendien is de rol van 
cytokines ondcrzocht in de regulatie van de diflerentiatie van naive helper T eellen. Tenslotte 
is er gekeken l1aa1' de rol van het eiwit SOCS-3 in helper T eel activatie en differentiatie. 
SOCS-eiwittell dempcn de reaetie van eellen op cytokines. 
SAMENVATTING VAN RET ONDERZOEK 
Dc transeriptiefactor GATA-3 is essentieel voor de ontwikkeling van T eellen in de thy-
mus en voor de differentiatie van naive helper T (Th) cellen in Th2 cellen. T eel ontwikkel-
ing is te onderseheiden in versehillende stadia op basis van de aanwezigheid van bepaaJde 
eiwitten op het eeloppervlak. Zo begint de ontwikkelende T eel als CD4 en CD8 dubbel-
negatief, en wordt vervolgens dubbel-positief. Op dit stadium difierentieeli de T eel tot CD4 
eukel positieve helper T eel, of tot CD8 enkel positive killer T eel. Rijpe Th cellen in het 
bloed differentieren na aetivatie tot Thl ofTh2 effector eel. Tenslotte differentieert de geac-
tivccrde T eel zich tot geheugen eel ofsterft in een proees dat activatie-gefudueeerde eeldood 
heet. 
In de bcsehreven shldie is onderzocht in welke fase van de T eel ontwikkeling de tran-
scriptiefactor GATA-3 nn precies van belang is. Hiertoe is de transeripie van het GATA-3 gen, 
dat codeeli vaor het GATA-3 eiwit, bestudeerd tijdens de T eel ontwikkeling. Hierbij bleek 
dat de transcriptie van het CATA-3 gen sterk wissel de tussen de versehillende fases van de T 
eel ontwikkeling. In fa sen waarin de cellen rustend waren, werd er weinig GATA-3 gen-tran-
scriptic gemeten, terwijl in fasen van eeldeling er veel GATA-3 gen-transeriptie plaatsvondt. 
am te bcstuderen voor welke fase van de vroege T eel ontwikkeling GATA-3 essentieel 
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is, werden GATA-3-deficiente embryonale stamcellen vergeleken met embtyonlac stam-
cellen die wei GATA-3 hadden. Hierbij bleck, dat GATA-3-deficiente embryonale stamcel-
lencellen in het geheel niet bijdroegen tot de T cel ontwikkeling vanafhet vroegst detecteer-
bare ontwikkelingsstadium in de thymus. 
Om het belang van de sterk wisselende niveau's van GATA-3 gen-transcriptie tijdcns de 
T cel ontwikkeling te bestuderen, werden trasngene l11uizen gemaakt. De eellen van dcze 
transgcne muizen bevatten een extra DNA-fragment met daarop het GATA-3 gen, waarvall de 
transcriptie op een andere manier gereguleerd wordt dan die van het eigen GATA-3 gen. 
Hierdoor was de GAIA-3 gentranscriptie gedurende de hele T celontwikkeling op een hoog 
niveau. Deze geforceerde GATA-3 gen-expressie had tot gevolg, dat in dubbel-positieve T 
eellen meer TCR op de eeimembraan werd gedeteeteerd. Bovendien was de uitrijping van 
CDS enkel-positieve eellen in de thymus ernstig versoord in de GATA-3 transgene muizen. 
Ongeveer de helft van de GATA-3 transgene muizen ontwikkelde cell T eel tUIllor (Iymfoom) 
billnen 9 maanden na de geboorte. lvletastasen van de lymfomen werden in de milt, de Iym-
feklieren, de lever en de nieren aangetroffen. De observatie, dat het manipuleren van de 
niveau's van GATA-3 gen-transcriptie, kan leiden tot het ontstaan T eel hllnoren, is zeer inte-
ressant cn behocft nader ondel'zock. 
Aangezien GATA-3 ook van groot belallg is voor de uitrijping van naive helper T cellen 
tot Th2 cell en, is het effect van de gemanipuleerde GATA-3 gentranscriptie op helper T cel 
differentiatie bestudeerd. Hierbij blijkt de geforceerde expressie van GATA-3 de Thl-
at1tankelijke afweerreacties te rell1lllen. Analyse van gezuiverde Th cellen toonde aan, dat 
deze cellen veel van de Th2 cytokines IL-5 en IL-l 0 maakten, maar slechts weillig van het 
Thl cytoldne IFNy. Ook werd aangetoond dat het aantal geheugen T cellen in de GATA-3 
transgene dieren was vcrhoogd. 
Amcnvattend tonen we aan, dat GATA-3 betrokken is bij eell aalltal belangrijke ontwik-
kelingsstadia van de T eel. Ten eerste is GATA-3 csscnticel voor de ontwikkeling van T cell en 
vanafhet vroegste stadium in de thymus. Vervolgens reguleert GATA-3 de CD4/CD8 ontwik-
keling door de mahuatie van CD8enkel-positieve T cell en te vcnnindcren. In rijpe Th cellen 
is GATA-3 van belang voor de Thl/Th2 differentiatie en tenslotte reguleeli GATA-3 ontwik-
keling van geheugen T cellen. In ons model reguleeli GATA-3 deze beslissingen in de T eel 
differentia tie door de induetie van de ene differentiatie-keuze (CD4ffh2/memory) en de 
inhibitie van de andere difterentiatie-keuze (CD8/Thllceldood). 
Daarnaast is er ook onderzock verricht naar de regulatie van helper T eel differentiatie 
door cytokine-gemedieerde signalen. Allereerst is de Th eel difterentiatie in de SJAl9 muis 
onderzocht. Deze muis heeft cell defect in de T eel populatie, dat leidt tot cell sterk vermin-
derde IgE respons, welke normal iter Th2 afhankelijk is. In de beschreven experimenten 
wordt aangetoond dat de Tb cellen van de SIAl9 muis tUdens een immuunrespons nauwelijks 
IL-4 aanmaken. Nadere analyse toont echter aan, dat SJAl9 Th cellen op kunstmatige wijze 
wei tot IL-4 productic kunnen worden aangezet. Na een afweerreaetie maken de SJA/9 Th 
cellen wei grate hoeveelheden van het cytokine lL-1 O. Neutralizatie van dit IL-IO tijdens de 
afweerreactie leidt echter niet tot herstel van de IgE respons. SJA/9 Th cellen hebben dus een 
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verstoorde IL-4 productie tijdens de afweeneactie. 
Tensiotte is er onderzoek gcdaan naar de rol van SOCS-3 in de Th eel aetivatie en dif-
ferentiatie. SOCS-eiwitten kunnen cytokinc-signalcn sterk dell1pen, en spelen dam·door 
mogelijk een ral by ThllTh2 differentiatie. Na Th eel activatie wordt SOCS-3 gen-transcrip-
tie geinduceerd. De rol van SOCS-3 in T eel activatie is daarom geanalysccrd door T eellen 
kunstmatig extra SOCS-3 eiwit te geven. Dil SOCS-3 verhindeli de inductie van cytokine 
gen-transeriptie na TCR-afhankelijke T eel aetivatie. Er is dus geen rol aangetoond voor 
SOCS-3 in de Thlffh2 differentiatie. Daarentegen lijkt SOCS3 een negatieve temgkoppel-
ing te geven op T eel activatie via de TCR. 
Samenvattend heef! het onderzoek aangetoond dat OATA-3 een ral speelt in het nemen 
van belangrijke differentiatie-beslissingen tijdens de T eel ontwikkeling. Dit doet OATA-3 
door de ontwikkeling in de ene richting te vergemakkelijken (CD4 enkel-positieve T eel, Th2 
eel, geheugen T eel), terwijl de ontwikkeling in de andere richting wordt bemoeilijkt (CD8 
enkel-positieve T eel, Thl eel, eeldood). Daarnaast is aangctoond dat een dergelijke reg-
ulerende ral niet wordt uilgevoerd door het SOCS-3 eiwit of door de genetische factoren die 
het defect van de SJAl9 Th cellen veroorzaken. 
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ABBREVIATIONS 
Ag 
AICD 
APC 
BCR 
CIS 
CpG 
DN 
DP 
ds 
DTH 
ELISA 
EPO 
ES 
FDG 
FISH 
FITC 
FSC 
FTOC 
yc 
GAS 
GEF 
GM-CSF 
HLH 
HMG 
HSA 
IFN 
Ig 
IL 
IL-4R 
IRS 
!TAM 
JAB 
Jak 
KLH 
LAT 
LCR 
LEF 
LT 
mAb 
antigen 
activation-induced cell death 
antigen-presenting cell(s) 
B ceIl receptor 
cytokine-induced SH-2-containing (protein) 
cytosine-guanine (dinucleotides) 
double negative 
double positive 
double-stranded 
delayed-type hypersensitivity 
enzyme-linked imlllullosorbent assay 
elythropoietill 
embryonic stem (ceIl) 
fl ou re see in -d i -13 -D-ga lactopyranosi de 
fluorescence in situ hybridization 
fluoresceine isothiocyanaat 
forward scatter 
fetal thymic organ culture 
C01lllllon gamma chain 
IFNy-activated sequence 
guanosine exchange factor 
granulocyte/macrophage colony stimulating factor 
helix-loop-helix 
high mobility group 
heat-stable antigen 
interferon 
immunoglobulin 
interleukin 
interleukin-4 receptor 
insulin-receptor substrate 
immullorcceptor tyrosine-based activation motif 
Jak-binding protein 
Janus kinase 
Keyhole Limpet hematocyanin 
linker for activation of T celIs 
loclls control region 
lymphoid cnhacer factor 
Iymphotoxin 
monoclonal antibody 
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MAP mitogen-activated protein 
MARE c-Mafrespollsive element 
MHC major histocompatibility antigens 
NF-AT nuclear i:1ctor of activated T cells 
NK natural killer 
nls nuclear localization signal 
PBS phosphate-buffered saline 
PE phyco-erythrine 
PGP-I phagocyte glyeoprotein-l 
PI,-K phosphat idyl-inositol 3-kinase 
PIP3 phosphatidyl-inositol 3 ,4,5-tri-phosphate 
PKC protein-kinase C 
PLC-yl phospholipase C-y I 
PSGL-I P-selectin glycoprotein ligand-l 
PTB phosphotyrosine binding 
PTK phosphotyrosine kinase 
PTP phosphotyrosine phosphatase 
Rag recombination-activating genes 
RDA representational difference analysis 
RE responsive element 
RE responsive element 
RIBP Rlk- and Itk-interacting protein 
RSS recombination signal sequence 
SH-2 Src-homology-2 
SHIP SH-2 containing inositol-5 phosphatase 
SHP SH-2 containing phosphatase 
sacs suppressor of cytokine signaling 
SP single positive 
SSC sideward scatter 
SSI Stat-induced Stat-inhibitor 
Stat signal transducer and activator of transcription 
T-bet T-box expressed in T cells 
TCF T cell factor 
TCR T cell receptor 
TGF transforming growth factor 
Th helper T (cell) 
Thll2 type-112 helper T (cell) 
TLP thymic lymphoid precursor 
TNF tumor necrosis factor 
TNP tri-nitro phenol 
Tr-l regulatory T cell-I 
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